UNITED STATES SECURITIES AND EXCHANGE COMMISSION
FORM 10-K
(Mark One)
|
|
|
þ
|
|
Annual report pursuant to Section 13 or 15(
d
) of
the securities exchange act of 1934
|
|
|
|
For the fiscal year ended
December 31, 2008
|
|
o
|
|
Transition report pursuant to section 13 or 15(
d
)
of the securities exchange act of 1934
|
Commission File Number 001-31225
ENPRO INDUSTRIES, INC.
(Exact name of registrant, as specified in its charter)
|
|
|
North Carolina
|
|
01-0573945
|
(State or other jurisdiction of incorporation)
|
|
(I.R.S. employer identification no.)
|
|
|
|
5605 Carnegie Boulevard, Suite 500,
|
|
28209
|
Charlotte, North Carolina
|
|
(Zip code)
|
(Address of principal executive offices)
|
|
|
(704) 731-1500
(Registrants telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Name of each exchange
|
Title of each class
|
|
on which registered
|
|
|
|
|
|
|
Common stock, $0.01 par value
Preferred stock purchase rights
|
|
New York Stock Exchange
New York Stock Exchange
|
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of
the Securities Act.
Yes
o
No
þ
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or
Section 15(d) of the Act.
Yes
o
No
þ
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
Yes
þ
No
o
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is
not contained herein, and will not be contained, to the best of the registrants knowledge, in
definitive proxy or information statements incorporated by reference in Part III of this Form 10-K
or any amendment to this Form 10-K.
þ
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer,
a non-accelerated filer, or a smaller reporting company.
See the definitions of large
accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer
þ
|
|
Accelerated filer
o
|
|
Non-accelerated filer
o
(Do not check if a smaller reporting company)
|
|
Smaller Reporting Company
o
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act).
Yes
o
No
þ
The aggregate market value of voting and nonvoting common stock of the registrant held by
non-affiliates of the registrant as of June 30, 2008 was $729,959,137. As of February 20, 2009,
there were 19,816,149 shares of common stock of the registrant outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the registrants definitive proxy statement for the 2009 annual meeting of shareholders
are incorporated by reference into Part III.
ENPRO INDUSTRIES, INC.
PART I
ITEM 1. BUSINESS
As used in this report, the terms we, us, our, EnPro and Company mean EnPro
Industries, Inc. and its subsidiaries (unless the context indicates another meaning). The term
common stock means the common stock of EnPro Industries, Inc., par value $0.01 per share. The
terms convertible debentures and debentures mean the 3.9375% Convertible Senior Debentures due
2015 issued by the Company in October 2005.
Background
We were incorporated under the laws of the State of North Carolina on January 11, 2002, as a
wholly owned subsidiary of Goodrich Corporation (Goodrich) in anticipation of Goodrichs
announced distribution of its Engineered Industrial Products segment to existing Goodrich
shareholders, which took place on May 31, 2002 (the Distribution). We are a leader in the
design, development, manufacturing, and marketing of proprietary engineered industrial products.
We have 43 primary manufacturing facilities located in the United States and 10 other countries.
Our sales by geographic region in 2008, 2007 and 2006 were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(in millions)
|
|
United States
|
|
$
|
610.6
|
|
|
$
|
565.7
|
|
|
$
|
543.0
|
|
Europe
|
|
|
329.7
|
|
|
|
277.8
|
|
|
|
222.8
|
|
Other
|
|
|
227.5
|
|
|
|
186.5
|
|
|
|
162.6
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
1,167.8
|
|
|
$
|
1,030.0
|
|
|
$
|
928.4
|
|
|
|
|
|
|
|
|
|
|
|
We maintain an Internet website at www.enproindustries.com. We will make this annual report,
in addition to our other annual reports on Form 10-K, quarterly reports on Form 10-Q, current
reports on Form 8-K and amendments to these reports, available free of charge on our website as
soon as reasonably practicable after we electronically file such material with, or furnish it to,
the Securities and Exchange Commission. Our Corporate Governance Guidelines and the charters for
each of our Board Committees (Audit and Risk Management, Compensation and Human Resources,
Executive, and Nominating and Corporate Governance committees) are also available on our website,
and copies of this information are available in print to any shareholder who requests it.
Information included on or linked to our website is not incorporated by reference into this annual
report.
Operations
We manage our business as three segments: a sealing products segment, which includes our
sealing products, heavy-duty wheel end components, polytetrafluoroethylene (PTFE) products, and
rubber products; an engineered products segment, which includes our bearings, rotary and
reciprocating air compressors, vacuum pumps, air systems and reciprocating compressor components;
and an engine products and services segment, which manufactures heavy-duty, medium-speed diesel,
natural gas and dual fuel reciprocating engines. For financial information with respect to our
business segments, see Item 7, Managements Discussion and Analysis of Financial Condition and
Results of Operations Results of Operations, and Note 16 to our Consolidated Financial
Statements. Item 7 and Note 16 contain
1
information about sales and profits for each segment, and Note 16 contains information about
each segments assets.
Sealing Products Segment
Overview
. Our Sealing Products segment designs, manufactures and sells sealing
products, including metallic, non-metallic and composite material gaskets, rotary seals,
compression packing, resilient metal seals, elastomeric seals, hydraulic components and expansion
joints, as well as wheel-end components and component systems, PTFE products, conveyor belting and
sheeted rubber products. These products are used in a variety of industries, including chemical
and petrochemical processing, petroleum extraction and refining, pulp and paper processing,
heavy-duty trucking, power generation, food and pharmaceutical processing, primary metal
manufacturing, mining, water and waste treatment, aerospace, medical, filtration and semiconductor
fabrication. In many of these industries, performance and durability are vital for safety and
environmental protection. Many of our products are used in applications that are highly demanding,
e.g., where extreme temperatures, extreme pressures, corrosive environments and/or worn equipment
make sealing difficult.
Products
. Our Sealing Products segment includes the product lines described below,
which are designed, manufactured and sold by our Garlock Sealing Technologies, Stemco, Plastomer
Technologies and Garlock Rubber Technologies operations.
Gasket products are used for sealing flange joints in chemical, petrochemical and pulp and
paper processing facilities where high pressures, high temperatures and corrosive chemicals create
the need for specialized and highly engineered sealing products. We sell these gasket products
under the Garlock
®
,
Gylon
®
,
Blue-Gard
®
,
Stress-Saver
®
,
Edge
®
, Graphonic
®
and Flexseal
®
brand names.
These products have a long-standing reputation within the industries we serve for performance and
reliability.
Rotary seals are used in rotating applications to contain the lubricants that protect the
bearings from excessive friction and heat generation. Because these sealing products are utilized
in dynamic applications, they are subject to wear. Durability, performance, and reliability are,
therefore, critical requirements of our customers. These rotary seals are used in demanding
applications in the steel industry, mining and pulp and paper processing under well-known brand
names including Klozure
®
and Model 64
®
.
Compression packing is used to provide sealing in pressurized, static and dynamic applications
such as pumps and valves. Major markets for compression packing products are the pulp and paper,
mining, petrochemical and hydrocarbon processing industries. Branded products for these markets
include EVSP, Synthepak
®
and Graph-lock
®
.
Resilient metal seals provide extremely tight sealing performance for highly demanding
applications such as nuclear power generation, semiconductor fabrication facilities, specific
chemical processing applications and race car engines. Branded products for these markets include
Helicoflex
®
and Ultraflex
®
.
Critical service flange gaskets, seals and electrical flange isolation kits are used in
high-pressure wellhead equipment, flow lines, water injection lines, sour hydrocarbon process
applications and crude oil and natural gas pipeline/transmission line applications. These products
are sold under the brand names Pikotek
®
, VCS, Flowlok and PGE.
Stemco manufactures a variety of high performance wheel-end, steering and suspension
components used by the heavy-duty trucking industry to improve the performance and longevity of
commercial tractors and trailers. Products for this market include hub oil seals, axle fasteners,
hub caps,
2
wheel bearings, mileage counters, king pin kits and suspension kits. We sell these sealing
products under the Stemco
®
, Stemco Kaiser
®
, Grit Guard
®
, Guardian
®
, Guardian HP
®
, Voyager
®
,
Discover
®
, Pro-Torq
®
, Sentinel
®
, DataTrac
®
, Qwikkit, Pluskit and Econokit brand names. We also
sell products under our RFID sensor-based BAT RF
®
product line.
Plastomer Technologies manufactures PTFE specialty tape, formed PTFE products, and PTFE sheets
and shapes. These PTFE products provide highly specialized and engineered solutions to our
customers in the aircraft, fluid handling and semiconductor industries, and are sold under the
Plastolon
®
, Texolon and Amicon brand names.
Garlock Rubber Technologies manufactures rubber bearing pads, conveyor belts and other rubber
products for industrial applications under the DuraKing
®
, FlexKing
®
, Viblon, Techflex and
HeatKing brand names.
Customers
. Our Sealing Products segment sells products to industrial agents and
distributors, original equipment manufacturers (OEMs), engineering and construction firms and end
users worldwide. Sealing products are offered to global customers, with approximately 43% of sales
delivered to customers outside the United States in 2008. Representative customers include Saudi
Aramco, Motion Industries, Applied Industrial Technologies, Electricite de France, AREVA, Bayer,
BASF Corporation, General Electric Company, Georgia-Pacific Corporation, Eastman Chemical Company,
Exxon Mobil Corporation, Minara Resources, Queensland Alumina, AK Steel Corporation, Volvo
Corporation, Utility Trailer, Great Dane, Mack Trucks, International Truck, PACCAR and Applied
Materials. In 2008, no single customer accounted for more than 2% of segment revenues.
Competition
. Competition in the sealing markets in which we operate is based on
proven product performance and reliability, as well as price, customer service, application
expertise, delivery terms, breadth of product offering, reputation for quality and the availability
of product. Our leading brand names, including Garlock
®
and Stemco
®
, have been built upon
long-standing reputations for reliability and durability. In addition, the breadth, performance
and quality of our product offerings allow us to achieve premium pricing and have made us a
preferred supplier among our agents and distributors. We believe that our record of product
performance in the major markets in which this segment operates is a significant competitive
advantage for us. Major competitors include A.W. Chesterton Company, Klinger Group, Teadit,
Lamons, SIEM/Flexitallic, SKF USA Inc., Freudenberg-NOK, Federal-Mogul Corporation and
Saint-Gobain.
Raw Materials and Components
. Our Sealing Products segment uses PTFE resins, aramid
fibers, specialty elastomers, elastomeric compounds, graphite and carbon, common and exotic metals,
cold-rolled steel, leather, aluminum die castings, nitrile rubber, powdered metal components, and
various fibers and resins. We believe that all of these raw materials and components are readily
available from various suppliers.
Engineered Products Segment
Overview
. Our Engineered Products segment includes operations that design,
manufacture and sell self-lubricating, non-rolling bearing products, aluminum blocks for hydraulic
applications, rotary and reciprocating air compressors, vacuum pumps, air systems and compressor
components.
Products
. Our Engineered Products segment includes the product lines described below,
which are designed, manufactured and sold by GGB, Quincy Compressor and Compressor Products
International.
3
GGB produces self-lubricating, non-rolling, metal polymer, solid polymer and filament wound
bearing products. The metal-backed or epoxy-backed bearing surfaces are made of PTFE or a mixture
that includes PTFE to provide maintenance-free performance and reduced friction. These products
typically perform as sleeve bearings or thrust washers under conditions of no lubrication, minimal
lubrication or pre-lubrication. These products are used in a wide variety of markets such as the
automotive, pump and compressor, construction, power generation and machine tool markets. We have
over 20,000 bearing part numbers of different designs and physical dimensions. GGB is a leading
and well recognized brand name in this product area.
Quincy Compressor
®
designs and manufactures rotary screw and reciprocating air compressors and
vacuum pumps, ranging from one-third to 500 horsepower, used in a wide range of industrial
applications, including the pharmaceutical, pulp and paper, gas transmission, health, construction,
petrochemical and automotive industries. Quincy
®
also sells a comprehensive line of dryers,
filters and air treatment products. In addition, Quincy performs comprehensive compressed air
system audits under the Air Science Engineering brand name and manufactures a complete line of
pneumatic and hydraulic cylinders under the Ortman brand name.
Compressor Products International designs, manufactures and services components for
reciprocating compressors and engines. These components (packing and wiper assemblies and rings,
piston and rider rings, compressor valve assemblies and components) are primarily utilized in the
refining, petrochemical, natural gas gathering, storage and transmission, and general industrial
markets. Brand names for our products include Hi-Flo, Valvealert, Mentor, Triple Circle, CPI
Special Polymer Alloys, Twin Ring and Liard. Compressor Products International also designs and
manufactures the Gar-Seal
®
family of PTFE lined butterfly valves.
Customers
. Our Engineered Products segment sells its products to a diverse customer
base using a combination of direct sales and independent distribution networks. GGB has customers
worldwide in all major industrial sectors, and supplies products both directly to customers through
their own local distribution system and indirectly to the market through independent agents and
distributors with their own local network. Quincy Compressor products are sold through a global
network of independent agents and distributors. Quincy Compressor also sells directly to national
accounts, OEMs and climate control houses. Compressor Products International sells its products
globally through a network of company salespersons, independent sales representatives and
distributors. In 2008, no single customer accounted for more than 3% of segment revenues.
Competition
. GGB has a number of competitors, including Kolbenschmidt Pierburg AG,
Norton Company and Federal-Mogul Corporation. In the markets in which GGB competes, competition is
based primarily on performance of the product for specific applications, product reliability,
delivery and price. Quincy Compressors major competitors include Gardner Denver, Inc., Sullair
Corporation, Ingersoll-Rand Company, Atlas Copco North America Inc. and Kaeser Compressors, Inc.
In the markets in which Quincy Compressor competes, competition generally is based on reliability,
quality, delivery times, energy efficiency, service and price. Compressor Products International
competes against other component manufacturers, such as Cook Compression, Hoerbiger Corporation,
OEMs and numerous smaller component manufacturers worldwide. Price, availability, product quality,
engineering support and reliability are the primary competitive drivers in the markets served by
Compressor Products International.
Raw Materials and Components
. GGBs major raw material purchases include steel coil,
bronze powder and PTFE. GGB sources components from a number of external suppliers. Quincy
Compressors primary raw materials are iron castings. Components used by Quincy Compressor are
motors, coolers and accessories such as air dryers, filters and electronic controls. Compressor
Products Internationals major raw material purchases include PTFE, PEEK (Polyetheretherketone),
compound additives, cast
4
iron, bronze, steel and stainless steel bar stock. We believe that all of these raw materials
and components are readily available from various suppliers.
Engine Products and Services Segment
Overview
. Our Engine Products and Services segment designs, manufactures, sells and
services heavy-duty, medium-speed diesel, natural gas and dual fuel reciprocating engines. We
market our products and services under the Fairbanks Morse Engine brand name.
Products
. Our Engine Products and Services segment manufactures licensed heavy-duty,
medium-speed diesel, natural gas and dual fuel reciprocating engines, in addition to its own
designs. The reciprocating engines range in size from 700 to 31,970 horsepower and from five to 20
cylinders. The government and the general industrial market for marine propulsion, power
generation, and pump and compressor applications use these products. We have been building engines
for over 115 years under the Fairbanks Morse Engine brand name and we have a large installed base
of engines for which we supply aftermarket parts and service. Additionally, we have been the U.S.
Navys supplier of choice for medium-speed diesel engines and have supplied engines to the U.S.
Navy for over 70 years.
Customers
. Our Engine Products and Services segment sells its products to customers
worldwide, including major shipyards, municipal utilities, institutional and industrial
organizations, sewage treatment plants, nuclear power plants and offshore oil and gas platforms.
We market our products through a direct sales force of engineers in North America and through
independent agents worldwide. Our representative customers include Northrop Grumman, General
Dynamics, Lockheed Martin, the U.S. Navy, the U.S. Coast Guard and Exelon. In 2008, the largest
customer accounted for approximately 25% of segment revenues.
Competition
. Major competitors for our Engine Products and Services segment include
MTU, Caterpillar Inc. and Wartsila Corporation. Price, delivery time, engineering and service
support, and engine efficiency relating to fuel consumption and emissions drive competition.
Raw Materials and Components
. Our Engine Products and Services segment purchases
multiple ferrous and non-ferrous castings, forgings, plate stock and bar stock for fabrication and
machining into engines. In addition, we buy a considerable amount of precision-machined engine
components. We believe that all of these raw materials and components are readily available from
various suppliers.
Research and Development
We refer to our research and development efforts as our EnNovation program. The goal of the
program is to strengthen our product portfolios for traditional markets while simultaneously
creating distinctive and breakthrough products. EnNovation incorporates a process to move
product innovations from concept to commercialization, and to identify, analyze, develop and
implement new product concepts and opportunities aimed at business growth.
We employ scientists, engineers and technicians throughout our operations to develop, design
and test new and improved products. We work closely with our customers to identify issues and
develop technical solutions. The majority of our research and development expenditures are
directed toward the development of new sealing products for hostile environments, the development
of truck and trailer fleet information systems, the development of bearing products and materials
with increased load carrying capability and superior friction and wear characteristics, and the
extension of our air compressor product line. Prior to introduction, new products are subject to
extensive testing at our various facilities and at beta test sites in conjunction with our
customers.
5
Backlog
At December 31, 2008, we had a backlog of orders valued at $259.4 million compared with $268.6
million at December 31, 2007. Approximately 62% of the backlog, mainly at Fairbanks Morse Engine,
is expected to be filled beyond 2009. Backlog represents orders on hand that we believe to be
firm. However, there is no certainty that the backlog orders will in fact result in actual sales
at the times or in the amounts ordered. In addition, for most of our business, backlog is not
particularly predictive of future performance because of our short lead times and some seasonality.
Quality Assurance
We believe that product quality is among the most important factors in developing and
maintaining strong, long-term relationships with our customers. In order to meet the exacting
requirements of our customers, we maintain stringent standards of quality control. We routinely
employ in-process inspection by using testing equipment as a process aid during all stages of
development, design and production to ensure product quality and reliability. These include
state-of-the-art CAD/CAM equipment, statistical process control systems, laser tracking devices,
failure mode and effect analysis and coordinate measuring machines. We are also able to extract
numerical quality control data as a statistical measurement of the quality of the parts being
manufactured from our CNC machinery. In addition, we perform quality control tests on parts that
we outsource. As a result, we are able to significantly reduce the number of defective parts and
therefore improve efficiency, quality and reliability.
As of December 31, 2008, 31 of our manufacturing facilities were ISO 9000, QS 9000 and/or TS
16949 certified with the remaining facilities working towards obtaining ISO and/or TS
certification. Twelve of our facilities are ISO 14001 certified. OEMs are increasingly requiring
these standards in lieu of individual certification procedures and as a condition of awarding
business.
Patents, Trademarks and Other Intellectual Property
We maintain a number of patents and trademarks issued by the U.S. and other countries relating
to the name and design of our products and have granted licenses to some of these trademarks and
patents. We routinely evaluate the need to protect new and existing products through the patent
and trademark systems in the U.S. and other countries. We also have proprietary information,
consisting of know-how and trade secrets relating to the design, manufacture and operation of our
products and their use that is not patented. We do not consider our business as a whole to be
materially dependent upon any particular patent, patent right, trademark, trade secret or license.
In general, we are the owner of the rights to the products that we manufacture and sell.
However, we also license patented and other proprietary technology and processes from various
companies and individuals in order to broaden our product offerings. We are dependent on the
ability of these third parties to diligently protect their intellectual property rights. In
several cases, the intellectual property licenses are integral to the manufacture of our products.
For example, Fairbanks Morse Engine licenses technology from MAN Diesel for the four-stroke
reciprocating engine, and Quincy Compressor licenses from Svenska Rotor Maskiner AB its rotary
screw compressor design and technology. A loss of these licenses or a failure on the part of the
third party to protect its own intellectual property could reduce our revenues. Although these
licenses are all long-term and subject to renewal, it is possible that we may not successfully
renegotiate these licenses or that they could be terminated for a material breach. If this were to
occur, our business, financial condition, results of operations and cash flows could be adversely
affected.
6
Employees and Labor Relations
We currently have approximately 5,100 employees worldwide. Approximately 2,800 employees are
located within the U.S. and approximately 2,300 employees are located outside the U.S., primarily
in Europe, Canada and Mexico. Approximately 30% of our U.S. employees are members of trade unions
covered by collective bargaining agreements. Union agreements relate, among other things, to
wages, hours and conditions of employment. The wages and benefits furnished are generally
comparable to industry and area practices.
We have collective bargaining agreements in place at four of our U.S. facilities. The hourly
employees who are unionized are covered by collective bargaining agreements with a number of labor
unions and with varying contract termination dates ranging from
November 2010 to June 2012. In
addition, some of our employees located outside the U.S. are subject to national collective
bargaining agreements.
ITEM 1A. RISK FACTORS
In addition to the risks stated elsewhere in this annual report, set forth below are certain
risk factors that we believe are material. If any of these risks occur, our business, financial
condition, results of operations, cash flows and reputation could be harmed. You should also
consider these risk factors when you read forward-looking statements elsewhere in this report.
You can identify forward-looking statements by terms such as may, hope, will, should,
expect, plan, anticipate, intend, believe, estimate, predict, or continue, the
negative of those terms or other comparable terms. Those forward-looking statements are only
predictions and can be adversely affected if any of these risks occur.
Risks Related to Our Business
Certain of our subsidiaries are defendants in asbestos litigation.
The historical business operations of certain subsidiaries of our subsidiary, Coltec
Industries Inc (Coltec), principally Garlock Sealing Technologies LLC and The Anchor Packing
Company (Anchor), have resulted in a substantial volume of asbestos litigation in which
plaintiffs have alleged personal injury or death as a result of exposure to asbestos fibers. Those
subsidiaries manufactured and/or sold industrial sealing products, predominately gaskets and
packing products, that contained encapsulated asbestos fibers. Anchor is an inactive and insolvent
indirect subsidiary of Coltec. There is no remaining insurance coverage available to Anchor and it
has no assets. Our subsidiaries exposure to asbestos litigation and their relationships with
insurance carriers are actively managed through another Coltec subsidiary, Garrison Litigation
Management Group, Ltd. Several risks and uncertainties may result in potential liabilities to us
in the future that could have a material adverse effect on our business, financial condition,
results of operations and cash flows. Those risks and uncertainties include the following:
|
|
|
the potential for a large number of future asbestos claims that are not covered by
insurance because insurance coverage is, or will be, depleted;
|
|
|
|
|
the uncertainty of the number and per claim value of pending and potential future
asbestos claims;
|
|
|
|
|
the results of litigation and the success of our litigation and settlement
strategies;
|
7
|
|
|
the potential for large adverse judgments against us not covered by insurance and
any surety/appeal bonds (and related cash collateral) required in connection with
appeals;
|
|
|
|
|
an increase in litigation costs, fees and expenses that are not covered by
insurance;
|
|
|
|
|
the financial viability of our subsidiaries insurance carriers and their
reinsurance carriers, and our subsidiaries ability to collect on claims from them;
|
|
|
|
|
the timing of claims, payments and insurance recoveries, and limitations imposed on
the amount that may be recovered from insurance in any year;
|
|
|
|
|
the unavailability of any insurance for claims alleging first exposure to asbestos
after July 1, 1984;
|
|
|
|
|
the potential for asbestos exposure to extend beyond specific Coltec subsidiaries
arising from corporate veil piercing efforts or other claims by asbestos plaintiffs;
|
|
|
|
|
bankruptcies of other defendants; and
|
|
|
|
|
the prospect for and impact of any federal legislation providing national asbestos
litigation reform.
|
When settlement payments exceed insurance recoveries from our subsidiaries carriers, our
subsidiaries will be required to fund these obligations from available cash. This could adversely
affect our ability to use cash for other purposes, including growth of our business, and adversely
affect our financial condition.
In addition, our estimated liability for claims is highly uncertain and is based on subjective
assumptions. The actual liability could vary significantly from the estimate recorded in our
financial statements.
Because of the uncertainty as to the number and timing of potential future asbestos claims, as
well as the amount that will have to be paid to settle or satisfy any such claims in the future
(including significant bonds required by certain states while we appeal adverse verdicts), and the
finite amount of insurance available for future payments, future asbestos claims could have a
material adverse effect on our financial condition, results of operations and cash flows.
For a further discussion of our asbestos exposure, see Managements Discussion and Analysis
of Financial Condition and Results of Operations Contingencies Asbestos.
Our business and some of the markets we serve are cyclical and distressed market conditions could
have a material adverse effect on our business.
The markets in which we sell our products, particularly chemical companies, petroleum
refineries, heavy-duty trucking, semiconductor manufacturing, capital equipment and the automotive
industry, are, to varying degrees, cyclical and have historically experienced periodic downturns.
Prior downturns have been characterized by diminished product demand, excess manufacturing capacity
and subsequent erosion of average selling prices in these markets resulting in negative effects on
our net sales, gross margins and net income. The current downward cycle has impacted our results
of operations for our most recent quarterly periods. The current economic environment may affect
our opportunities for organic growth and a continued downward cycle could adversely affect our
operating results. Moreover, a prolonged downward cycle may critically impair the continued
viability of certain of our customers and
8
may adversely impact our accounts receivable with these customers. A prolonged and severe
downward cycle in our markets could have a material adverse effect on our business, financial
condition, results of operations and cash flows.
We face intense competition that could have a material adverse effect on our business.
We encounter intense competition in almost all areas of our business. Customers for many of
our products are attempting to reduce the number of vendors from which they purchase in order to
reduce inventories. To remain competitive, we need to invest continuously in manufacturing,
marketing, customer service and support and our distribution networks. We also need to develop new
products to continue to meet the needs and desires of our customers. We may not have sufficient
resources to continue to make such investments or maintain our competitive position. Additionally,
some of our competitors are larger than we are and have substantially greater financial resources
than we do. As a result, they may be better able to withstand the effects of periodic economic
downturns. Pricing and other competitive pressures could adversely affect our business, financial
condition, results of operations and cash flows.
If we fail to retain the independent agents and distributors upon whom we rely to market our
products, we may be unable to effectively market our products and our revenue and profitability may
decline.
Our marketing success in the U.S. and abroad depends largely upon our independent agents and
distributors sales and service expertise and relationships with customers in our markets. Many of
these agents have developed strong ties to existing and potential customers because of their
detailed knowledge of our products. A loss of a significant number of these agents or
distributors, or of a particular agent or distributor in a key market or with key customer
relationships, could significantly inhibit our ability to effectively market our products, which
could have a material adverse effect on our business, financial condition, results of operations
and cash flows.
Increased costs for raw materials or the termination of existing supply agreements could have a
material adverse effect on our business.
The prices for raw materials we purchase increased in 2008. While we have been successful in
passing along a portion of these higher costs, there can be no assurance that we will be able to
continue doing so without losing customers. Similarly, the loss of a key supplier or the
unavailability of a key raw material could adversely affect our business, financial condition,
results of operations and cash flows.
We have exposure to some contingent liabilities relating to discontinued operations, which could
have a material adverse effect on our financial condition, results of operations or cash flows in
any fiscal period.
We have some contingent liabilities related to discontinued operations of our predecessors,
including environmental liabilities and liabilities for certain products and other matters. In
some instances we have indemnified others against those liabilities, and in other instances we have
received indemnities from third parties against those liabilities.
Claims could arise relating to products or other matters related to our discontinued
operations. Some of these claims could seek substantial monetary damages. Specifically, we may
potentially be subject to the liabilities related to the firearms manufactured prior to 1990 by
Colt Firearms, a former operation of Coltec, and for electrical transformers manufactured prior to
1994 by Central Moloney, another former Coltec operation. Coltec also has ongoing obligations with
regard to workers compensation, retiree medical and other retiree benefit matters associated with
discontinued operations that relate to Coltecs periods of ownership of those operations.
9
We have insurance, reserves and funds held in trust to address these liabilities. However, if
our insurance coverage is depleted, our reserves are not adequate or the funds held in trust are
insufficient, environmental and other liabilities relating to discontinued operations could have a
material adverse effect on our financial condition, results of operations and cash flows.
We conduct a significant amount of our sales activities outside of the U.S., which subjects us to
additional business risks that may cause our profitability to decline.
Because we sell our products in a number of foreign countries, we are subject to risks
associated with doing business internationally. In 2008, we derived approximately 48% of our
revenues from sales of our products outside of the U.S. Our international operations are, and will
continue to be, subject to a number of risks, including:
|
|
|
unfavorable fluctuations in foreign currency exchange rates;
|
|
|
|
|
adverse changes in foreign tax, legal and regulatory requirements;
|
|
|
|
|
difficulty in protecting intellectual property;
|
|
|
|
|
trade protection measures and import or export licensing requirements;
|
|
|
|
|
differing labor regulations;
|
|
|
|
|
political and economic instability; and
|
|
|
|
|
acts of hostility, terror or war.
|
Any of these factors, individually or together, could have a material adverse effect on our
business, financial condition, results of operations and cash flows.
We intend to continue to pursue international growth opportunities, which could increase our
exposure to risks associated with international sales and operations. As we expand our
international operations, we may also encounter new risks that could adversely affect our revenues
and profitability. For example, as we focus on building our international sales and distribution
networks in new geographic regions, we must continue to develop relationships with qualified local
agents, distributors and trading companies. If we are not successful in developing these
relationships, we may not be able to increase sales in these regions.
If we are unable to protect our intellectual property rights and knowledge relating to our
products, our business and prospects may be negatively impacted.
We believe that proprietary products and technology are important to our success. If we are
unable to adequately protect our intellectual property and know-how, our business and prospects
could be negatively impacted. Our efforts to protect our intellectual property through patents,
trademarks, service marks, domain names, trade secrets, copyrights, confidentiality, non-compete
and nondisclosure agreements and other measures may not be adequate to protect our proprietary
rights. Patents issued to third parties, whether before or after the issue date of our patents,
could render our intellectual property less valuable. Questions as to whether our competitors
products infringe our intellectual property rights or whether our products infringe our
competitors intellectual property rights may be disputed. In addition, intellectual property
rights may be unavailable, limited or difficult to enforce in some jurisdictions, which could make
it easier for competitors to capture market share in those jurisdictions.
10
Our competitors may capture market share from us by selling products that claim to mirror the
capabilities of our products or technology. Without sufficient protection nationally and
internationally for our intellectual property, our competitiveness worldwide could be impaired,
which would negatively impact our growth and future revenue. As a result, we may be required to
spend significant resources to monitor and police our intellectual property rights.
Risks Related to Ownership of Our Common Stock
The market price and trading volume of our common stock may be volatile.
A relatively small number of shares traded in any one day could have a significant affect on
the market price of our common stock. The market price of our common stock could fluctuate
significantly for many reasons, including in response to the risks described in this section and
elsewhere in this report or for reasons unrelated to our operations, such as reports by industry
analysts, investor perceptions or negative announcements by our customers, competitors or suppliers
regarding their own performance, as well as industry conditions and general financial, economic and
political instability. In particular, reports concerning asbestos litigation or asbestos reform
could cause a significant increase or decrease in the market price of our common stock.
Because our quarterly revenues and operating results may vary significantly in future periods, our
stock price may fluctuate.
Our revenue and operating results may vary significantly from quarter to quarter. A high
proportion of our costs are fixed, due in part to significant selling and manufacturing costs.
Small declines in revenues could disproportionately affect operating results in a quarter and the
price of our common stock may fall. We may also incur charges to income to cover increases in the
estimate of our subsidiaries future asbestos liability. Other factors that could affect quarterly
operating results include, but are not limited to:
|
|
|
demand for our products;
|
|
|
|
|
the timing and execution of customer contracts;
|
|
|
|
|
the timing of sales of our products;
|
|
|
|
|
payments related to asbestos litigation or annual costs related to asbestos
litigation that are not covered by insurance;
|
|
|
|
|
the timing of receipt of insurance proceeds;
|
|
|
|
|
increases in manufacturing costs due to equipment or labor issues;
|
|
|
|
|
changes in foreign currency exchange rates;
|
|
|
|
|
unanticipated delays or problems in introducing new products;
|
|
|
|
|
announcements by competitors of new products, services or technological innovations;
|
|
|
|
|
changes in our pricing policies or the pricing policies of our competitors;
|
11
|
|
|
increased expenses, whether related to sales and marketing, raw materials or
supplies, product development or administration;
|
|
|
|
|
major changes in the level of economic activity in North America, Europe, Asia and
other major regions in which we do business;
|
|
|
|
|
costs related to possible future acquisitions or divestitures of technologies or
businesses;
|
|
|
|
|
an increase in the number or magnitude of product liability claims;
|
|
|
|
|
our ability to expand our operations and the amount and timing of expenditures
related to expansion of our operations, particularly outside the United States; and
|
|
|
|
|
economic assumptions and market factors used to determine post-retirement benefits
and pension liabilities.
|
Various provisions and laws could delay or prevent a change of control.
The anti-takeover provisions of our articles of incorporation and bylaws, our shareholder
rights plan and provisions of North Carolina law could delay or prevent a change of control or may
impede the ability of the holders of our common stock to change our management. In particular, our
articles of incorporation and bylaws, among other things, will:
|
|
|
require a supermajority shareholder vote to approve any business combination
transaction with an owner of 5% or more of our shares unless the transaction is
recommended by disinterested directors;
|
|
|
|
|
limit the right of shareholders to remove directors and fill vacancies;
|
|
|
|
|
regulate how shareholders may present proposals or nominate directors for election
at shareholders meetings; and
|
|
|
|
|
authorize our board of directors to issue preferred stock in one or more series,
without shareholder approval.
|
Our shareholder rights plan will also make an acquisition of a controlling interest in EnPro
in a transaction not approved by our board of directors more difficult.
Future sales of our common stock in the public market could lower the market price for our common
stock and adversely impact the trading price of our convertible debentures.
In the future, we may sell additional shares of our common stock to raise capital. In
addition, a substantial number of shares of our common stock are reserved for issuance under our
equity compensation plans, including shares to be issued upon the exercise of stock options, and
upon conversion of our convertible debentures. We cannot predict the size of future issuances or
the effect, if any, that they may have on the market price for our common stock. The issuance and
sales of substantial amounts of common stock, or the perception that such issuances and sales may
occur, could adversely affect the trading price of the debentures and the market price of our
common stock.
12
Absence of dividends could reduce our attractiveness to investors.
We have never declared or paid cash dividends on our common stock. Moreover, our current
senior secured credit facility restricts our ability to pay cash dividends on common stock if
availability under the facility falls below $20 million. As a result, our common stock may be less
attractive to certain investors than the stock of companies with a history of paying regular
dividends.
Risks Related to Our Capital Structure
Our debt agreement imposes limitations on our operations, which could impede our ability to respond
to market conditions, address unanticipated capital investments and/or pursue business
opportunities.
We have a $75 million senior secured revolving credit facility that imposes limitations on our
operations, such as limitations on distributions, limitations on incurrence and repayment of
indebtedness, and maintenance of a fixed charge coverage financial ratio. These limitations could
impede our ability to respond to market conditions, address unanticipated capital investment needs
and/or pursue business opportunities.
We may not have sufficient cash to repurchase our convertible debentures at the option of the
holder or upon a change of control or to pay the cash payable upon a conversion.
Upon a change of control, subject to certain conditions, we will be required to make an offer
to repurchase for cash all outstanding convertible debentures at 100% of their principal amount
plus accrued and unpaid interest, including liquidated damages, if any, up to but not including the
date of repurchase. Upon a conversion, we will be required to make a cash payment of up to $1,000
for each $1,000 in principal amount of debentures converted. However, we may not have enough
available cash or be able to obtain financing at the time we are required to make repurchases of
tendered debentures or settlement of converted debentures. Any credit facility in place at the
time of a repurchase or conversion of the debentures may also limit our ability to use borrowings
to pay any cash payable on a repurchase or conversion of the debentures and may prohibit us from
making any cash payments on the repurchase or conversion of the debentures if a default or event of
default has occurred under that facility without the consent of the lenders under that credit
facility. Our current $75 million senior secured credit facility prohibits distributions from our
subsidiaries to us to make payments of interest on the debentures if a default or event of default
exists under the facility. Our senior secured credit facility also prohibits prepayments of the
debentures or distributions from our subsidiaries to us to make principal payments or payments upon
conversion of the debentures if a default or event of default exists under the facility or the
amount of the borrowing base under the facility, less the amount of outstanding borrowings under
the facility and letters of credit and reserves, is less than $20 million. Our failure to
repurchase tendered debentures at a time when the repurchase is required by the indenture or to pay
any cash payable on a conversion of the debentures would constitute a default under the indenture.
A default under the indenture or the change of control itself could lead to a default under the
other existing and future agreements governing our indebtedness. If the repayment of the related
indebtedness were to be accelerated after any applicable notice or grace periods, we may not have
sufficient funds to repay the indebtedness and repurchase the debentures or make cash payments upon
conversion thereof.
Risks Related to the Current Global Financial Crisis
The volatility and disruption of global credit markets and adverse changes arising from the current
global financial crisis may negatively impact our ability to access financing and expose us to
unexpected risks.
13
The current global financial and credit crisis exposes us to a variety of risks. We have
historically funded our business with cash from operations and the proceeds from the issuance of
our convertible debentures. We have a $75 million senior secured revolving credit facility with a
group of lenders as a backstop to our liquidity needs and there have been no borrowings under this
facility to date. In light of the unprecedented disruption of global credit markets and the
instability of financial institutions that until recently were of unquestioned strength, there is a
risk that a borrowing request properly made under the credit facility would not be honored by one
or more of our lenders. Under the terms of the credit facility, no lender is obligated to fund a
portion of a borrowing request that is not funded by another lender. Accordingly, in such an
instance actual borrowings under our credit facility may be insufficient to support our liquidity
needs and we would be required to seek alternate sources of liquidity. In light of the current
capital and credit market disruption and volatility, we cannot assure you that such alternate
funding will be available to us on terms and conditions acceptable to us, or at all. As of the
date of this filing we have no reason to believe that a borrowing request, properly submitted by
us, would not be honored by any of our lenders, all of whom have assured us of their continuing
ability to fund our facility. In addition, we maintain deposit accounts with numerous financial
institutions around the world in amounts that exceed applicable governmental deposit insurance
levels. While we actively monitor our deposit relationships, we are subject to risk of loss in the
event of the unanticipated failure of a financial institution in which we maintain deposits, which
loss could be material to our results of operations and financial condition.
Derivative transactions may expose us to unexpected risk and potential losses.
We are party to certain derivative transactions, such as foreign exchange contracts and call
options (hedge and warrant transactions) with respect to our convertible debentures, with financial
institutions to hedge against certain financial risks. In light of current economic uncertainty
and potential for financial institution failures, we may be exposed to the risk that our
counterparty in a derivative transaction may be unable to perform its obligations as a result of
being placed in receivership or otherwise. In the event that a counterparty to a material
derivative transaction is unable to perform its obligations thereunder, we may experience material
losses that could materially adversely affect our results of operations and financial condition.
ITEM 1B. UNRESOLVED STAFF COMMENTS
Not applicable.
ITEM 2. PROPERTIES
We are headquartered in Charlotte, North Carolina and have 43 primary manufacturing facilities
in 12 states within the U.S. and 10 countries outside of the U.S. The following table outlines the
location, business segment and size of our largest facilities, along with whether we own or lease
each facility:
|
|
|
|
|
|
|
|
|
|
|
Owned/
|
|
Size
|
Location
|
|
Segment
|
|
Leased
|
|
(Square Feet)
|
U.S.
|
|
|
|
|
|
|
Palmyra, New York
|
|
Sealing Products
|
|
Owned
|
|
538,000
|
Longview, Texas
|
|
Sealing Products
|
|
Owned
|
|
210,000
|
Paragould, Arkansas
|
|
Sealing Products
|
|
Owned
|
|
142,000
|
Quincy, Illinois
|
|
Engineered Products
|
|
Owned
|
|
323,000
|
Bay Minette, Alabama.
|
|
Engineered Products
|
|
Leased
|
|
143,000
|
Thorofare, New Jersey
|
|
Engineered Products
|
|
Owned
|
|
120,000
|
Beloit, Wisconsin
|
|
Engine Products and Services
|
|
Owned
|
|
433,000
|
14
|
|
|
|
|
|
|
|
|
|
|
Owned/
|
|
Size
|
Location
|
|
Segment
|
|
Leased
|
|
(Square Feet)
|
Foreign
|
|
|
|
|
|
|
Mexico City, Mexico
|
|
Sealing Products
|
|
Owned
|
|
131,000
|
Saint Etienne, France
|
|
Sealing Products
|
|
Owned
|
|
108,000
|
Annecy, France
|
|
Engineered Products
|
|
Leased
|
|
196,000
|
Heilbronn, Germany
|
|
Engineered Products
|
|
Owned
|
|
127,000
|
Sucany, Slovakia
|
|
Engineered Products
|
|
Owned
|
|
109,000
|
Our manufacturing capabilities are flexible and allow us to customize the manufacturing
process to increase performance and value for our customers and meet particular specifications. We
also maintain numerous sales offices and warehouse facilities in strategic locations in the U.S.,
Canada and other countries. We believe our facilities and equipment are generally in good
condition and are well maintained and able to continue to operate at present levels.
ITEM 3. LEGAL PROCEEDINGS
Descriptions of environmental, asbestos and legal matters are included in Item 7 of this
annual report under the heading Managements Discussion and Analysis of Financial Condition and
Results of Operations Contingencies and in Note 17 to our Consolidated Financial Statements
which descriptions are incorporated by reference herein.
In addition to the matters referenced above, we are from time to time subject to, and are
presently involved in, other litigation and legal proceedings arising in the ordinary course of
business. We believe that the outcome of such other litigation and legal proceedings will not have
a material adverse affect on our financial condition, results of operations or cash flows.
We
were not subject to any penalties associated with any failure to disclose reportable
transactions under Section 6707A of the Internal Revenue Code.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
No matter was submitted to a vote of security holders during the fourth quarter of the fiscal
year covered by this annual report.
EXECUTIVE OFFICERS OF THE REGISTRANT
Information concerning our executive officers is set forth below:
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position
|
Stephen E. Macadam
|
|
|
48
|
|
|
President, Chief Executive Officer and Director
|
|
|
|
|
|
|
|
William Dries
|
|
|
57
|
|
|
Senior Vice President and Chief Financial
Officer
|
|
|
|
|
|
|
|
Richard L. Magee
|
|
|
51
|
|
|
Senior Vice President, General Counsel
and Secretary
|
15
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position
|
J. Milton Childress II
|
|
|
51
|
|
|
Vice President, Strategic Planning and
Business Development
|
|
|
|
|
|
|
|
Dale A. Herold
|
|
|
41
|
|
|
Vice President, Continuous Improvement
|
|
|
|
|
|
|
|
Robert P. McKinney
|
|
|
45
|
|
|
Vice President, Human Resources
|
|
|
|
|
|
|
|
Donald G. Pomeroy II
|
|
|
41
|
|
|
Vice President
|
|
|
|
|
|
|
|
Robert D. Rehley
|
|
|
48
|
|
|
Vice President and Controller
|
|
|
|
|
|
|
|
Orville G. Lunking
|
|
|
53
|
|
|
Vice President and Treasurer
|
Stephen E. Macadam has served as our Chief Executive Officer and President and as a director
since April 2008. Prior to accepting these positions with EnPro, Mr. Macadam served as Chief
Executive Officer of BlueLinx Holdings Inc. since October 2005. Before joining BlueLinx Holdings
Inc., Mr. Macadam was the President and Chief Executive Officer of Consolidated Container Company
LLC since August 2001. He served previously with Georgia-Pacific Corp. where he held the position
of Executive Vice President, Pulp & Paperboard from July 2000 until August 2001, and the position
of Senior Vice President, Containerboard & Packaging from March 1998 until July 2000. Mr. Macadam
held positions of increasing responsibility with McKinsey and Company, Inc. from 1988 until 1998,
culminating in the role of principal in charge of McKinseys Charlotte, North Carolina operation.
Mr. Macadam is a director of Solo Cup Company.
William Dries is currently Senior Vice President and Chief Financial Officer and has held
these positions since May 2002. He served as a consultant to Goodrich Corporation from September
2001 through December 2001 and was employed by Coltec Industries Inc from January 2002 through
April 2002. Prior to that, Mr. Dries was employed by United Dominion Industries, Inc. He was
Senior Vice President and Chief Financial Officer of United Dominion from December 1999 until May
2001, having previously served as Senior Vice President Finance, Vice President and Controller.
Mr. Dries, a certified public accountant, was with Ernst & Young LLP in New York prior to joining
United Dominion in 1985. Mr. Dries is a director of Polypore International, Inc.
Richard L. Magee is currently Senior Vice President, General Counsel and Secretary and has
held these positions since May 2002. He served as a consultant to Goodrich Corporation from
October 2001 through December 2001, and was employed by Coltec Industries Inc from January 2002
through April 2002. Prior to that, Mr. Magee was Senior Vice President, General Counsel and
Secretary of United Dominion Industries, Inc. from April 2000 until July 2001, having previously
served as Vice President, Secretary and General Counsel. Mr. Magee was a partner in the Charlotte,
North Carolina law firm Robinson, Bradshaw & Hinson, P.A. prior to joining United Dominion in 1989.
J. Milton Childress II is currently Vice President, Strategic Planning and Business
Development and has held this position since February 2006, after having joined the EnPro corporate
staff in December 2005. He was a co-founder of and served from October 2001 through December 2005
as Managing Director of Charlotte-based McGuireWoods Capital Group. Prior to that, Mr. Childress
was Senior Vice President, Planning and Development of United Dominion Industries, Inc. from
December 1999 until May 2001, having previously served as Vice President. Mr. Childress held a
number of positions with Ernst & Youngs corporate finance consulting group prior to joining United
Dominion in 1992.
16
Dale A. Herold is currently Vice President, Continuous Improvement and has held this position
since August 2008. Prior to joining EnPro, Mr. Herold was a regional vice president for BlueLinx
Holdings Inc. from October 2007 to August 2008. Previously,
he was that companys Vice President,
Marketing and Sales Excellence from January 2006 to October 2007. Prior to joining BlueLinx, Mr.
Herold worked in a variety of marketing and manufacturing roles at Consolidated Container Company
from March 2004 to January 2006, and at General Electric from July 1989 to March 2004.
Robert P. McKinney is currently Vice President, Human Resources and has held this position
since April 2008, after having previously served as Deputy General Counsel from May 2002 to April
2008. Prior to joining EnPro, Mr. McKinney was General Counsel at Tredegar Corporation and
Assistant General Counsel with The Pittston Company, both in Richmond, Virginia. From 1990 to
1999, Mr. McKinney was employed by United Dominion Industries, Inc. in Charlotte, North Carolina,
as Corporate Counsel and subsequently Assistant General Counsel. Prior to joining United Dominion,
he was an associate with the law firm of Smith Helms Mulliss & Moore.
Donald G. Pomeroy II is currently Vice President with responsibility for pricing strategies in
the Companys Continuous Improvement organization. He has held this position since November 2008,
after having previously served as the Companys Vice President and Controller since September 2007
and from May 2002 through August 2004, Mr. Pomeroy served as the Vice President, Finance for
Garlock Sealing Technologies from August 2004 until August 2007. He was Vice President, Finance
and Information Technology at Stemco for Coltec Industries Inc from August 1998 until October 2001,
and an employee of Coltec Industries Inc from November 2001 through May 2002. From May 1995 to
February 1996, Mr. Pomeroy was a financial analyst, and from February 1996 to August 1998, he was
Controller International Operations at Garlock Sealing Technologies. Prior to joining Garlock
Sealing Technologies, Mr. Pomeroy, a certified public accountant, was with Coopers & Lybrand LLP.
Robert D. Rehley is currently Vice President and Controller and has held these positions since
November 2008, after having previously served as the Companys Vice President and Treasurer since
May 2002. He was employed by Coltec Industries Inc from January 2002 through April 2002. Mr.
Rehley was Assistant Treasurer of Metaldyne Corporation from October 2001 to January 2002, and was
Executive Director Corporate Tax for Metaldyne from December 2000 until October 2001.
Previously, he was Treasurer of Simpson Industries from April 1998 until December 2000. Mr. Rehley
was Director Finance and Business Development for Cummins Engine Company, Inc. from October 1996
until April 1998.
Orville G. Lunking is currently Vice President and Treasurer and has held these positions
since February 2009. Prior to joining EnPro, Mr. Lunking served as Vice President and Treasurer
for Novelis Inc. from January 2005 to March 2008. Prior to that, he was Corporate Treasurer for
Smithfield Foods, Inc. from July 2001 to December 2004. He previously served as Assistant
Treasurer International at Sara Lee Corporation from July 1997 to June 2001. Prior to this time,
he worked in different finance-related roles at Allied Signal Inc., Bankers Trust Company, General
Motors Corporation and Milliken & Company.
PART II
ITEM 5. REGISTRANTS COMMON EQUITY AND RELATED SHAREHOLDER MATTERS
Our common stock is publicly traded on the New York Stock Exchange (NYSE) under the symbol
NPO. As required by Section 3.03A.12(a) of the NYSE listing standards, we filed with the NYSE
the certification of our Chief Executive Officer that he is not aware of any violation by the
Company of NYSE corporate governance listing standards.
17
As of February 20, 2008, there were 5,343 holders of record of our common stock. The price
range of our common stock from January 1, 2007 through December 31, 2008 is listed below by
quarter:
|
|
|
|
|
|
|
|
|
|
|
Low
|
|
High
|
|
|
Sale Price
|
|
Sale Price
|
Fiscal 2008:
|
|
|
|
|
|
|
|
|
Fourth Quarter
|
|
$
|
14.40
|
|
|
$
|
37.25
|
|
Third Quarter
|
|
|
33.56
|
|
|
|
43.68
|
|
Second Quarter
|
|
|
31.21
|
|
|
|
40.81
|
|
First Quarter
|
|
|
24.40
|
|
|
|
33.46
|
|
|
|
|
|
|
|
|
|
|
Fiscal 2007:
|
|
|
|
|
|
|
|
|
Fourth Quarter
|
|
$
|
29.65
|
|
|
$
|
43.32
|
|
Third Quarter
|
|
|
31.01
|
|
|
|
46.46
|
|
Second Quarter
|
|
|
35.85
|
|
|
|
44.99
|
|
First Quarter
|
|
|
30.87
|
|
|
|
40.70
|
|
We did not declare any cash dividends to our shareholders during 2008. For a discussion of
the restrictions on payment of dividends on our common stock, see Managements Discussion and
Analysis of Financial Condition and Results of Operations Liquidity and Capital Resources
Dividends.
The following table sets forth all purchases made by us or on our behalf or any affiliated
purchaser, as defined in Rule 10b-18(a)(3) under the Exchange Act, of shares of our common stock
during each month in the fourth quarter of 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(d) Maximum Number
|
|
|
|
|
|
|
|
|
|
|
(c) Total Number of
|
|
(or Approximate Dollar
|
|
|
|
|
|
|
|
|
|
|
Shares (or Units)
|
|
Value) of Shares (or
|
|
|
|
|
|
|
|
|
|
|
Purchased as Part of
|
|
Units) that May Yet Be
|
|
|
(a) Total Number
|
|
(b) Average Price
|
|
Publicly Announced
|
|
Purchased Under the
|
|
|
of Shares (or
|
|
Paid per Share
|
|
Plans or Programs
|
|
Plans or Programs
|
Period
|
|
Units) Purchased
|
|
(or Unit)
|
|
(1) (2)
|
|
(1) (2)
|
October 1
October 31, 2008
|
|
|
252,400
|
(2)
|
|
|
28.05
|
(2)
|
|
|
252,400
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November 1
November 30, 2008
|
|
|
-0-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 1
December 31, 2008
|
|
|
2,230
|
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
254,630
|
(1)(2)
|
|
|
28.05
|
(2)
|
|
|
252,400
|
|
|
|
|
|
|
|
|
(1)
|
|
A total of 2,230 shares were transferred to a rabbi trust that we established in connection
with our Deferred Compensation Plan for Non-Employee Directors, pursuant to which non-employee
directors may elect to defer directors fees into common stock units. Coltec, which is a
wholly owned subsidiary of EnPro, furnished these shares in exchange for management and other
services provided by EnPro. These shares were valued at a price of $21.02 per share, the
average of the high and low prices of our common stock on December 31, 2008. We do not
consider the
|
18
|
|
|
|
|
transfer of shares from Coltec in this context to be pursuant to a publicly announced plan
or program.
|
|
(2)
|
|
Pursuant to a share repurchase authorization approved by our board of directors and in
accordance with the terms of a plan to repurchase shares of our common stock up to $38
million, which we announced on September 8, 2008, we purchased 252,400 shares of our common
stock at an aggregate price of approximately $7.09 million from October 1, 2008 to October 29,
2008, including commissions and other fees. On October 29, 2008, in light of the volatility
in the financial and credit markets, the board of directors terminated the share repurchase
plan.
|
CUMULATIVE TOTAL RETURN PERFORMANCE GRAPH
Set forth below is a line graph showing the yearly percentage change in the cumulative total
shareholder return for our common stock as compared to similar returns for the Russell 2000
®
Stock
Index and a group of our peers consisting of Flowserve Corporation, Robbins & Myers, Inc., Gardner
Denver, Inc., Circor International, Inc., IDEX Corporation and The Gormann-Rupp Company. These
manufacturing companies were chosen because they are all similarly situated to EnPro in terms of
size and markets served. Each of the returns is calculated assuming the investment of $100 in each
of the securities on December 31, 2003 and reinvestment of dividends into additional shares of the
respective equity securities when paid. The graph plots the respective values beginning on
December 31, 2003 and continuing through December 31, 2008. Past performance is not necessarily
indicative of future performance.
COMPARISON OF 5-YEAR CUMULATIVE TOTAL RETURN
AMONG ENPRO INDUSTRIES, INC.,
RUSSELL 2000 INDEX AND PEER GROUP INDEX
ITEM 6. SELECTED CONSOLIDATED FINANCIAL DATA
The following historical consolidated financial information as of and for each of the years
ended December 31, 2008, 2007, 2006, 2005 and 2004 has been derived from, and should be read
together with, our audited Consolidated Financial Statements and the related notes, for each of
those years. The audited Consolidated Financial Statements and related notes as of December 31,
2008 and 2007 and for the years ended December 31, 2008, 2007 and 2006 are included elsewhere in
this annual report. The information
19
presented below with respect to the last three completed fiscal years should also be read together
with Item 7, Managements Discussion and Analysis of Financial Condition and Results of
Operations.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
2008
|
|
2007
|
|
2006
|
|
2005
|
|
2004
|
|
|
(in millions, except per share data)
|
Statement of Operations Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
1,167.8
|
|
|
$
|
1,030.0
|
|
|
$
|
928.4
|
|
|
$
|
838.6
|
|
|
$
|
826.3
|
|
Income (loss) before extraordinary
item
|
|
$
|
53.5
|
|
|
$
|
37.7
|
|
|
$
|
(158.9
|
)
|
|
$
|
58.6
|
|
|
$
|
33.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets (1)
|
|
$
|
1,352.5
|
|
|
$
|
1,470.3
|
|
|
$
|
1,406.6
|
|
|
$
|
1,276.2
|
|
|
$
|
1,181.0
|
|
Long-term debt (including current
portion)
|
|
$
|
182.2
|
|
|
$
|
185.7
|
|
|
$
|
185.7
|
|
|
$
|
185.2
|
|
|
$
|
164.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Per Common Share Data Diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before extraordinary
item
|
|
$
|
2.54
|
|
|
$
|
1.69
|
|
|
$
|
(7.60
|
)
|
|
$
|
2.75
|
|
|
$
|
1.60
|
|
|
|
|
(1)
|
|
For 2004, the total assets reported in the table above contains immaterial errors relating to
the translation of foreign currency denominated goodwill and other intangible assets. If the
translation adjustments had been properly recorded, total assets would have been $1,213.2
million. There would have been no impact upon net income, earnings per share or cash flows
for the period due to the errors.
|
ITEM 7. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following is managements discussion and analysis of certain significant factors that have
affected our consolidated financial condition and operating results during the periods included in
the accompanying audited Consolidated Financial Statements and the related notes. You should read
the following discussion in conjunction with our audited Consolidated Financial Statements and the
related notes, included elsewhere in this annual report.
Forward-Looking Statements
This report contains certain statements that are forward-looking statements as that term is
defined under the Private Securities Litigation Reform Act of 1995 (the Act) and releases issued
by the Securities and Exchange Commission. The words may, hope, will, should, expect,
plan, anticipate, intend, believe, estimate, predict, potential, continue, and
other expressions which are predictions of or indicate future events and trends and which do not
relate to historical matters identify forward-looking statements. We believe that it is important
to communicate our future expectations to our shareholders, and we therefore make forward-looking
statements in reliance upon the safe harbor provisions of the Act. However, there may be events in
the future that we are not able to accurately predict or control, and our actual results may differ
materially from the expectations we describe in our forward-looking statements. Forward-looking
statements involve known and unknown risks, uncertainties and other factors, which may cause our
actual results, performance or achievements to differ materially from anticipated future results,
performance or achievements expressed or implied by such forward-looking statements. We advise you
to read further about certain of these and other risk factors set forth in Item 1A of this annual
report, entitled Risk Factors We undertake no obligation to publicly update or revise any
forward-looking statement, either as a result of new
20
information, future events or otherwise. Whenever you read or hear any subsequent written or oral
forward-looking statements attributed to us or any person acting on our behalf, you should keep in
mind the cautionary statements contained or referred to in this section.
Overview and Outlook
Overview
. EnPro was incorporated under the laws of the State of North Carolina on
January 11, 2002. We design, develop, manufacture and market proprietary engineered industrial
products. We have 43 primary manufacturing facilities located in the United States and 10
countries outside the United States.
We manage our business as three segments: a Sealing Products segment, an Engineered Products
segment, and an Engine Products and Services segment.
Our Sealing Products segment designs, manufactures and sells sealing products, including
metallic, non-metallic and composite material gaskets, rotary seals, compression packing, resilient
metal seals, elastomeric seals, hydraulic components and expansion joints, as well as wheel-end
component systems, PTFE products, conveyor belting and sheeted rubber products. These products are
used in a variety of industries, including chemical and petrochemical processing, petroleum
extraction and refining, pulp and paper processing, heavy-duty trucking, power generation, food and
pharmaceutical processing, primary metal manufacturing, mining, water and waste treatment,
aerospace, medical, filtration and semiconductor fabrication.
Our Engineered Products segment includes operations that design, manufacture and sell
self-lubricating, non-rolling, metal-polymer, solid polymer and filament wound bearing products,
aluminum blocks for hydraulic applications, rotary and reciprocating air compressors, vacuum pumps,
air systems and compressor components. These products are used in a wide range of applications,
including the automotive, pharmaceutical, pulp and paper, natural gas, health, pump and compressor
construction, power generation, machine tools, air treatment, refining, petrochemical and general
industrial markets.
Our Engine Products and Services segment designs, manufactures, sells and services heavy-duty,
medium-speed diesel, natural gas and dual fuel reciprocating engines. The United States government
and the general markets for marine propulsion, power generation, and pump and compressor
applications use these products and services.
In January 2008, we acquired certain assets and assumed certain liabilities of Sinflex Sealing
Technologies, a distributor and manufacturer of industrial sealing products, located in Shanghai,
China. The operation conducts business as Garlock Sealing Technologies (Shanghai) Co. Ltd. and is
operated and managed as part of the global Garlock Sealing Technologies business unit in the
Sealing Products segment. Sinflex was Garlocks principal distributor in China for over a decade.
In February 2008, we acquired the stock of V.W. Kaiser Engineering, a manufacturer of pins,
bushings and suspension kits primarily for the heavy-duty truck and bus aftermarket. V.W. Kaiser
Engineering is located in Michigan. It is operated and managed as part of the Stemco business
unit, which is in the Sealing Products segment.
In May 2008, we acquired certain assets and assumed certain liabilities of Air Perfection in
California. Air Perfection is engaged in the audit, sale, distribution, rental and service of
compressed air systems and the various components that comprise such systems. The business is
operated and managed as part of the Quincy Compressor business unit, which is in the Engineered
Products segment.
21
In June 2008, we purchased the 20% ownership of the minority shareholder of Garlock Pty
Limited in Australia. Subsequent to the share purchase, we own 100% of Garlock Pty Limited, which
is in the Sealing Products segment.
In October and November 2008, we acquired certain assets of and assumed certain liabilities of
three businesses which provide components and aftermarket services for reciprocating compressors to
customers in the petroleum, natural gas, PET bottle molding and chemical processing industries.
The acquired businesses are Horizon Compressor Services, Inc., located in Houston, Texas; RAM Air,
Inc., located in New Smyrna Beach, Florida; and C&P Services (Northern) Limited, located in
Warrington, UK. The businesses are operated and managed as part of the CPI business unit in the
Engineered Products segment.
In December 2008, we acquired certain assets and assumed certain liabilities of Northern
Gaskets and Mouldings Limited (NGM), a distributor of sealing products and a manufacturer of
gaskets, located in Batley, UK. NGM operates as part of Garlock (Great Britain) Limited in the
Sealing Products segment. NGM increases Garlocks presence in the petrochemical, pharmaceutical
and oil and gas industries in the UK.
On March 3, 2008, pursuant to a $100 million share repurchase authorization approved by our
board of directors, we entered into an accelerated share repurchase (ASR) agreement with a
financial institution to provide for the immediate retirement of $50 million of our common stock.
Under the ASR agreement, we purchased approximately 1.7 million shares of our common stock from a
financial institution at an initial price of $29.53 per share. Total consideration paid at initial
settlement to repurchase these shares, including commissions and other fees, was approximately
$50.2 million and was recorded in shareholders equity as a reduction of common stock and
additional paid-in capital. The price adjustment period under the ASR terminated on August 29,
2008. In connection with the finalization of the ASR, we remitted in cash a final settlement
adjustment of $11.9 million to the financial institution that executed the ASR. The final
settlement adjustment, recorded as a reduction of additional paid-in capital, was based on the
average of the reported daily volume-weighted average price of our common stock during the term of
the ASR. It resulted in a remittance to the financial institution because the volume-weighted
average price of our common stock during the term of the ASR exceeded the initial price of $29.53
per share. After the final settlement adjustment, we had completed about $62 million of the share
repurchase authorization.
Pursuant to the share repurchase authorization and in accordance with the terms of a plan to
repurchase shares announced on September 8, 2008, we acquired 252,400 shares of our common stock in
open-market transactions at an average price of about $28.00 per share, resulting in total
repurchases of approximately $7.1 million, including commissions and fees, from October 1, 2008 to
October 29, 2008. On October 29, 2008, in light of the volatility in the financial and credit
markets, the board of directors terminated the share repurchase plan.
As described elsewhere in this Managements Discussion and Analysis of Financial Condition and
Results of Operations, we actively manage the asbestos claims against our subsidiaries and the
remaining insurance assets available for the payment of these claims. We accrue an estimated
liability for both pending and future asbestos claims for the next ten years. For additional
information on this subject discussed in this section, see Contingencies Asbestos.
Outlook
We believe we are making progress in connection with our business priorities to pursue
operational, commercial, pricing and sourcing excellence; to accelerate growth through new
products, new markets and acquisitions; and to effectively manage cash. We believe the
acquisitions we have
22
completed contribute to the geographic expansion of our key businesses and that they improve
our product offerings. However, in the current economic environment, activity in our markets has
slowed significantly. Short lead times for most of our products give us a very limited view of the
future, which is made even more uncertain by the deterioration of many of our markets in recent
months. Circumstances that include facility shutdowns by customers in the automotive industry,
curtailed demand for many of our industrial products, and less favorable foreign exchange rates
lead us to expect lower sales and operating income in 2009 compared to 2008.
As
a result of recent structural and organizational changes we have made
in our European operations, we anticipate that our effective tax
rate for 2009 should be less than 30%. The actual effective tax rate
will depend on several factors, including our mix of domestic and
foreign earnings and our actual results versus the projections used
in estimating the effective tax rate. Due to these factors, the
actual effective tax rate may vary significantly from the estimate.
For years beyond 2009, we anticipate that our effective tax rate
should generally be lower than historical rates, but may not be
as low as we expect to experience in 2009.
We anticipate that cash flows in 2009 should benefit from reduced expenditures for share
repurchases and lower capital expenditures partially offset by reduced operating income.
Due to recent volatility in the equity and fixed income investment markets, we, like many
companies, have experienced a significant decline in the value of the assets that fund our U.S.
defined benefit pension plans and an increase in the value of plan liabilities. Based on currently
available data, which is subject to change, we estimate that we will be required to make cash
contributions in 2009 totaling $6.4 million. We estimate that the annual U.S. pension expense will
increase to approximately $14.0 $15.0 million in 2009 compared to $4.8 million in 2008.
In connection with our business strategy to accelerate growth, we will continue to evaluate
acquisitions and divestitures in 2009; however, the impact of such acquisitions and divestitures
cannot be predicted and therefore is not reflected in this outlook.
Results of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(in millions)
|
|
Sales
|
|
|
|
|
|
|
|
|
|
|
|
|
Sealing Products
|
|
$
|
503.5
|
|
|
$
|
457.3
|
|
|
$
|
432.5
|
|
Engineered Products
|
|
|
524.1
|
|
|
|
445.5
|
|
|
|
391.7
|
|
Engine Products and Services
|
|
|
142.1
|
|
|
|
128.1
|
|
|
|
105.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,169.7
|
|
|
|
1,030.9
|
|
|
|
929.4
|
|
Intersegment sales
|
|
|
(1.9
|
)
|
|
|
(0.9
|
)
|
|
|
(1.0
|
)
|
|
|
|
|
|
|
|
|
|
|
Total sales
|
|
$
|
1,167.8
|
|
|
$
|
1,030.0
|
|
|
$
|
928.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Profit
|
|
|
|
|
|
|
|
|
|
|
|
|
Sealing Products
|
|
$
|
90.4
|
|
|
$
|
78.0
|
|
|
$
|
76.5
|
|
Engineered Products
|
|
|
68.1
|
|
|
|
69.4
|
|
|
|
61.5
|
|
Engine Products and Services
|
|
|
20.8
|
|
|
|
15.3
|
|
|
|
4.9
|
|
|
|
|
|
|
|
|
|
|
|
Total segment profit
|
|
|
179.3
|
|
|
|
162.7
|
|
|
|
142.9
|
|
|
Corporate expenses
|
|
|
(34.5
|
)
|
|
|
(34.1
|
)
|
|
|
(31.6
|
)
|
Asbestos-related expenses
|
|
|
(52.1
|
)
|
|
|
(68.4
|
)
|
|
|
(359.4
|
)
|
Interest income (expense), net
|
|
|
(5.3
|
)
|
|
|
0.2
|
|
|
|
(3.2
|
)
|
Other income (expense), net
|
|
|
(6.7
|
)
|
|
|
(2.4
|
)
|
|
|
(2.9
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
|
|
|
80.7
|
|
|
|
58.0
|
|
|
|
(254.2
|
)
|
Income tax benefit (expense)
|
|
|
(27.2
|
)
|
|
|
(20.3
|
)
|
|
|
95.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before extraordinary item
|
|
|
53.5
|
|
|
|
37.7
|
|
|
|
(158.9
|
)
|
Extraordinary item, net of taxes
|
|
|
|
|
|
|
2.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
53.5
|
|
|
$
|
40.2
|
|
|
$
|
(158.9
|
)
|
|
|
|
|
|
|
|
|
|
|
23
Segment profit is total segment revenue reduced by operating expenses and restructuring and
other costs identifiable with the segment. Corporate expenses include general corporate
administrative costs. Expenses not directly attributable to the segments, corporate expenses, net
interest expense, asbestos-related expenses, gains/losses or impairments related to the sale of
assets and income taxes are not included in the computation of segment profit. The accounting
policies of the reportable segments are the same as those for EnPro.
2008 Compared to 2007
Sales of $1.17 billion in 2008 increased 13% from $1.03 billion in 2007. The results of
acquisitions added six percentage points of the sales increase. Five percentage points of growth
were primarily the result of selected price increases and additional volume at several businesses
partially offset by lower volume at Stemco due to a decline in demand from OEM heavy-duty truck and
trailer manufacturers and aftermarket customers. The increase in the values of foreign currencies
relative to the U.S. dollar contributed the remaining two percentage points to the increase.
Segment profit, managements primary measure of how our operations perform, increased 10% from
$162.7 million in 2007 to $179.3 million in 2008. Segment profit increased primarily due to
selected price increases, increased volume and acquisitions. These improvements were partially
offset by cost increases in several areas, particularly raw materials and other manufacturing input
costs. Segment margins, defined as segment profit divided by sales, decreased from 15.8% in 2007
to 15.4% in 2008.
Asbestos expenses in 2008 were $52.1 million and included net cash outlays of $26.2 million
for legal fees and expenses incurred during the year and $25.9 million in non-cash charges to
maintain a ten-year liability estimate for future claims and to reflect an adjustment in insurance
value, asbestos trust interest income and accrued legal fees. In 2007, asbestos expenses were
$68.4 million. The higher expense in 2007 was primarily the result of adjustments made to
managements estimation model in the fourth quarter of 2007.
Net interest expense in 2008 was $5.3 million compared to net interest income of $0.2 million
in 2007. The net interest expense was a result of the decrease in invested cash balances and lower
yields on investments.
Our effective tax rate for 2008 was 33.7% compared to 35.0% in 2007. The change in the rate
is principally a result of the reversal of reserves for uncertain tax positions in connection with
the settlement of various tax audits and the benefit of reductions in statutory income tax rates in
several countries.
Net income was $53.5 million, or $2.54 per share, in 2008 compared to $40.2 million, or $1.80
per share, in 2007. Earnings per share are expressed on a diluted basis.
Following is a discussion of operating results for each segment during the year:
Sealing Products
. Sales of $503.5 million in 2008 were 10% higher than the $457.3
million reported in 2007, however, the year-to-year improvement decelerated as the year progressed.
Acquisitions added three percentage points of the growth while organic growth contributed five
percentage points. The favorable impact of foreign currency exchange rates versus the U.S. dollar
accounted for two percentage points of the growth. Sales at Garlock Sealing Technologies increased
12%. Its sales were favorably impacted by increased demand in European markets; strength in the
oil and gas, energy, mining and primary metals sectors; selected price increases; and increases in
the value of foreign currencies. Stemcos sales during the year increased 10% as a result of the
acquisition of the V.W. Kaiser business in late February. Its OEM and aftermarket sales for the
U.S. heavy-duty truck market continued to be lower compared to 2007 as the number of new trailers
built and usage of existing
24
trucks decreased as a result of the U.S. economic slowdown. Garlock Rubber Technologies
experienced a sales increase of 16% due to strong demand for belt and sheet products. Sales for
Plastomer Technologies were down 12% in 2008 compared to last year due to slowdowns in its
semi-conductor markets.
Segment profit of $90.4 million in 2008 increased 16% compared to the $78.0 million reported
in 2007. An increase in profit at Garlock Sealing Technologies resulted from lower restructuring
charges and reflects the benefits of its higher sales volumes. Stemco reported a 6% increase in
profit due to the impact of the addition of the V.W. Kaiser business, partially offset by the
slowdown in the heavy-duty vehicle markets. As a result of its increase in sales, Garlock Rubber
Technologies contributed to the increase in segment profit. Costs associated with the
consolidation of its facilities and lower volumes negatively impacted Plastomer Technologies
results compared to last year. Operating margins for the segment increased to 18.0% in 2008 from
17.1% in 2007 primarily as a result of the earnings improvement at Garlock Sealing Technologies.
Engineered Products
. Sales of $524.1 million in 2008 were 18% higher than 2007 sales
of $445.5. Acquisitions favorably impacted revenue by nine percentage points and increased
activity in the segments operations added five percentage points. The increase in the value of
foreign currencies contributed four percentage points of the sales increase. Sales for Compressor
Products International in 2008 were higher than 2007 due to acquisitions and increased volumes.
Despite a significant decline late in the year, GGB sales in 2008 exceeded 2007 sales due to
favorable foreign exchange rates and an acquisition. Quincy Compressors sales increased as a
result of the acquisition completed in the second quarter of 2008 and more shipments of
higher-priced compressors than in 2007.
Segment profits were $68.1 million in 2008, which compares to $69.4 million reported in 2007.
GGBs profits decreased in 2008 due to material cost increases that exceeded price increases.
Significant market declines in the second half largely negated first half volume gains and resulted
in lower productivity. Quincy Compressor reported slightly lower profit as a result of material
and other cost increases and competitive pricing conditions which offset the benefit of more
favorable sales mix. Profits at Compressor Products International increased as a result of higher
volumes and acquisitions. Operating margins for the segment decreased from 15.6% in 2007 to 13.0%
in 2008.
Engine
Products and Services
. Sales increased from $128.1 million in 2007 to $142.1
million in 2008. The increase in sales was principally due to higher revenue from engines and
higher parts sales in 2008.
The segment reported a profit of $20.8 million in 2008 compared to $15.3 million in 2007. The
improvement resulted from higher margins on engine sales, increased parts volumes and productivity
improvements in 2008 compared to 2007. Operating margins for the segment increased to 14.6% in
2008 from 11.9% in 2007.
2007 Compared to 2006
Sales were $1.03 billion in 2007, an 11% increase compared to the $928.4 million recorded in
2006. Increases in foreign currency exchange rates relative to the U.S. dollar, with the euro
being the most significant, and acquisitions added approximately six percentage points to revenue
growth on a year-over-year basis. The five percentage points of organic growth were the result of
stronger demand from Garlock Sealing Technologies U.S. and European markets, higher shipments from
GGBs European operations, continued strong demand in the energy-related markets of Compressor
Products International, increased engine and parts shipments from Fairbanks Morse Engine, and
selected price increases at several businesses. These favorable variances were partially offset by
lower OEM and aftermarket volumes in Stemcos heavy duty truck market, a drop in demand for
Plastomer Technologies products in
25
the semiconductor and industrial markets, and a small decrease in shipments from Quincy Compressor,
coming off of a strong year in 2006, for key markets such as energy, industrial and contractors.
Segment profit, one of managements primary measures of how our operations perform, increased
14% from $142.9 million in 2006 to $162.7 million in 2007. Segment profit was impacted by selected
price increases and increased sales volume at several businesses, improved margins on Fairbanks
Morse Engine shipments, a contract loss provision for Fairbanks Morse Engine in 2006 that did not
recur this year, a reduction in U.S. defined benefit pension expense, contributions from
acquisitions, and favorable foreign currency exchange rates. The defined benefit pension expense
declined because amendments to our U.S. salaried defined benefit plan implemented in the first
quarter of 2007 lowered service costs and because returns on pension assets improved. Despite the
lower demand experienced by Quincy Compressor and Garlock Rubber Technologies, each contributed to
the year-over-year increase in segment profit as a result of cost savings and price increases.
Volume declines at Stemco and Plastomer Technologies and an increase in restructuring expenses in
2007 partially offset the favorable affects of the previously mentioned items. Restructuring
expenses in 2007 were $6.0 million compared to $2.3 million in 2006. The restructuring costs in
each year were primarily for the modernization project at the Garlock Sealing Technologies
facilities in Palmyra, New York. Segment margins, defined as segment profit divided by sales,
increased from 15.4% in 2006 to 15.8% in 2007.
Asbestos expenses in 2007 were $68.4 million and included net cash outlays of $25.8 million
for legal fees and expenses incurred during the year and $42.6 million in non-cash charges to
maintain a ten-year liability estimate for future claims and to reflect an adjustment to our
internal estimate of the liability. In 2006, asbestos expenses were $359.4 million. The higher
expense in 2006 was primarily the result of an adjustment we made to record the asbestos liability
at a point that we believe to be the best estimate within our outside experts range of equally
likely estimates for the next ten years. For a further discussion of asbestos expenses, see
Contingencies Asbestos.
Net interest income in 2007 was $0.2 million compared to net interest expense of $3.2 million
last year. The net interest income was a result of the increase in invested cash balances while
the yield on those funds was essentially flat.
Our effective tax rate for 2007 was 35.0% compared to 37.5% in 2006. The decrease in the rate
for 2007 was principally due to the effect on our deferred tax balances of the enactment of reduced
income and trade tax rates in Germany. This was partially offset by an unfavorable change in the
mix of foreign and U.S. state and local taxable income.
In 2007, we recorded an extraordinary gain of $2.5 million, net of $1.6 million of taxes,
related to the acquisition of the outstanding shares of a subsidiary held by minority shareholders.
Following is a discussion of operating results for each segment during the year:
Sealing Products
. Sales of $457.3 million in 2007 were 6% higher than the $432.5
million reported in 2006. The favorable impact of the euro accounted for three percentage points
of the growth. Sales at Garlock Sealing Technologies benefited from increased demand in its
European markets, continued strength in the oil and gas sector, selected price increases and the
stronger euro. Aftermarket and OEM sales decreased at Stemco due to lower demand in the U.S.
heavy-duty truck market. Fewer new trucks and trailers were built as usage of existing trucks
declined. A decline in sales to Plastomer Technologies semiconductor market partially offset the
increase attributable to including the Amicon business, acquired in July 2006, for a full year in
2007.
Segment profit increased by 2% from $76.5 million in 2006 to $78.0 million in 2007. Profits
at Garlock Sealing Technologies benefited from higher volumes and selected price increases. These
26
benefits were partially offset by increased restructuring costs for the modernization project
at the Garlock Sealing Technologies facilities in Palmyra, NY and additional spending in marketing,
business development and R&D. Stemco reported a decline in profit in connection with its sales
decrease and increased costs, but the decline was partially mitigated by price increases. Garlock
Rubber Technologies increased its profit significantly in 2007 by focusing on cost reductions that
increased operating margins. Lower volumes negatively impacted Plastomer Technologies results, as
did increased restructuring expenses for the reorganization of its facilities. Segment margins
decreased from 17.7% in 2006 to 17.1% in 2007.
Engineered Products
. Sales of $445.5 million in 2007 were 14% higher than the $391.7
million reported in 2006. The increase in the value of the euro and the acquisitions completed in
2007 favorably impacted revenue by eleven percentage points when compared to 2006. Sales for
Compressor Products International were higher in 2007 due to the additional volume from the
acquisitions completed in 2006 and 2007 and increased activity in its North American and European
markets. In 2007, GGB benefited from the favorable euro exchange rate and increased volume in
Europe. Quincy Compressors sales were below the record levels of 2006 as demand declined in
energy and construction markets.
Segment profits of $69.4 million in 2007 were 13% higher than the $61.5 million reported in
2006. GGBs profits increased in 2007, when compared to 2006, due to higher volumes, a stronger
euro and selected price increases. Profits at Compressor Products International improved
principally as a result of the acquisitions and selected price increases. However, amortization of
intangible assets associated with the acquisitions resulted in lower operating margins at both CPI
and the segment. Despite the decline in revenue, Quincy Compressor was able to increase its
profitability slightly as a result of price increases and cost reductions. Segment margins were
essentially flat at 15.6% in 2007 and 15.7% in 2006.
Engine
Products and Services
. Sales increased 22% from the $105.2 million reported in
2006 to $128.1 million in 2007. About half of the increase was attributable to additional engine
and related parts shipments for U.S. Navy shipbuilding programs with the other half from sales of
aftermarket parts and service and selected price increases.
The segment reported a profit of $15.3 million in 2007 compared to $4.9 million in 2006. The
year-over-year improvement was a result of better margins on engine shipments, an increase in parts
shipments, which have better margins than engine sales, net cost savings in manufacturing and
administration expenses, and a $3.1 million contract loss on a U.S. Navy engine program recorded in
2006. Segment margins in 2007 were 11.9% compared to 4.7% in 2006.
Restructuring and Other Costs
Restructuring expense was $4.6 million, $6.0 million and $2.3 million for 2008, 2007 and 2006,
respectively. The expense in all three years was primarily related to restructuring activities
associated with the modernization project at our Garlock Sealing Technologies manufacturing
facilities in Palmyra, New York. The project, which commenced in 2005 and is expected to end in
2011, will reduce the number of buildings on the site from 26 to 7 and eliminate approximately
350,000 square feet of space, or approximately half of the space under roof at the beginning of the
project. See Note 3 to the Consolidated Financial Statements for additional information regarding
restructuring and other costs in each year.
Liquidity and Capital Resources
Cash requirements for working capital, capital expenditures, acquisitions, debt repayments and
common stock repurchases have been funded from cash balances on hand and cash generated from
operations. The Company is proactively pursuing acquisition opportunities, some of which may be of
a
27
size which would exceed our cash balances at the time of closing. Should we need additional
capital, we have other resources available, which are discussed under the heading of Capital
Resources.
Cash Flows
Operating activities provided $98.2 million, $104.8 million and $75.6 million in 2008, 2007
and 2006, respectively. The decrease in operating cash flows in 2008 versus 2007 was primarily
attributable to an increase in working capital and higher net outflows for asbestos. As expected,
asbestos-related insurance collections were lower in 2008 than in 2007 and amounted to $72.7
million and $90.2 million, respectively. The decrease in insurance collections was partially
offset by a decrease in asbestos-related payments, which amounted to $109.7 million in 2008 and
$115.1 million in 2007. We made a $10 million contribution to the U.S. defined benefit pension
plans in 2007 but no contribution in 2008. In 2007, operating cash flows increased from 2006
chiefly as a result of higher net earnings, lower net asbestos payments and a decrease in working
capital levels. These improvements were partially offset by an increase in payments for
environmental remediation activities in 2007, which were included in the change in other noncurrent
assets and liabilities. In 2006, working capital increased primarily due to higher inventories and
customer receivables at several of our operations. Inventory levels were higher in 2006 primarily
due to higher material requirements for engine programs at Fairbanks Morse Engine. Although the
2006 working capital was impacted by an increase in accounts receivable relating to increased sales
activity, the days sales outstanding for receivables remained constant on a year-over-year basis at
51 days. Payments for asbestos-related claims and expenses, net of insurance recoveries, were
$24.9 million in 2007 compared to $38.0 million in 2006.
We used $73.2 million, $142.3 million and $27.5 million in investing activities in 2008, 2007
and 2006, respectively. We made net payments for acquisitions of $43.4 million in 2008 compared to
$77.0 million in 2007 and $27.3 million in 2006. In addition, we received $10.5 million from the
distribution of proceeds from an investment and $4.2 million in proceeds from asset sales in 2008.
Our investing activities in 2008 included capital expenditures of $49.1 million associated with our
manufacturing facilities, compared to $46.8 million in 2007 and $41.3 million in 2006. The
increases in capital expenditures in 2008, 2007 and 2006 reflected spending associated with the
modernization activities at our manufacturing facilities in Palmyra, New York and our continued
strategy to expand geographically and to increase investments in our operations as part of an
effort to improve customer satisfaction and reduce costs. The results in 2007 were impacted by the
reclassification of $19.5 million of unrestricted cash balances to other current and noncurrent
assets based on changes in expected maturity dates of the underlying investments. The 2006 results
benefited from the reclassification of $39.8 million from restricted cash to unrestricted cash due
to the resolution of several verdicts on appeal.
In 2008, we paid $69.2 million in connection with the repurchase of approximately 1.9 million
shares of our common stock under the ASR agreement and share repurchase plan. These transactions
were reflected as financing activities in the Consolidated Statements of Cash Flows.
Capital Resources
Our primary U.S. operating subsidiaries have a senior secured revolving credit facility with a
group of banks, which matures on April 21, 2011. We have not borrowed against this facility. The
facility is collateralized by our receivables, inventories, intellectual property, insurance
receivables and all other personal property assets (other than fixed assets) of its U.S.
subsidiaries, and by pledges of 65% of the capital stock of our direct foreign subsidiaries and
100% of the capital stock of our direct and indirect U.S. subsidiaries. The facility contains
covenants and restrictions that are customary for an asset-based loan, including limitations on
dividends, limitations on incurrence of indebtedness and maintenance of a fixed charge coverage
financial ratio. Certain of the covenants and restrictions apply only if availability under the
facility falls below certain levels.
28
The maximum initial amount available for borrowings under the facility is $75 million. Under
certain conditions, the borrowers may request that the facility be increased by up to $25 million,
to $100 million in total. Actual borrowing availability at any date is determined by reference to
a borrowing base of specified percentages of eligible accounts receivable and inventory and is
reduced by usage of the facility, which includes outstanding letters of credit, and any reserves.
We issued $172.5 million of convertible debentures in 2005. The debentures bear interest at
an annual rate of 3.9375%, and we pay accrued interest on April 15 and October 15 of each year.
The debentures will mature on October 15, 2015. The debentures are direct, unsecured and
unsubordinated obligations and rank equal in priority with our unsecured and unsubordinated
indebtedness and will be senior in right of payment to all subordinated indebtedness. They
effectively rank junior to our secured indebtedness to the extent of the value of the assets
securing such indebtedness. The debentures do not contain any financial covenants. Holders may
convert the debentures into cash and shares of our common stock, if any, at an initial conversion
rate of 29.5972 shares of common stock per $1,000 principal amount of debentures (which is equal to
an initial conversion price of $33.79 per share), subject to adjustment, before the close of
business on October 15, 2015. Upon conversion, we would deliver (i) cash equal to the lesser of
the aggregate principal amount of the debentures to be converted or our total conversion
obligation, and (ii) shares of our common stock in respect of the remainder, if any, of our
conversion obligation. Conversion is permitted only under certain circumstances that had not
occurred at December 31, 2008.
We used a portion of the net proceeds from the sale of the debentures to enter into call
options (hedge and warrant transactions), which entitle us to purchase shares of our stock from a
financial institution at $33.79 per share and entitle the financial institution to purchase shares
of our stock from us at $46.78 per share. This will reduce potential dilution to our common
stockholders from conversion of the debentures and have the effect to us of increasing the
conversion price of the debentures to $46.78 per share.
We paid $3.1 million in the second quarter of 2008 to satisfy the outstanding 7
1
/
2
% Coltec
Senior Notes. Industrial revenue bonds, in the amount of $9.6 million at December 31, 2008, are
payable in full in the first quarter of 2009. The industrial revenue bonds bear interest at rates
ranging from 6.4% to 6.55%.
Dividends
To date, we have not paid dividends. If availability under our senior secured revolving
credit facility falls below $20 million, we would be limited in our ability to pay dividends. The
indenture that governs the convertible debentures does not restrict us from paying dividends.
Critical Accounting Policies and Estimates
The preparation of our Consolidated Financial Statements, in accordance with accounting
principles generally accepted in the United States, requires us to make estimates and judgments
that affect the reported amounts of assets, liabilities, revenues and expenses, and related
disclosures pertaining to contingent assets and liabilities. Note 1, Overview and Significant
Accounting Policies, to the Consolidated Financial Statements describes the significant accounting
policies used to prepare the Consolidated Financial Statements. On an ongoing basis we evaluate
our estimates, including, but not limited to, those related to bad debts, inventories, intangible
assets, income taxes, warranty obligations, restructuring, pensions and other postretirement
benefits, and contingencies and litigation. We base our estimates on historical experience and on
various other assumptions that we believe to be reasonable under the circumstances. Actual results
may differ from these estimates.
29
We believe that the following accounting policies and estimates are the most critical. Some
of them involve significant judgments and uncertainties and could potentially result in materially
different results under different assumptions and conditions.
Revenue Recognition
Revenue is recognized at the time title and risk of ownership is transferred or when services
are rendered. Any shipping costs billed to customers are recognized as revenue and expensed in
cost of goods sold.
Asbestos
In 2005 and the first three quarters of 2006, we recorded a liability related to asbestos
claims at the low end of a broad ten-year range of equally likely estimates provided by the firm of Bates White, LLC (Bates White), a recognized expert in the field
of estimating asbestos-related liabilities. Due to the uncertain nature of the estimated
liability, we and Bates White believed that no single amount in the range was a better estimate
than any other amount in the range. In accordance with the applicable accounting rules, we
recorded a liability for these claims at the low end of the range of estimated potential
liabilities. In the fourth quarter of 2006, based on our experience during the preceding two years
and other factors, we identified a best estimate within the Bates White range and adjusted the
liability accordingly.
The significant assumptions underlying the material components of the estimated liability
include: the number and trend of claims to be asserted; the mix of alleged diseases or impairment;
the trend in the number of claims for non-malignant cases; the probability that some existing and
potential future claims will eventually be dismissed without payment; the estimated amount to be
paid per claim; and the timing and impact of large amounts that will become available for the
payment of claims from the 524(g) trusts of former defendants in bankruptcy. The actual number of
future actions filed per year and the payments made to resolve those claims could exceed those
reflected in our estimate.
With the assistance of Bates White, we periodically review the period over which we can make a
reasonable estimate, the assumptions underlying our estimate, the range of reasonably possible
potential liabilities and managements estimate of the
liability, and adjust the estimate if necessary. Changing circumstances and new data that may become available could cause a change in
the estimated liability in the future by an amount that cannot currently be reasonably estimated,
and that increase could be significant and material. Additional discussion is included in this
Managements Discussion and Analysis of Financial Condition and Results of Operations in
Contingencies Asbestos.
Derivative Instruments and Hedging Activities
We have entered into contracts to hedge forecasted transactions occurring at various dates
through December 2010 that are denominated in foreign currencies. These contracts are accounted
for as cash flow hedges. As cash flow hedges, the effective portion of the gain or loss on the
contracts is reported in other comprehensive income and the ineffective portion is reported in
income. Amounts in accumulated other comprehensive income are reclassified into income in the
period when the hedged transactions occur.
30
Pensions and Postretirement Benefits
We and certain of our subsidiaries sponsor domestic and foreign defined benefit pension and
other postretirement plans. Major assumptions used in the accounting for these employee benefit
plans include the discount rate, expected return on plan assets, rate of increase in employee
compensation levels and assumed health care cost trend rates. Assumptions are determined based on
data available to us and appropriate market indicators, and are evaluated each year as of the
plans measurement date. A change in any of these assumptions could have a material effect on net
periodic pension and postretirement benefit costs reported in the Consolidated Statements of
Operations, as well as amounts recognized in the Consolidated Balance Sheets. See Note 12 to the
Consolidated Financial Statements for a discussion of pension and postretirement benefits.
Income Taxes
We use the asset and liability method of accounting for income taxes. Temporary differences
arising from the difference between the tax and book basis of an asset or liability are used to
compute future tax assets or liabilities. Deferred tax assets and liabilities are measured using
enacted tax rates expected to apply to the taxable income (losses) in the years in which those
temporary differences are expected to be recovered or settled. The effect on deferred tax assets
and liabilities from a change in tax rates is recognized in the period that includes the enactment
date. See Note 5 to the Consolidated Financial Statements for a discussion of income taxes.
Goodwill and Other Intangible Assets
The goodwill asset impairment test involves comparing the fair value of a reporting unit to
its carrying amount. If the carrying amount of a reporting unit exceeds its fair value, a second
step of comparing the implied fair value of the reporting units goodwill to the carrying amount of
that goodwill is required to measure the potential goodwill impairment loss. There are inherent
assumptions and estimates used in developing future cash flows which require management to apply
judgment to the analysis of intangible asset impairment, including projecting revenues, interest
rates, the cost of capital, royalty rates and tax rates. Many of the factors used in assessing
fair value are outside the control of management and it is reasonably likely that assumptions and
estimates will change in future periods. These changes can result in future impairments.
New
Accounting Pronouncements
See
Note 1 to the Consolidated Financial Statements for a description of
new accounting pronouncements, including the expected dates of
adoption and the expected effects on results of operations, cash
flows and financial condition, if any.
Contingencies
General
Various claims, lawsuits and administrative proceedings with respect to commercial, product
liability, asbestos and environmental matters, all arising in the ordinary course of business, are
pending or threatened against us or our subsidiaries and seek monetary damages and/or other
remedies. We believe that any liability that may finally be determined with respect to commercial
and non-asbestos product liability claims should not have a material effect on our consolidated
financial condition or results of operations. From time to time, we and our subsidiaries are also
involved as plaintiffs in legal proceedings involving contract, patent protection, environmental,
insurance and other matters.
Environmental
Our facilities and operations are subject to federal, state and local environmental and
occupational health and safety requirements of the U.S. and foreign countries. We take a proactive
approach in our efforts to comply with environmental, health and safety laws as they relate to our
manufacturing operations and in proposing and implementing any remedial plans that may be
necessary. We also
31
regularly conduct comprehensive environmental, health and safety audits at our facilities to
maintain compliance and improve operational efficiency.
Although we believe past operations were in substantial compliance with the then applicable
regulations, we or one of our subsidiaries have been named as a potentially responsible party, or
are otherwise involved, at 20 sites where the costs to us are expected to exceed $100,000.
Investigations have been completed for 15 sites and are in progress at the other five sites. The
majority of these sites relate to remediation projects at former operating facilities that were
sold or closed and primarily deal with soil and groundwater contamination.
As of December 31, 2008 and 2007, EnPro had accrued liabilities of $22.1 million and $27.7
million, respectively, for estimated future expenditures relating to environmental contingencies.
See Note 17 to the Consolidated Financial Statements for additional information regarding our
environmental contingencies.
Colt Firearms and Central Moloney
We have contingent liabilities related to divested businesses for which certain of our
subsidiaries retained liability or are obligated under indemnity agreements. These contingent
liabilities include, but are not limited to, potential product liability and associated claims
related to firearms manufactured prior to 1990 by Colt Firearms, a former operation of Coltec, and
for electrical transformers manufactured prior to 1994 by Central Moloney, another former Coltec
operation. No product liability claims are currently pending against Coltec related to Colt
Firearms or Central Moloney. Coltec also has ongoing obligations, which are included in retained
liabilities of previously owned businesses in our Consolidated Balance Sheets, with regard to
workers compensation, retiree medical and other retiree benefit matters that relate to Coltecs
periods of ownership of these operations.
Crucible Materials Corporation
Crucible Materials Corporation (Crucible), which is engaged primarily in the manufacture and
distribution of specialty metal products, was a wholly owned subsidiary of Coltec until 1985 when a
majority of the outstanding shares were sold. Coltec divested its remaining minority interest in
2004. See Note 17 to the Consolidated Financial Statements for information about certain
liabilities relating to Coltecs ownership of Crucible.
Debt and Capital Lease Guarantees
As of December 31, 2008, we had contingent liabilities for potential payments on guarantees of
certain debt and lease obligations totaling $6.2 million. These guarantees arose from the
divestitures of Crucible and Central Moloney, and expire at various dates through 2010. There is
no liability for these guarantees reflected in our Consolidated Balance Sheets. In the event that
the other parties do not fulfill their obligations under the debt or lease agreements, we could be
responsible for these obligations.
Asbestos
History
. Certain of our subsidiaries, primarily Garlock Sealing Technologies LLC
(Garlock) and The Anchor Packing Company (Anchor), are among a large number of defendants in
actions filed in various states by plaintiffs alleging injury or death as a result of exposure to
asbestos fibers. Among the products at issue in these actions are industrial sealing products,
including gaskets and packing products. Since the first asbestos-related lawsuits were filed
against Garlock in 1975, Garlock and Anchor have processed more than 900,000 asbestos claims to
conclusion (including judgments, settlements and dismissals) and, together with their insurers,
have paid almost $1.4 billion in settlements
32
and judgments and over $400 million in fees and expenses. See Note 17 to the Consolidated
Financial Statements for information on the disease mix in the claims, new claims recently filed,
product defenses asserted by our subsidiaries, recent trial and appellate results, and settlements.
Status of Anchor
. Anchor is an inactive and insolvent indirect subsidiary of Coltec.
There is no remaining insurance coverage available to Anchor. Anchor has no remaining assets and
has not committed to settle any actions since 1998. As cases reach the trial stage, Anchor is
typically dismissed without payment.
Insurance Coverage
. At December 31, 2008, Garlock had available $307.4 million of
insurance and trust coverage that we believe will be available to
cover current and future asbestos claims and
certain expense payments. We believe that Garlock may also recover some
additional insurance from insolvent carriers over time. Garlock collected approximately $0.1 million and $1.0
million, respectively, from insolvent carriers in 2008 and 2007. There can be no assurance that
Garlock will collect any additional insurance from insolvent carriers. See Note 17 to the Consolidated Financial Statements for
additional information about the quality of Garlocks insurance, arrangements for payments with
certain insurers, the resolution of past insurance disputes, and coverage exclusions for exposure
after July 1, 1984.
Our Liability Estimate
. Prior to mid-2004, we maintained that our subsidiaries
liability for unasserted claims was not reasonably estimable. We estimated and recorded
liabilities only for pending claims in advanced stages of processing, for which we believed we had
a basis for making a reasonable estimate. We disclosed the significance of the total potential
liability for unasserted claims in considerable detail. During 2004 we authorized counsel to
retain Bates White to assist in estimating our subsidiaries liability for pending and future
asbestos claims.
Bates Whites first report, dated February 17, 2005, provided an estimate of the liability as
of December 31, 2004 for the following ten years, which represented a time horizon within which
Bates White believed such liability was both probable and estimable within a range of values.
Bates White has updated its estimate every quarter since the end of 2004. Each quarter until the
fourth quarter of 2006, we adopted the Bates White estimate and adjusted the liability to equal the
low end of the then-current range.
The estimated range of potential liabilities provided by Bates White at December 31, 2008 was
$431 million to $627 million. According to Bates White, increases in the range over time have been
attributable primarily to (1) the propensity to sue Garlock, (2) an increase in settlement values
of mesothelioma claims, (3) an increase in claims filings and values in some jurisdictions, most
notably California, and (4) the delay in, and uncertain impact of, the funding and implementation
of trusts formed under Section 524(g) of the United States Bankruptcy Code to pay asbestos claims
against numerous defendants in Chapter 11 reorganization cases. Because the 524(g) trusts are
estimated by some, including Bates White, to have billions of dollars available for the payment of
asbestos claims, they could have a significant impact on our future settlement payments and could
therefore significantly affect our liability.
We have independently developed internal estimates for asbestos-related liabilities. We have
used those estimates for a variety of purposes, including guidance for settlement negotiations and
trial strategy, in our strategic planning, budgeting and cash flow planning processes, and in
setting targets for annual and long-term incentive compensation. Our internal estimate has been
within the Bates White range of equally likely estimates and has proven to be a more precise
predictor of the actual amounts spent on settlements and verdicts than the low end of the Bates
White range. As a result, while the low end of the Bates White range still provides a reasonable
lower boundary of possible outcomes, Bates White and management believe that our internal estimate
for the next ten years represents the most likely
33
point within the range. Accordingly, we adjusted the recorded liability from the low end of
the Bates White estimate to our point estimate in the fourth quarter of 2006 and have adjusted the
liability in each subsequent quarter consistent with our internal estimate.
We currently estimate that the liability of our subsidiaries for the indemnity cost of
resolving asbestos claims for the next ten years will be $458.7 million. The estimated liability
of $458.7 million is before any tax benefit and is not discounted to present value, and it does not
include fees and expenses, which are recorded as incurred. The recorded liability will continue to
be impacted by actual claims and settlement experience and any change in the legal environment that
could cause a significant increase or decrease in the long-term expectations of management and
Bates White. We expect the recorded liability to fluctuate, perhaps significantly. Any
significant change in the estimated liability could have a material effect on our consolidated
financial position and results of operations.
Our estimate is within the Bates White range, developed independently, and we believe that our
estimate is the best estimate within the Bates White range of reasonable and probable estimates of
Garlocks future obligation.
Bates White also indicated a broader range of potential estimates from $189 million to $711
million. We caution that points within that broader range remain possible outcomes. Also, while
we agree with Bates White that beyond two to four years for Garlocks economically-driven
non-malignant claims and beyond ten years for Garlocks cancer claims and medically-driven
non-malignant claims, there are reasonable scenarios in which the [asbestos] expenditure is
de
minimus
, we caution that the process of estimating future liabilities is highly uncertain.
Adjusting our liability to the best estimate within the range does not change that fact. In the
words of the Bates White report, the reliability of estimates of future probable expenditures of
Garlock for asbestos-related personal injury claims declines significantly for each year further
into the future. Scenarios continue to exist that could result in a total future asbestos
liability for Garlock in excess of $1 billion.
As previously mentioned, the liability estimate does not include legal fees and expenses,
which add considerably to the costs each year. Over the last two years, these expenses have
averaged approximately $7 million per quarter. In addition to these legal fees and expenses, we
expect to continue to record charges to income in future quarters for:
|
|
|
Increases or decreases, if any, in our estimate of Garlocks potential liability,
plus
|
|
|
|
|
Increases, if any, that result from additional quarters added to maintain the
ten-year estimation period (increases of this type have averaged approximately $6 7
million per quarter for the last two years), plus
|
|
|
|
|
Amounts, if any, of solvent insurance lost or commuted, offset by insolvent
recoveries and earnings from insurance settlement trusts.
|
In 2008, we recorded a pre-tax charge of $52.1 million to reflect net cash outlays of $26.2
million for legal fees and expenses paid during the year and a $25.9 million non-cash charge. The
non-cash charge included $23.8 million, primarily to add an estimate of the liability for 2018 to
maintain a ten-year estimate and $2.1 million to reduce the remaining insurance estimated to be
available from remaining policies with various London market carriers.
In 2007, we recorded a pre-tax charge to income of $68.4 million to reflect net cash outlays
of $25.8 million for legal fees and expenses incurred during the year, and a $42.6 million non-cash
charge. The non-cash charge included $23.2 million related to the addition of periods to maintain
a ten-year liability estimate and $19.4 million to adjust the liability based on revisions to
managements estimate in the fourth quarter of 2007. We made this adjustment based on our review
of negotiations and payment
34
trends and our belief that it is more likely that, in the future, a higher percentage of
settlement commitments made in any year will also be paid in that same year.
See Note 17 to the Consolidated Financial Statements for additional information about our
liability estimate.
Quantitative Claims and Insurance Information
. Our liability as of December 31, 2008
was $465.5 million (our estimate of the liability described above of $458.7 million plus $6.8
million of accrued legal and other fees already incurred but not yet paid). The liability included
$85.3 million classified as a current liability and $380.2 million classified as a noncurrent
liability. The recorded amounts do not include legal fees and expenses to be incurred in the
future. See Note 17 to the Consolidated Financial Statements for additional information about
pending cases, insurance, cash flows and our liability.
Strategy
. Garlocks strategy is to focus on trial-listed cases and other cases in
advanced stages, to reduce new settlement commitments each year, to carefully manage and maximize
insurance collections, and to proactively support legislative and other efforts aimed at meaningful
asbestos reform. We believe that this strategy should result in the reduction of the negative
annual cash flow impact from asbestos claims over time. However, the risk of large verdicts
sometimes impacts the implementation of the strategy, and therefore it is likely that, from time to
time, Garlock will enter into settlements that involve large numbers of cases, including
early-stage cases. We believe that, as predicted in various epidemiological studies that are
publicly available, the incidence of asbestos-related disease is in decline and should continue to
decline steadily over the next decade and thereafter, so that claims activity against Garlock will
eventually decline to a level that can be paid from the cash flow expected from Garlocks
operations, even after Garlock exhausts its insurance coverage. However, there can be no assurance
that epidemiological predictions about incidence of asbestos-related disease will prove to be
accurate, or that, even if they are, there will be a commensurate decline in the number of
asbestos-related claims filings.
Considering the foregoing, as well as the experience of our subsidiaries and other defendants
in asbestos litigation, the likely sharing of judgments among multiple responsible defendants,
bankruptcies of other defendants, and legislative efforts, and given the amount of insurance
coverage available to our subsidiaries from solvent insurance carriers, we believe that pending
asbestos actions against our subsidiaries are not likely to have a material adverse effect on our
financial condition, but could be material to our results of operations or cash flows in given
future periods. We anticipate that asbestos claims will continue to be filed against our
subsidiaries. Because of (1) the uncertainty as to the number and timing of potential future
claims and the amount that will have to be paid to litigate, settle or satisfy claims, and (2) the
finite amount of insurance available for future payments, future claims could have a material
adverse effect on our financial condition, results of operations and cash flows.
Off Balance Sheet Arrangements
Lease Agreements
We have several operating leases primarily for real estate, equipment and vehicles. Operating
lease arrangements are generally utilized to secure the use of assets from time to time if the
terms and conditions of the lease or the nature of the asset makes the lease arrangement more
favorable than a purchase. As of December 31, 2008, approximately $57.3 million of future minimum
lease payments were outstanding under these agreements. See Note 17, Commitments and
Contingencies Other Commitments, to the Consolidated Financial Statements for additional
disclosure.
35
Debt and Capital Lease Guarantees
At December 31, 2008, we have outstanding contingent liabilities for guaranteed debt and lease
payments of $6.2 million related to previously divested businesses.
Contractual Obligations
A summary of our contractual obligations and commitments at December 31, 2008 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments Due by Period (in millions)
|
|
|
|
|
|
|
|
Less than
|
|
|
|
|
|
|
|
|
|
|
More than
|
|
Contractual Obligations
|
|
Total
|
|
|
1 Year
|
|
|
1-3 Years
|
|
|
3-5 Years
|
|
|
5 Years
|
|
Long-term debt
|
|
$
|
182.2
|
|
|
$
|
9.6
|
|
|
$
|
0.1
|
|
|
$
|
|
|
|
$
|
172.5
|
|
Interest on long-term debt
|
|
|
46.8
|
|
|
|
6.9
|
|
|
|
13.6
|
|
|
|
13.6
|
|
|
|
12.7
|
|
Operating leases
|
|
|
57.3
|
|
|
|
13.0
|
|
|
|
20.2
|
|
|
|
14.5
|
|
|
|
9.6
|
|
Other long-term
liabilities
|
|
|
54.9
|
|
|
|
5.2
|
|
|
|
5.7
|
|
|
|
5.1
|
|
|
|
38.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
341.2
|
|
|
$
|
34.7
|
|
|
$
|
39.6
|
|
|
$
|
33.2
|
|
|
$
|
233.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payment for long-term debt may be accelerated under certain circumstances because the
convertible debentures due in 2015 may be converted earlier, requiring payment of the principal
amount thereof in cash. Additional discussion regarding the convertible debentures is included in
this Managements Discussion and Analysis of Financial Condition and Results of Operations in
Liquidity and Capital Resources Capital Resources, and in Note 10 to the Consolidated
Financial Statements.
Payments for other long-term liabilities are estimates of amounts that will be paid for
environmental and retained liabilities of previously owned businesses included in the Consolidated
Balance Sheets at December 31, 2008. These estimated payments are based on information currently
known to us. However, it is possible that these estimates will vary from actual results if new
information becomes available in the future or if there are changes in the facts and circumstances
related to these liabilities. Additional discussion regarding these liabilities is included
earlier in this Managements Discussion and Analysis of Financial Condition and Results of
Operations in Contingencies Environmental, Contingencies Colt Firearms and Central Moloney,
Contingencies Crucible Materials Corporation, and in Note 17 to the Consolidated Financial
Statements.
At December 31, 2008, we had a $5.1 million reserve for unrecognized tax benefits which is not
reflected in the table above. Substantially all of this tax reserve is classified in other
long-term liabilities and deferred income taxes in our Consolidated Balance Sheet. The table also
does not include obligations under our pension and postretirement benefit plans, which are included
in Note 12 to the Consolidated Financial Statements.
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are exposed to certain market risks as part of our ongoing business operations, including
risks from changes in foreign currency exchange rates and interest rates that could impact our
financial condition, results of operations and cash flows. We manage our exposure to these and
other market risks through regular operating and financing activities and through the use of
derivative financial instruments. We intend to use derivative financial instruments as risk
management tools and not for speculative investment purposes.
36
Interest Rate Risk
We are exposed to interest rate risk as a result of our outstanding debt obligations. The
table below provides information about our debt obligations as of December 31, 2008. The table
represents principal cash flows (in millions) and related weighted average interest rates by
expected (contractual) maturity dates.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair
|
|
|
2009
|
|
2010
|
|
2011
|
|
2012
|
|
2013
|
|
Thereafter
|
|
Total
|
|
Value
|
Fixed rate debt
|
|
$
|
9.6
|
|
|
$
|
0.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
172.5
|
|
|
$
|
182.2
|
|
|
$
|
145.1
|
|
Average
interest rate
|
|
|
6.5
|
%
|
|
|
9.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.9
|
%
|
|
|
4.1
|
%
|
|
|
|
|
Foreign Currency Risk
We are exposed to foreign currency risks that arise from normal business operations. These
risks include the translation of local currency balances on our foreign subsidiaries balance
sheets, intercompany loans with foreign subsidiaries and transactions denominated in foreign
currencies. Our objective is to control our exposure to these risks through our normal operating
activities and, where appropriate, through foreign currency forward or option contracts. The
following table provides information about our outstanding foreign currency forward and option
contracts as of December 31, 2008.
|
|
|
|
|
|
|
|
|
|
|
Notional Amount
|
|
|
|
|
|
|
|
Outstanding in
|
|
|
|
|
|
|
|
Millions of U.S.
|
|
|
|
|
|
Transaction Type
|
|
Dollars (USD)
|
|
|
Maturity Dates
|
|
Exchange Rate Ranges
|
Forward Contracts
|
|
|
|
|
|
|
|
|
Sell Slovakian koruna/buy euro
|
|
$
|
27.5
|
|
|
Jan 2009
|
|
30.138 to 30.156 koruna/euro
|
Sell British pound/buy euro
|
|
|
20.3
|
|
|
Jan 2009
|
|
0.977 to 0.978 pound/euro
|
Sell euro/buy Australian dollar
|
|
|
18.4
|
|
|
Jan 2009
|
|
2.049 to 2.053 Australian dollar/euro
|
Buy US dollar/sell euro
|
|
|
17.0
|
|
|
Jan 2009 Dec 2009
|
|
1.455 to 1.468 USD/euro
|
Buy euro/sell US dollar
|
|
|
12.9
|
|
|
Jan 2009 Mar 2010
|
|
1.299 to 1.516 USD/euro
|
Buy US dollar/sell Australian dollar
|
|
|
4.2
|
|
|
Jan 2009 Dec 2009
|
|
0.825 to 0.851 USD/Australian dollar
|
Buy British
pound/sell euro
|
|
|
4.2
|
|
|
Jan 2009 Dec 2009
|
|
0.795 to 0.799 pound/euro
|
Sell US dollar/buy Canadian dollar
|
|
|
4.0
|
|
|
Jan 2009 Dec 2009
|
|
1.061 to 1.064 Canadian dollar/USD
|
Buy euro/sell peso
|
|
|
2.4
|
|
|
Jan 2009
|
|
18.443 to 18.612 peso/euro
|
|
|
|
|
|
|
|
|
|
|
|
110.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Option Contracts
|
|
|
|
|
|
|
|
|
Buy euro/sell US dollar
|
|
|
19.4
|
|
|
Jan 2009 Dec 2010
|
|
1.336 USD/euro
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
130.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
37
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTAL DATA
ENPRO INDUSTRIES, INC.
Index to Consolidated Financial Statements
|
|
|
|
|
|
|
Page
|
Report of Independent Registered Public Accounting Firm
|
|
|
47
|
|
Consolidated Statements of Operations for the years ended December 31, 2008, 2007 and 2006
|
|
|
49
|
|
Consolidated Statements of Cash Flows for the years ended December 31, 2008, 2007 and 2006
|
|
|
50
|
|
Consolidated Balance Sheets as of December 31, 2008 and 2007
|
|
|
51
|
|
Consolidated Statements of Changes in Shareholders Equity for the years ended December 31,
2008, 2007 and 2006
|
|
|
52
|
|
Notes to Consolidated Financial Statements
|
|
|
53
|
|
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
Not applicable.
ITEM 9A. CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
As of the end of the period covered by this report, we carried out an evaluation, under the
supervision and with the participation of our chief executive officer and chief financial officer,
of the effectiveness of the design and operation of our disclosure controls and procedures. The
purpose of our disclosure controls and procedures is to provide reasonable assurance that
information required to be disclosed in our reports filed under the Exchange Act, including this
report, is recorded, processed, summarized and reported within the time periods specified, and that
such information is accumulated and communicated to our management to allow timely decisions
regarding disclosure.
Management does not expect that our disclosure controls and procedures or internal controls
will prevent all errors and all fraud. A control system, no matter how well conceived or operated,
can provide only reasonable, not absolute, assurance that the objectives of the control system are
met. Further, the design of a control system must reflect the fact that there are resource
constraints, and the benefits of controls must be considered relative to their costs. Because of
the inherent limitations in all control systems, no evaluation of controls can provide absolute
assurance that all control issues and instances of fraud, if any, within the company have been
detected. These inherent limitations include the realities that judgments in decision-making can
be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be
circumvented by the individual acts of some persons, by collusion of two or more people, or by
management override of the controls. The design of any system of controls is based in part on
certain assumptions about the likelihood of future events, and there can be no assurance that any
design will succeed in achieving its stated goals under all potential future conditions. Over
time, controls may become inadequate because of changes in conditions or deterioration in the
degree of compliance with polices or procedures. Because of the inherent limitations in a
cost-effective control system, misstatements due to error or fraud may occur and not be detected.
Based on the controls evaluation, our chief executive officer and chief financial officer have
concluded that our disclosure controls and procedures are effective to reasonably ensure that
information
38
required to be disclosed in our reports filed under the Exchange Act is recorded, processed,
summarized and reported within the time periods specified, and that management will be timely
alerted to material information required to be included in our periodic reports filed with the
Securities and Exchange Commission.
In addition, no change in our internal control over financial reporting has occurred during
the quarter ended December 31, 2008 that has materially affected, or is reasonably likely to
materially affect, our internal control over financial reporting.
Managements Report on Internal Control over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over
financial reporting, as such term is defined in Rule 13a-15(f) under the Exchange Act. Our
internal control over financial reporting is a process designed to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles. Because of its
inherent limitations, internal control over financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation of effectiveness to future periods are subject
to the risk that controls may become inadequate because of changes in conditions, or that the
degree of compliance with policies and procedures may deteriorate. Therefore, even those systems
determined to be effective can provide only reasonable assurance with respect to financial
statement preparation and presentation.
We carried out an evaluation, under the supervision and with the participation of our chief
executive officer and our chief financial officer, of the effectiveness of our internal control
over financial reporting as of the end of the period covered by this report. However, the
assessment did not include the following operations that we acquired within the past year, none of
which, individually or in the aggregate, would be considered significant under Rule 1-02(w) of
Regulation SX of the SEC: Air Perfection, Inc., C&P Services (Northern) Ltd., Horizon Compressor
Services, Inc., Northern Gaskets & Mouldings Ltd., Reciprocating Aircompressor Maintenance, Inc.
(d/b/a RAM Air, Inc.), Shanghai Sinflex Sealing Technologies Co. and V.W. Kaiser Engineering, Inc.
In making this assessment, we used the criteria set forth by the Committee of Sponsoring
Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework. Based on
our assessment, we have concluded that, as of December 31, 2008, our internal control over
financial reporting was effective based on those criteria.
The effectiveness of our internal control over financial reporting as of December 31, 2008,
has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm,
as stated in their report which appears in this Annual Report on Form 10-K.
ITEM 9B. OTHER INFORMATION
Not applicable.
39
PART III
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Information concerning our directors and officers appearing under the captions Election of
Directors, Legal Proceedings, Corporate Governance Policies and Practices, and information
under the caption Security Ownership of Certain Beneficial Owners and Management Section 16(a)
Beneficial Ownership Reporting Compliance in our definitive proxy statement for the 2009 annual
meeting of shareholders is incorporated herein by reference.
We have adopted a written Code of Business Conduct that applies to all of our directors,
officers and employees, including our principal executive officer, principal financial officer and
principal accounting officer. The Code is available on our Internet site at
www.enproindustries.com. We intend to disclose on our Internet site any substantive changes to the
Code and any waivers granted under the Code to the specified officers.
ITEM 11. EXECUTIVE COMPENSATION
A description of the compensation of our executive officers is set forth under the caption
Executive Compensation in our definitive proxy statement for the 2009 annual meeting of
shareholders and is incorporated herein by reference.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS
Security ownership data appearing under the caption Security Ownership of Certain Beneficial
Owners and Management in our definitive proxy statement for the 2009 annual meeting of
shareholders is incorporated herein by reference.
The table below contains information as of December 31, 2008, with respect to our Amended and
Restated 2002 Equity Compensation Plan, the only compensation plan or arrangement (other than our
tax-qualified plans) under which we have options, warrants or rights to receive equity securities
authorized for issuance.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities
|
|
|
|
|
|
|
|
|
|
|
Remaining Available for
|
|
|
Number of Securities
|
|
|
|
|
|
Future Issuance Under
|
|
|
to be Issued Upon
|
|
Weighted-Average
|
|
Equity Compensation
|
|
|
Exercise of Outstanding
|
|
Exercise Price of
|
|
Plans (Excluding
|
|
|
Options, Warrants
|
|
Outstanding Options,
|
|
Securities Reflected in
|
Plan Category
|
|
and Rights
|
|
Warrants and Rights
|
|
Column (a))
|
|
|
(a)
|
|
(b)
|
|
(c)
|
Equity compensation plans
approved by security holders
|
|
|
1,398,955
|
(1)
|
|
$
|
9.35
|
(2)
|
|
|
695,596
|
|
Equity
compensation plans not approved by security holders
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
1,398,955
|
(1)
|
|
$
|
9.35
|
(2)
|
|
|
695,596
|
|
|
|
|
(1)
|
|
Includes performance shares awarded under our Amended and Restated 2002 Equity Compensation
Plan at the level paid for the 2006 2008 performance cycle and the maximum levels payable
for the 2007 2009 and 2008 2010 performance cycles.
|
40
|
|
|
(2)
|
|
The weighted average exercise price does not take into account awards of performance shares
or phantom shares made under our Amended and Restated 2002 Equity Compensation Plan.
Information with respect to these awards is incorporated by reference to the information
appearing under the captions Corporate Governance Policies and Practices Director
Compensation and Executive Compensation Grants of Plan Based Awards LTIP Awards in
our definitive proxy statement for the 2009 annual meeting of shareholders.
|
Information
concerning the inducement awards granted in 2008 to our Chief Executive Officer outside of our
Amended and Restated 2002 Equity Compensation Plan is incorporated by reference to the
information appearing under the caption Executive Compensation Employment Agreement in
our definitive proxy statement for the 2009 annual meeting of shareholders.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
Information concerning the independence of our directors is set forth under the caption
Corporate Governance Policies and Practices Director Independence in our definitive proxy
statement for the 2009 annual meeting of shareholders and is incorporated herein by reference.
ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
Information appearing under the caption Independent Registered Public Accounting Firm in our
definitive proxy statement for the 2009 annual meeting of shareholders is incorporated herein by
reference.
PART IV
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a) The following documents are filed as part of this report:
1. Financial Statements
The financial statements filed as part of this report are listed in Part II, Item 8 of this
report on the Index to Consolidated Financial Statements.
2. Financial Statement Schedule
Schedule II Valuation and Qualifying Accounts for the years ended December 31, 2008, 2007
and 2006 appears on page 93.
Other schedules are omitted because of the absence of conditions under which they are required
or because the required information is provided in the Consolidated Financial Statements or notes
thereto.
3. Exhibits
The exhibits to this report on Form 10-K are listed in the Exhibit Index appearing on pages 43
to 46.
41
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the
City of Charlotte, North Carolina on this 2
nd
day of March, 2009.
|
|
|
|
|
|
ENPRO INDUSTRIES, INC.
|
|
Date: March 2, 2009
|
By:
|
/s/ Richard L. Magee
|
|
|
|
Richard L. Magee
|
|
|
|
Senior Vice President, General Counsel and
Secretary
|
|
|
|
|
|
|
By:
|
/s/ William Dries
|
|
|
|
William Dries
|
|
|
|
Senior Vice President and Chief Financial Officer
(Principal Accounting Officer)
|
|
|
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been
signed below by the following persons, or in their behalf by their duly appointed attorney-in-fact,
on behalf of the registrant in the capacities and on the date indicated.
|
|
|
|
|
Signatures
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/ Stephen E. Macadam
Stephen E. Macadam
|
|
President and
Chief Executive Officer
(Principal Executive Officer) and Director
|
|
March 2, 2009
|
|
|
|
|
|
/s/ William R. Holland
William R. Holland*
|
|
Chairman of the Board and Director
|
|
March 2, 2009
|
|
|
|
|
|
/s/ J. P. Bolduc
J. P. Bolduc*
|
|
Director
|
|
March 2, 2009
|
|
|
|
|
|
/s/ Peter C. Browning
Peter C. Browning*
|
|
Director
|
|
March 2, 2009
|
|
|
|
|
|
/s/ Don DeFossett
Don DeFossett
|
|
Director
|
|
March 2, 2009
|
|
|
|
|
|
/s/ Joe T. Ford
Joe T. Ford*
|
|
Director
|
|
March 2, 2009
|
|
|
|
|
|
/s/ Gordon D. Harnett
Gordon D. Harnett*
|
|
Director
|
|
March 2, 2009
|
|
|
|
|
|
/s/ David L. Hauser
David L. Hauser*
|
|
Director
|
|
March 2, 2009
|
|
|
|
|
|
/s/ Wilbur J. Prezzano, Jr.
Wilbur J.
Prezzano, Jr.*
|
|
Director
|
|
March 2, 2009
|
|
|
|
|
|
* By:
|
|
/s/ Richard L. Magee
Richard L. Magee, Attorney-in-Fact
|
|
|
42
EXHIBIT INDEX
3.1
|
|
Restated Articles of Incorporation of EnPro Industries, Inc., (incorporated by reference to
Exhibit 3.1 to the Form 10-Q for the period ended June 30, 2008 filed by EnPro Industries,
Inc. (File No. 001-31225))
|
|
3.2
|
|
Amended Bylaws of EnPro Industries, Inc. (incorporated by reference to Exhibit 99.1 to the
Form 8-K dated December 12, 2007 filed by EnPro Industries, Inc. (File No. 001-31225))
|
|
4.1
|
|
Form of certificate representing shares of common stock, par value $0.01 per share, of EnPro
Industries, Inc. (incorporated by reference to Amendment No. 4 of the Registration Statement
on Form 10 of EnPro Industries, Inc. (File No. 001-31225))
|
|
4.2
|
|
Rights Agreement between EnPro Industries, Inc. and The Bank of New York, as rights agent
(incorporated by reference to Exhibit 4.7 to the Registration Statement on Form S-8 filed by
EnPro Industries, Inc., the EnPro Industries, Inc. Retirement Savings Plan for Hourly Workers
and the EnPro Industries, Inc. Retirement Savings Plan for Salaried Workers (File No.
333-89576))
|
|
4.5
|
|
Indenture dated as of October 26, 2005 between EnPro Industries, Inc. and Wachovia Bank,
National Association, as trustee (incorporated by reference to Exhibit 10.1 to the Form 8-K
dated October 26, 2005 filed by EnPro Industries, Inc. (File No. 001-31225))
|
|
10.1
|
|
Form of Indemnification Agreement for directors and officers (incorporated by reference to
Exhibit 10.5 to Amendment No. 3 of the Registration Statement on Form 10 of EnPro Industries,
Inc. (File No. 001-31225))
|
|
10.2+
|
|
EnPro Industries, Inc. 2002 Equity Compensation Plan (2005 Amendment and Restatement)
(incorporated by reference to Appendix A to the Proxy Statement on Schedule 14A dated March
29, 2005 filed by EnPro Industries, Inc. (File No. 001-31225))
|
|
10.3+
|
|
EnPro Industries, Inc. Senior Executive Annual Performance Plan (incorporated by reference
to Appendix A to the Proxy Statement on Schedule 14A dated March 22, 2007 filed by EnPro
Industries, Inc. (File No. 001-31225))
|
|
10.4+
|
|
EnPro Industries, Inc. Long-Term Incentive Plan (incorporated by reference to Appendix B to
the Proxy Statement on Schedule 14A dated March 22, 2007 filed by EnPro Industries, Inc. (File
No. 001-31225))
|
|
10.5+
|
|
Form of EnPro Industries, Inc. Long-Term Incentive Plan Award Grant (incorporated by
reference to Exhibit 10.5 to the Form 10-K for the year ended December 31, 2007 filed by EnPro
Industries, Inc. (File No. 001-31225))
|
|
10.6+
|
|
Form of EnPro Industries, Inc. Phantom Share Award Grant for Outside Directors (2005
Amendment and Restatement) (incorporated by reference to Exhibit 10.6 to the Form 10-K for the
year ended December 31, 2007 filed by EnPro Industries, Inc. (File No. 001-31225))
|
|
10.7+
|
|
Form of EnPro Industries, Inc. Restricted Share Award Agreement (incorporated by reference
to Exhibit 10.1 to the Form 8-K dated February 14, 2008 filed by EnPro Industries, Inc. (File
No. 001-31225))
|
43
10.8+
|
|
EnPro Industries, Inc. Defined Benefit Restoration Plan (amended and restated effective as
of January 1, 2007) (incorporated by reference to Exhibit 10.25 to the Form 10-K for the year
ended December 31, 2006 filed by EnPro Industries, Inc. (File No. 001-31225))
|
|
10.9+
|
|
EnPro Industries, Inc. Deferred Compensation Plan (as amended and restated effective January
1, 2007) (incorporated by reference to Exhibit 10.9 to the Form 10-K for the year ended
December 31, 2007 filed by EnPro Industries, Inc. (File No. 001-31225))
|
|
10.10+
|
|
EnPro Industries, Inc. Deferred Compensation Plan for Non-Employee Directors (as amended and
restated effective February 12, 2008) (incorporated by reference to Exhibit 10.1 to the Form
10-Q for the period ended March 31, 2008 filed by EnPro Industries, Inc. (File No. 001-31225))
|
|
10.11+
|
|
EnPro Industries, Inc. Outside Directors Phantom Share Plan (incorporated by reference to
Exhibit 10.14 to the Form 10-K for the year ended December 31, 2002 filed by EnPro Industries,
Inc. (File No. 001-31225))
|
|
10.12
|
|
Amended and Restated Loan and Security Agreement, dated April 26, 2006 by and among Coltec
Industries Inc, Coltec Industrial Products LLC, Garlock Sealing Technologies LLC, GGB LLC,
Corrosion Control Corporation and Stemco LP, as Borrowers; EnPro Industries, Inc., as Parent;
QFM Sales and Services, Inc., Coltec International Services Co, Garrison Litigation Management
Group, Ltd., GGB, Inc., Garlock International Inc, Stemco Delaware LP, Stemco Holdings, Inc.,
Stemco Holdings Delaware, Inc. and Garlock Overseas Corporation, as Subsidiary Guarantors; the
various financial institutions listed on the signature pages thereof, as Lenders; Bank of
America, N.A., as Agent and Issuing Bank; and Banc of America Securities LLC, as Sole Lead
Arranger and Sole Book Manager (incorporated by reference to Exhibit 10.1 to the Form 8-K
dated April 26, 2006 filed by EnPro Industries, Inc. (File No. 001-31225))
|
|
10.13+*
|
|
Management Continuity Agreement dated as of April 14, 2008 between EnPro Industries, Inc.
and Stephen E. Macadam
|
|
10.14+
|
|
Management Continuity Agreement dated as of August 1, 2002 between EnPro Industries, Inc.
and William Dries (incorporated by reference to Exhibit 10.23 to the Form 10-K for the year
ended December 31, 2002 filed by EnPro Industries, Inc. (File No. 001-31225))
|
|
10.15+
|
|
Management Continuity Agreement dated as of August 1, 2002 between EnPro Industries, Inc.
and Richard L. Magee (incorporated by reference to Exhibit 10.25 to the Form 10-K for the year
ended December 31, 2002 filed by EnPro Industries, Inc. (File No. 001-31225))
|
|
10.16+
|
|
Management Continuity Agreement dated as of August 1, 2002 between EnPro Industries, Inc.
and Robert D. Rehley (incorporated by reference to Exhibit 10.28 to the Form 10-K for the year
ended December 31, 2002 filed by EnPro Industries, Inc. (File No. 001-31225))
|
|
10.17+
|
|
Management Continuity Agreement dated as of January 30, 2006 between EnPro Industries, Inc.
and J. Milton Childress II (incorporated by reference to Exhibit 10.28 to the Form 10-K for
the year ended December 31, 2005 filed by EnPro Industries, Inc. (File No. 001-31225))
|
|
10.18+
|
|
Management Continuity Agreement dated as of September 1, 2007 between EnPro Industries, Inc.
and Donald G. Pomeroy II (incorporated by reference to Exhibit 10.1 to the Form 8-K dated
August 17, 2007 filed by EnPro Industries, Inc. (File No. 001-31225))
|
44
10.19+*
|
|
Management Continuity Agreement dated as of February 11, 2009 between EnPro Industries, Inc.
and Orville G. Lunking
|
|
10.20+
|
|
Death Benefits Agreement dated as of December 12, 2002 between EnPro Industries, Inc. and
William Dries (incorporated by reference to Exhibit 10.31 to the Form 10-K for the year ended
December 31, 2002 filed by EnPro Industries, Inc. (File No. 001-31225))
|
|
10.21+
|
|
Death Benefits Agreement dated as of December 12, 2002 between EnPro Industries, Inc. and
Richard L. Magee (incorporated by reference to Exhibit 10.33 to the Form 10-K for the year
ended December 31, 2002 filed by EnPro Industries, Inc. (File No. 001-31225))
|
|
10.22+
|
|
Supplemental Retirement and Death Benefits Agreement dated as of November 8, 2005 between
EnPro Industries, Inc. and William Dries (incorporated by reference to Exhibit 10.2 to the
Form 10-Q for the quarter ended September 30, 2005 filed by EnPro Industries, Inc. (File No.
001-31225))
|
|
10.23+
|
|
Supplemental Retirement and Death Benefits Agreement dated as of November 8, 2005 between
EnPro Industries, Inc. and Richard L. Magee (incorporated by reference to Exhibit 10.3 to the
Form 10-Q for the quarter ended September 30, 2005 filed by EnPro Industries, Inc. (File No.
001-31225))
|
|
10.24+
|
|
EnPro Industries, Inc. Senior Officer Severance Plan (effective as of January 1, 2008)
(incorporated by reference to Exhibit 10.25 to the Form 10-K for the year ended December 31,
2007 filed by EnPro Industries, Inc. (File No. 001-31225))
|
|
10.25
|
|
Variable Term Accelerated Share Repurchase Transaction dated March 3, 2008 between EnPro
Industries, Inc. and Credit Suisse International (incorporated by reference to Exhibit 10.1 to
the Form 8-K dated March 3, 2008 filed by EnPro Industries, Inc. (File No. 001-31225))
|
|
10.26
|
|
Settlement Agreement dated as of April 11, 2008 among EnPro Industries, Inc. and Steel
Partners II, L.P., Steel Partners II GP LLC, Steel Partners II Master Fund L.P., Steel
Partners LLC, Warren G. Lichtenstein, James R. Henderson, John J. Quicke, Kevin C. King, Don
DeFosset and Delyle Bloomquist (incorporated by reference to Exhibit 10.1 to the Form 8-K
dated April 11, 2008 filed by EnPro Industries, Inc. (File No. 001-31225))
|
|
10.27+*
|
|
Summary of Executive and Director Compensation Arrangements
|
|
10.28*
|
|
Letter Agreement dated December 16, 2008 by and among
Coltec Industries Inc, Coltec Industrial Products LLC, Garlock
Sealing Technologies LLC, GGB LLC, Corrosion Control Corporation,
Stemco LP and V.W. Kaiser Engineering, Incorporated, as
Borrowers; EnPro Industries, Inc., QFM Sales and Services, Inc.,
Coltec International Services Co., Garrison Litigation Management
Group, Ltd., GGB, Inc., Garlock International Inc., Garlock Overseas
Corporation, Stemco Holdings, Inc., Compressor Products Holdings,
Inc. and Compressor Services Holdings, Inc., as Guarantors; the
various financial institutions listed on the signature pages thereof,
as Lenders; and Bank of America, N.A., in its capacity as a Lender
and as collateral and administrative agent for Lenders, which letter
agreement includes amendments to the Amended and Restated Loan and
Security Agreement dated April 26, 2006
|
|
14
|
|
EnPro Industries, Inc. Code of Business Conduct (incorporated by reference to Exhibit 14 to
the Form 10-K for the year ended December 31, 2002 filed by EnPro Industries, Inc. (File No.
001-31225))
|
|
21*
|
|
List of Subsidiaries
|
|
23.1*
|
|
Consent of PricewaterhouseCoopers LLP
|
|
23.2*
|
|
Consent of Bates White, LLC
|
|
24.1*
|
|
Power of Attorney from J. P. Bolduc
|
|
24.2*
|
|
Power of Attorney from Peter C. Browning
|
|
24.3*
|
|
Power of Attorney from Joe T. Ford
|
45
24.4*
|
|
Power of Attorney from Gordon D. Harnett
|
|
24.5*
|
|
Power of Attorney from David L. Hauser
|
|
24.6*
|
|
Power of Attorney from William R. Holland
|
|
24.7*
|
|
Power of Attorney from Wilbur J. Prezzano, Jr.
|
|
24.8*
|
|
Power of Attorney from Don DeFosset
|
|
31.1*
|
|
Certification of Chief Executive Officer pursuant to
Rule 13a - 14(a)/15d - 14(a)
|
|
31.2*
|
|
Certification of Chief Financial Officer pursuant to
Rule 13a - 14(a)/15d - 14(a)
|
|
32*
|
|
Certification pursuant to Section 1350
|
|
|
|
*
|
|
Items marked with an asterisk are filed herewith.
|
|
+
|
|
Management contract or compensatory plan required to be filed under Item 15(c) of this report
and Item 601 of Regulation S-K of the Securities and Exchange Commission.
|
46
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Shareholders of EnPro Industries, Inc.:
In our opinion, the consolidated financial statements listed in the accompanying index present
fairly, in all material respects, the financial position of EnPro Industries, Inc. and its
subsidiaries at December 31, 2008 and 2007, and the results of their operations and their cash
flows for each of the three years in the period ended December 31, 2008 in conformity with
accounting principles generally accepted in the United States of America. In addition, in our
opinion, the financial statement schedule listed in the accompanying index
presents
fairly, in all material respects, the information set forth therein when read in conjunction with
the related consolidated financial statements. Also in our opinion, the Company maintained, in all
material respects, effective internal control over financial reporting as of December 31, 2008,
based on criteria established in
Internal Control Integrated Framework
issued by the Committee of
Sponsoring Organizations of the Treadway Commission (COSO). The Companys management is responsible
for these financial statements and financial statement schedule, for maintaining effective internal
control over financial reporting and for its assessment of the effectiveness of internal control
over financial reporting, included in Managements Report on Internal Control over Financial
Reporting appearing under Item 9A. Our responsibility is to express opinions on these financial
statements, on the financial statement schedule, and on the Companys internal control over
financial reporting based on our integrated audits. We conducted our audits in accordance with the
standards of the Public Company Accounting Oversight Board (United States). Those standards
require that we plan and perform the audits to obtain reasonable assurance about whether the
financial statements are free of material misstatement and whether effective internal control over
financial reporting was maintained in all material respects. Our audits of the financial
statements included examining, on a test basis, evidence supporting the amounts and disclosures in
the financial statements, assessing the accounting principles used and significant estimates made
by management, and evaluating the overall financial statement presentation. Our audit of internal
control over financial reporting included obtaining an understanding of internal control over
financial reporting, assessing the risk that a material weakness exists, and testing and evaluating
the design and operating effectiveness of internal control based on the assessed risk. Our audits
also included performing such other procedures as we considered necessary in the circumstances. We
believe that our audits provide a reasonable basis for our opinions.
A companys internal control over financial reporting is a process designed to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting principles. A
companys internal control over financial reporting includes those policies and procedures that (i)
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the
transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that
transactions are recorded as necessary to permit preparation of financial statements in accordance
with generally accepted accounting principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of management and directors of the company;
and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized
acquisition, use, or disposition of the companys assets that could have a material effect on the
financial statements.
47
Because of its inherent limitations, internal control over financial reporting may not prevent or
detect misstatements. Also, projections of any evaluation of effectiveness to future periods are
subject to the risk that controls may become inadequate because of changes in conditions, or that
the degree of compliance with the policies or procedures may deteriorate.
/s/ PricewaterhouseCoopers LLP
Charlotte, North Carolina
March 2, 2009
48
PART I. FINANCIAL INFORMATION
ENPRO INDUSTRIES, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
Years Ended December 31, 2008, 2007 and 2006
(in millions, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
Net sales
|
|
$
|
1,167.8
|
|
|
$
|
1,030.0
|
|
|
$
|
928.4
|
|
Cost of sales
|
|
|
760.5
|
|
|
|
670.0
|
|
|
|
621.1
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
407.3
|
|
|
|
360.0
|
|
|
|
307.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses
|
|
|
264.1
|
|
|
|
228.4
|
|
|
|
196.3
|
|
Asbestos-related expenses
|
|
|
52.1
|
|
|
|
68.4
|
|
|
|
359.4
|
|
Other operating expense (income)
|
|
|
(0.3
|
)
|
|
|
6.0
|
|
|
|
2.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
315.9
|
|
|
|
302.8
|
|
|
|
558.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income (loss)
|
|
|
91.4
|
|
|
|
57.2
|
|
|
|
(251.3
|
)
|
Interest expense
|
|
|
(8.0
|
)
|
|
|
(8.1
|
)
|
|
|
(8.1
|
)
|
Interest income
|
|
|
2.7
|
|
|
|
8.3
|
|
|
|
4.9
|
|
Other income (expense)
|
|
|
(5.4
|
)
|
|
|
0.6
|
|
|
|
0.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
|
|
|
80.7
|
|
|
|
58.0
|
|
|
|
(254.2
|
)
|
Income tax benefit (expense)
|
|
|
(27.2
|
)
|
|
|
(20.3
|
)
|
|
|
95.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before extraordinary item
|
|
|
53.5
|
|
|
|
37.7
|
|
|
|
(158.9
|
)
|
Extraordinary item, net of taxes
|
|
|
|
|
|
|
2.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
53.5
|
|
|
$
|
40.2
|
|
|
$
|
(158.9
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before extraordinary item
|
|
$
|
2.64
|
|
|
$
|
1.77
|
|
|
$
|
(7.60
|
)
|
Extraordinary item
|
|
|
|
|
|
|
0.12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
2.64
|
|
|
$
|
1.89
|
|
|
$
|
(7.60
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before extraordinary item
|
|
$
|
2.54
|
|
|
$
|
1.69
|
|
|
$
|
(7.60
|
)
|
Extraordinary item
|
|
|
|
|
|
|
0.11
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
2.54
|
|
|
$
|
1.80
|
|
|
$
|
(7.60
|
)
|
|
|
|
|
|
|
|
|
|
|
See notes to Consolidated Financial Statements.
49
ENPRO INDUSTRIES, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
Years Ended December 31, 2008, 2007 and 2006
(in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
OPERATING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
53.5
|
|
|
$
|
40.2
|
|
|
$
|
(158.9
|
)
|
Adjustments to reconcile net income (loss) to net cash
provided by operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation
|
|
|
30.9
|
|
|
|
29.1
|
|
|
|
26.4
|
|
Amortization
|
|
|
13.9
|
|
|
|
11.1
|
|
|
|
8.8
|
|
Deferred income taxes
|
|
|
1.2
|
|
|
|
(8.4
|
)
|
|
|
(104.5
|
)
|
Stock-based compensation
|
|
|
3.9
|
|
|
|
3.6
|
|
|
|
5.5
|
|
Excess tax benefits from stock-based compensation
|
|
|
(0.8
|
)
|
|
|
(3.8
|
)
|
|
|
(1.3
|
)
|
Loss (gain) on sale of assets, net
|
|
|
(2.4
|
)
|
|
|
|
|
|
|
0.6
|
|
Extraordinary gain, net of taxes
|
|
|
|
|
|
|
(2.5
|
)
|
|
|
|
|
Change in assets and liabilities, net of effects of
acquisitions of businesses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Asbestos liabilities, net of insurance receivables
|
|
|
15.2
|
|
|
|
43.0
|
|
|
|
321.4
|
|
Accounts and notes receivable
|
|
|
8.3
|
|
|
|
(11.0
|
)
|
|
|
(7.9
|
)
|
Inventories
|
|
|
(14.0
|
)
|
|
|
18.2
|
|
|
|
(9.7
|
)
|
Accounts payable
|
|
|
(12.7
|
)
|
|
|
11.9
|
|
|
|
3.7
|
|
Other current assets and liabilities
|
|
|
(3.6
|
)
|
|
|
(6.4
|
)
|
|
|
(2.9
|
)
|
Other noncurrent assets and liabilities
|
|
|
4.8
|
|
|
|
(20.2
|
)
|
|
|
(5.6
|
)
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
|
98.2
|
|
|
|
104.8
|
|
|
|
75.6
|
|
|
|
|
|
|
|
|
|
|
|
INVESTING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of property, plant and equipment
|
|
|
(49.1
|
)
|
|
|
(46.8
|
)
|
|
|
(41.3
|
)
|
Proceeds from sales of assets
|
|
|
4.2
|
|
|
|
0.3
|
|
|
|
0.2
|
|
Proceeds from liquidation of investments
|
|
|
10.5
|
|
|
|
|
|
|
|
|
|
Reclassification of investments from cash equivalents
|
|
|
|
|
|
|
(19.5
|
)
|
|
|
|
|
Receipts from restricted cash accounts
|
|
|
1.1
|
|
|
|
0.2
|
|
|
|
39.8
|
|
Acquisitions, net of cash acquired
|
|
|
(43.4
|
)
|
|
|
(77.0
|
)
|
|
|
(27.3
|
)
|
Other
|
|
|
3.5
|
|
|
|
0.5
|
|
|
|
1.1
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(73.2
|
)
|
|
|
(142.3
|
)
|
|
|
(27.5
|
)
|
|
|
|
|
|
|
|
|
|
|
FINANCING ACTIVITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
Repayments of debt
|
|
|
(4.1
|
)
|
|
|
(2.1
|
)
|
|
|
(0.5
|
)
|
Common stock repurchases
|
|
|
(69.2
|
)
|
|
|
|
|
|
|
|
|
Proceeds from issuance of common stock
|
|
|
0.4
|
|
|
|
1.0
|
|
|
|
0.7
|
|
Excess tax benefits from stock-based compensation
|
|
|
0.8
|
|
|
|
3.8
|
|
|
|
1.3
|
|
Other
|
|
|
|
|
|
|
|
|
|
|
(0.6
|
)
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities
|
|
|
(72.1
|
)
|
|
|
2.7
|
|
|
|
0.9
|
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash and cash
equivalents
|
|
|
(5.8
|
)
|
|
|
3.0
|
|
|
|
2.5
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
(52.9
|
)
|
|
|
(31.8
|
)
|
|
|
51.5
|
|
Cash and cash equivalents at beginning of year
|
|
|
129.2
|
|
|
|
161.0
|
|
|
|
109.5
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of year
|
|
$
|
76.3
|
|
|
$
|
129.2
|
|
|
$
|
161.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures of cash flow information:
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid during the year for:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
$
|
8.0
|
|
|
$
|
8.1
|
|
|
$
|
7.9
|
|
Income taxes
|
|
$
|
37.0
|
|
|
$
|
21.7
|
|
|
$
|
13.0
|
|
Asbestos-related claims and expenses, net of
insurance recoveries
|
|
$
|
37.0
|
|
|
$
|
24.9
|
|
|
$
|
38.0
|
|
See notes to Consolidated Financial Statements.
50
ENPRO INDUSTRIES, INC.
CONSOLIDATED BALANCE SHEETS
As of December 31, 2008 and 2007
(in millions, except share amounts)
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
ASSETS
|
|
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
76.3
|
|
|
$
|
129.2
|
|
Accounts and notes receivable, less allowance for doubtful accounts
of $4.9 in 2008 and $3.6 in 2007
|
|
|
157.7
|
|
|
|
167.6
|
|
Asbestos insurance receivable
|
|
|
67.9
|
|
|
|
70.0
|
|
Inventories
|
|
|
84.8
|
|
|
|
70.3
|
|
Other current assets
|
|
|
40.9
|
|
|
|
55.3
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
427.6
|
|
|
|
492.4
|
|
Property, plant and equipment
|
|
|
206.1
|
|
|
|
193.5
|
|
Goodwill
|
|
|
218.1
|
|
|
|
213.8
|
|
Other intangible assets
|
|
|
103.4
|
|
|
|
103.5
|
|
Asbestos insurance receivable
|
|
|
239.5
|
|
|
|
311.5
|
|
Deferred income taxes
|
|
|
96.5
|
|
|
|
90.3
|
|
Other assets
|
|
|
61.3
|
|
|
|
65.3
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
1,352.5
|
|
|
$
|
1,470.3
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS EQUITY
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
Current maturities of long-term debt
|
|
$
|
9.6
|
|
|
$
|
3.6
|
|
Accounts payable
|
|
|
66.4
|
|
|
|
80.1
|
|
Asbestos liability
|
|
|
85.3
|
|
|
|
86.9
|
|
Other accrued expenses
|
|
|
86.4
|
|
|
|
89.8
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
247.7
|
|
|
|
260.4
|
|
Long-term debt
|
|
|
172.6
|
|
|
|
182.1
|
|
Asbestos liability
|
|
|
380.2
|
|
|
|
437.5
|
|
Pension liability
|
|
|
80.3
|
|
|
|
18.9
|
|
Other liabilities
|
|
|
74.6
|
|
|
|
96.3
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
955.4
|
|
|
|
995.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders equity
|
|
|
|
|
|
|
|
|
Common stock $.01 par value; 100,000,000 shares authorized;
issued 20,031,709 shares at December 31, 2008 and 21,631,176
shares at December 31, 2007
|
|
|
0.2
|
|
|
|
0.2
|
|
Additional paid-in capital
|
|
|
363.0
|
|
|
|
427.2
|
|
Retained earnings (accumulated deficit)
|
|
|
52.8
|
|
|
|
(0.7
|
)
|
Accumulated other comprehensive income (loss)
|
|
|
(17.4
|
)
|
|
|
49.9
|
|
Common stock held in treasury, at cost 217,790 shares at
December 31, 2008 and 223,081 shares at December 31, 2007
|
|
|
(1.5
|
)
|
|
|
(1.5
|
)
|
|
|
|
|
|
|
|
Total shareholders equity
|
|
|
397.1
|
|
|
|
475.1
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity
|
|
$
|
1,352.5
|
|
|
$
|
1,470.3
|
|
|
|
|
|
|
|
|
See notes to Consolidated Financial Statements.
51
ENPRO INDUSTRIES, INC.
CONSOLIDATED
STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY
Years Ended December 31, 2008, 2007 and 2006
(dollars and shares in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retained
|
|
|
Accumulated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional
|
|
|
Earnings
|
|
|
Other
|
|
|
|
|
|
|
Total
|
|
|
|
Common Stock
|
|
|
Paid-in
|
|
|
(Accumulated
|
|
|
Comprehensive
|
|
|
Treasury
|
|
|
Shareholders
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Capital
|
|
|
Deficit)
|
|
|
Income (Loss)
|
|
|
Stock
|
|
|
Equity
|
|
Balance, December 31, 2005
|
|
|
20.8
|
|
|
$
|
0.2
|
|
|
$
|
411.4
|
|
|
$
|
117.9
|
|
|
$
|
12.0
|
|
|
$
|
(1.6
|
)
|
|
$
|
539.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(158.9
|
)
|
|
|
|
|
|
|
|
|
|
|
(158.9
|
)
|
Other comprehensive loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative translation
adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17.3
|
|
|
|
|
|
|
|
17.3
|
|
Minimum pension liability
adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11.9
|
|
|
|
|
|
|
|
11.9
|
|
Gain on cash flow hedges
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.7
|
|
|
|
|
|
|
|
0.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(129.0
|
)
|
Adjustment to initially apply
SFAS No. 158, net of tax
benefit of $8.7 million
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(14.6
|
)
|
|
|
|
|
|
|
(14.6
|
)
|
Exercise of stock options and
other incentive plan activity
|
|
|
0.2
|
|
|
|
|
|
|
|
7.5
|
|
|
|
|
|
|
|
|
|
|
|
0.1
|
|
|
|
7.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2006
|
|
|
21.0
|
|
|
|
0.2
|
|
|
|
418.9
|
|
|
|
(41.0
|
)
|
|
|
27.3
|
|
|
|
(1.5
|
)
|
|
|
403.9
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40.2
|
|
|
|
|
|
|
|
|
|
|
|
40.2
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative translation
adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25.3
|
|
|
|
|
|
|
|
25.3
|
|
Pension and other postretirement
benefit plans
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2.7
|
)
|
|
|
|
|
|
|
(2.7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
62.8
|
|
Adjustment to initially apply
FIN 48
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.1
|
|
|
|
|
|
|
|
|
|
|
|
0.1
|
|
Exercise of stock options and
other incentive plan activity
|
|
|
0.4
|
|
|
|
|
|
|
|
8.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2007
|
|
|
21.4
|
|
|
|
0.2
|
|
|
|
427.2
|
|
|
|
(0.7
|
)
|
|
|
49.9
|
|
|
|
(1.5
|
)
|
|
|
475.1
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
53.5
|
|
|
|
|
|
|
|
|
|
|
|
53.5
|
|
Other comprehensive income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative translation
adjustment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(31.6
|
)
|
|
|
|
|
|
|
(31.6
|
)
|
Pension and other postretirement
benefit plans
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(35.6
|
)
|
|
|
|
|
|
|
(35.6
|
)
|
Loss on cash flow hedges
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(0.1
|
)
|
|
|
|
|
|
|
(0.1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(13.8
|
)
|
Common stock repurchases
|
|
|
(1.9
|
)
|
|
|
|
|
|
|
(69.2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(69.2
|
)
|
Exercise of stock options and
other incentive plan activity
|
|
|
0.3
|
|
|
|
|
|
|
|
5.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance, December 31, 2008
|
|
|
19.8
|
|
|
$
|
0.2
|
|
|
$
|
363.0
|
|
|
$
|
52.8
|
|
|
$
|
(17.4
|
)
|
|
$
|
(1.5
|
)
|
|
$
|
397.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See notes to Consolidated Financial Statements.
52
ENPRO INDUSTRIES, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. Overview and Significant Accounting Policies
Overview
EnPro Industries, Inc. (EnPro or the Company) is a leader in the design, development,
manufacturing and marketing of well recognized, proprietary engineered industrial products that
include sealing products, metal and metal polymer bearings and filament wound products, air
compressors, and heavy-duty, medium-speed diesel, natural gas and dual fuel reciprocating engines.
Summary of Significant Accounting Policies
Principles of Consolidation
The Consolidated Financial Statements reflect the accounts of
the Company and its majority-owned and controlled subsidiaries. All significant intercompany
accounts and transactions have been eliminated.
Use of Estimates
- The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and assumptions that affect
the amounts reported in the financial statements and accompanying notes. Actual results could
differ from those estimates.
Reclassifications
Certain prior year amounts in the accompanying prior year annual
financial statements have been reclassified to conform with the current year presentation.
Revenue Recognition
Revenue is recognized at the time title and risk of product ownership
is transferred or when services are rendered. Any shipping costs billed to customers are
recognized as revenue and expensed in cost of goods sold.
Foreign Currency Translation
The financial statements of those operations whose functional
currency is a foreign currency are translated into U.S. dollars using the current rate method.
Under this method, all assets and liabilities are translated into U.S. dollars using current
exchange rates, and income statement activities are translated using weighted average exchange
rates. The foreign currency translation adjustment is reflected in the Consolidated Statements of
Changes in Shareholders Equity and is included in accumulated other comprehensive income (loss) in
the Consolidated Balance Sheets. Gains and losses on foreign currency transactions are included in
operating income. Foreign currency transaction gains (losses) totaled $(3.8) million, $0.1 million
and $(0.5) million for 2008, 2007 and 2006, respectively.
Research and Development Expense
Costs related to research and development activities are
expensed as incurred. The Company performs research and development under Company-funded programs
for commercial products. Total research and development expenditures in 2008, 2007 and 2006 were
$15.3 million, $14.1 million and $12.8 million, respectively.
Income Taxes
The Company uses the asset and liability method of accounting for income
taxes. Temporary differences arising from the difference between the tax basis of an asset or
liability and its carrying amount on the Consolidated Balance Sheet are used to calculate future
income tax assets or liabilities. This method also requires the recognition of deferred tax
benefits, such as net operating loss carryforwards, to the extent that realization of such benefits
is more likely than not. Deferred tax assets and liabilities are measured using enacted tax rates
expected to apply to taxable income (losses) in the
53
years in which those temporary differences are expected to be recovered or settled. The
effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in
the period that includes the enactment date.
Cash and Cash Equivalents
Cash and cash equivalents include cash on hand, demand deposits
and highly liquid investments with a maturity of three months or less at the time of purchase. The
Consolidated Statement of Cash Flows for the year ended December 31, 2007, reflects the
reclassification of $19.5 million of unrestricted cash balances to other current and noncurrent
assets based on changes in expected maturity dates of the underlying investments. Much of this has
subsequently been collected and only $7.1 million remains classified in other current and
noncurrent assets at December 31, 2008.
Receivables
Accounts receivable are stated at the historical carrying amount net of
write-offs and allowance for doubtful accounts. The Company establishes an allowance for doubtful
accounts receivable based on historical experience and any specific customer collection issues that
the Company has identified. Doubtful accounts receivable are written off when a settlement is
reached for an amount that is less than the outstanding historical balance or when the Company has
determined the balance will not be collected.
The balances billed but not paid by customers pursuant to retainage provisions in long-term
contracts and programs will be due upon completion of the contracts and acceptance by the owner.
At December 31, 2008, the Company had $3.1 million of retentions expected to be collected in 2009
recorded in accounts and notes receivable and $3.2 million of retentions expected to be collected
beyond 2009 recorded in other noncurrent assets in the Consolidated Balance Sheets. At December
31, 2007, the Company had $3.9 million of current retentions and $2.4 million of non-current
retentions recorded in the Consolidated Balance Sheets.
Inventories
Certain domestic inventories are valued by the last-in, first-out (LIFO) cost
method. Inventories not valued by the LIFO method, other than inventoried costs relating to
long-term contracts and programs, are valued using the first-in, first-out (FIFO) cost method,
and are recorded at the lower of cost or market. Approximately 39% and 45% of inventories were
valued by the LIFO method in 2008 and 2007, respectively.
Inventoried costs relating to long-term contracts and programs are stated at the actual
production cost, including factory overhead, incurred to date. Progress payments related to
long-term contracts and programs are shown as a reduction of inventories. Initial program start-up
costs and other nonrecurring costs are expensed as incurred. Inventoried costs relating to
long-term contracts and programs are reduced by any amounts in excess of estimated realizable value
and charged to cost of sales.
Property, Plant and Equipment
Property, plant and equipment are recorded at cost. Major
renewals and betterments are capitalized; whereas, maintenance and repairs are expensed as
incurred. Depreciation of plant and equipment is determined on the straight-line method over the
following estimated useful lives of the assets: buildings and improvements, 3 to 40 years;
machinery and equipment, 3 to 20 years.
Goodwill and Other Intangible Assets
Goodwill represents the excess of the purchase price
over the fair value of the net assets of acquired businesses. Goodwill is not amortized, but
instead is subject to annual impairment testing conducted each year as of October 1. The goodwill
asset impairment test involves comparing the fair value of a reporting unit to its carrying amount.
If the carrying amount of a reporting unit exceeds its fair value, a second step of comparing the
implied fair value of the reporting units goodwill to the carrying amount of that goodwill is
required to measure the potential goodwill impairment loss. Interim tests may be required if an
event occurs or circumstances change that would more likely than not reduce the fair value of a
reporting unit below its carrying amount. The Company
54
completed its required annual impairment tests of goodwill as of October 1, 2008, 2007 and
2006. The results of these assessments did not indicate any impairment of the goodwill.
As of November 30, 2008, due to the recent deterioration in the global economic environment
and the decline in the Companys market capitalization, the Company concluded there was an
indication of possible impairment and conducted an interim goodwill impairment test. Certain key
assumptions used to determine the fair value of each reporting unit as of November 30, 2008 were
revised to reflect: (a) significant reductions in future expected cash flows for the period from
2009 to 2013 due to the continuing soft economy, and (b) a discount rate of 12.3%, which was based
on the Companys best estimate of the after-tax weighted average cost of capital, adjusted for its
increased level of financial risk and the increased risk associated with its future operations.
As a result of the first step of the interim goodwill impairment analysis, the fair value of
each reporting unit exceeded its carrying value. Therefore, the second step was not necessary.
However, a 7% decline in fair value of the Companys GGB reporting unit or a 16% decline in fair
value of the Companys Plastomer Technologies reporting unit would have caused the carrying values
for these reporting units to be in excess of fair values which would require the second step to be
performed. The second step could have resulted in an impairment loss for goodwill.
While the Company believes it has made reasonable estimates and assumptions to calculate the
fair value of the reporting units and other intangible assets, it is possible a material change
could occur. If the Companys actual results are not consistent with its estimates and assumptions
used to calculate fair value, it may be required to perform the second step which could result in a
material impairment of its goodwill at some point in the future.
Other intangible assets are recorded at cost, or when acquired as a part of a business
combination, at estimated fair value. These assets include customer relationships, patents and
other technology agreements, trademarks, licenses and non-compete agreements. Intangible assets
that have definite lives are amortized using a method that reflects the pattern in which the
economic benefits of the assets are consumed or the straight-line method over estimated useful
lives of 2 to 25 years. Intangible assets with indefinite lives are subject to at least annual
impairment testing, which compares the fair value of the intangible asset with its carrying amount.
The results of these assessments did not indicate any impairment to these intangible assets for
the years presented.
Asbestos
In 2005 and the first three quarters of 2006, the Company recorded a liability
related to asbestos claims at the low end of a broad ten-year range
of equally likely estimates
provided by the firm of Bates White, LLC (Bates White), a recognized expert in the field of
estimating asbestos-related liabilities. Due to the uncertain nature of the estimated liability,
the Company and Bates White believed that no single amount in the range was a better estimate than
any other amount within the range. In accordance with the applicable accounting rules, the Company
recorded a liability for these claims at the lower end of the range of estimated potential
liabilities. In the fourth quarter of 2006, based on the Companys experience over the prior two
years and other factors, management identified a best estimate within the Bates White range and
adjusted the liability accordingly.
The significant assumptions underlying the material components of the estimated liability
include: the number and trend of claims to be asserted; the mix of alleged diseases or impairment;
the trend in the number of claims for non-malignant cases; the probability that some existing and
potential future claims will eventually be dismissed without payment; the estimated amount to be
paid per claim, and the timing and impact of large amounts that will become available for the
payment of claims from the 524(g) trusts of former defendants in bankruptcy. The actual number of
future actions filed per year and the payments made to resolve those claims could exceed those
reflected in managements estimate of the liability.
55
With the assistance of Bates White, the Company periodically reviews the period over which it
can make a reasonable estimate, the assumptions underlying the Companys estimate, the range of
reasonably possible potential liabilities and managements estimate of the liability, and adjusts
the estimate if necessary. Changing circumstances and new data that may become available could
cause a change in the estimated liability in the future by an amount that cannot currently be
reasonably estimated, and that increase could be significant and material. Additional discussion
is included in Note 17 to the Consolidated Financial Statements, Commitments and Contingencies
Asbestos.
Derivative Instruments
The Company uses derivative financial instruments to manage its
exposure to various risks. The use of these financial instruments modifies the exposure with the
intent of reducing the risk to the Company. The Company does not use financial instruments for
trading purposes, nor does it use leveraged financial instruments. The counterparties to these
contractual arrangements are major financial institutions. The Company uses several different
financial institutions for derivative contracts to minimize the concentration of credit risk.
Statement of Financial Accounting Standards No. 133, Accounting for Derivative Instruments and
Hedging Activities (SFAS 133), as amended, requires that all derivative instruments be reported
in the Consolidated Balance Sheets at fair value and that changes in a derivatives fair value be
recognized currently in earnings unless specific hedge criteria are met.
The Company is exposed to foreign currency risks that arise from normal business operations.
These risks include the translation of local currency balances on its foreign subsidiaries balance
sheets, intercompany loans with foreign subsidiaries and transactions denominated in foreign
currencies. The Company strives to control its exposure to these risks through its normal
operating activities and, where appropriate, through derivative instruments. The Company has
entered into contracts to hedge forecasted transactions occurring at various dates through December
2010 that are denominated in foreign currencies. The notional amount of foreign exchange contracts
hedging foreign currency transactions was $130.3 million and $141.5 million at December 31, 2008
and 2007, respectively. These contracts are accounted for as cash flow hedges. As cash flow
hedges, the effective portion of the gain or loss on the contracts is reported in accumulated other
comprehensive income and the ineffective portion is reported in income. Amounts in accumulated
other comprehensive income are reclassified into income in the period that the hedged transactions
affect earnings. It is anticipated that $0.2 million of the amounts within accumulated other
comprehensive income at December 31, 2008, will be reclassified into income within the next twelve
months.
Fair Value Measurements
On January 1, 2008, the Company adopted Statement of Financial
Accounting Standards No. 157,
Fair Value Measurements,
(SFAS 157) for financial assets and
liabilities. As permitted by FASB Staff Position No. FAS 157-2,
Effective Date of FASB Statement
No 157
, the Company elected to defer the adoption of SFAS 157 for all nonfinancial assets and
nonfinancial liabilities. SFAS 157 provides a framework for measuring fair value and requires
expanded disclosures regarding fair value measurements. SFAS 157 defines fair value as the
exchange price that would be received for an asset or paid to transfer a liability (an exit price)
in the principal or most advantageous market for the asset or liability in an orderly transaction
between market participants on the measurement date.
SFAS 157 utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques
used to measure fair value into three broad levels. The following is a brief description of those
three levels:
|
|
|
Level 1: Observable inputs such as quoted prices in active markets for identical
assets or liabilities.
|
|
|
|
|
Level 2: Inputs other than quoted prices that are observable for the asset or
liability, either directly or indirectly. These include quoted prices for similar
assets or liabilities in active
|
56
|
|
|
markets and quoted prices for identical or similar assets or liabilities in markets that
are not active.
|
|
|
|
|
Level 3: Unobservable inputs that reflect the reporting entitys own assumptions.
|
New Accounting Pronouncements
In December 2008, the Financial Accounting Standards Board
(FASB) issued FASB Staff Position No. 132(R)-1,
Employers Disclosures about Postretirement
Benefit Plan Assets
(FSP 132(R)-1). FSP 132(R)-1 amends FASB Statement No. 132(R),
Employers
Disclosures about Pensions and Other Postretirement Benefits
to require additional disclosures
about assets held in an employers defined benefit pension or other postretirement plan. FSP
132(R)-1 is effective for fiscal years ending after December 15, 2009. Since FSP 132(R)-1 requires
only additional disclosures, adoption of the standard will not affect the Companys financial
condition, results of operations or cash flows.
In May 2008, the FASB issued FASB Staff Position No. APB 14-1,
Accounting for Convertible
Debt Instruments That May Be Settled in Cash Upon Conversion (Including Partial Cash Settlement)
(APB 14-1). APB 14-1 requires the issuer of certain convertible debt instruments that may be
settled in cash on conversion to separately account for the liability and equity components of the
instrument in a manner that reflects the issuers nonconvertible debt borrowing rate. APB 14-1 is
effective for financial statements issued for fiscal years beginning after December 15, 2008, and
interim periods within those fiscal years. Early application is not permitted; however, the
transition guidance requires retrospective application to all periods presented.
The impact of adopting APB 14-1 as of January 1, 2009 is expected to result in decreases in
noncurrent assets (deferred tax assets and capitalized debt issuance costs) totaling $18.7 million,
a decrease in long-term debt of $47.7 million and an increase in equity of $29.0 million.
If the Company had accounted for its convertible debt using APB 14-1 for the years ended
December 31, 2008, 2007 and 2006, pro forma net income (loss) and earnings (loss) per share would
have been as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
Net income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
As reported
|
|
$
|
53.5
|
|
|
$
|
40.2
|
|
|
$
|
(158.9
|
)
|
APB 14-1 impact
|
|
|
(2.9
|
)
|
|
|
(2.6
|
)
|
|
|
(2.3
|
)
|
|
|
|
|
|
|
|
|
|
|
Pro forma
|
|
$
|
50.6
|
|
|
$
|
37.6
|
|
|
$
|
(161.2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
As reported
|
|
$
|
2.64
|
|
|
$
|
1.89
|
|
|
$
|
(7.60
|
)
|
Pro forma
|
|
$
|
2.50
|
|
|
$
|
1.77
|
|
|
$
|
(7.72
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
As reported
|
|
$
|
2.54
|
|
|
$
|
1.80
|
|
|
$
|
(7.60
|
)
|
Pro forma
|
|
$
|
2.40
|
|
|
$
|
1.68
|
|
|
$
|
(7.72
|
)
|
It is estimated that annual earnings after taxes will be reduced between $3.1 million and $5.1
million over the remaining life of the convertible debt as a result of the increase in non-cash
interest expense that will need to be recorded using the effective interest rate method for the
debt discount amortization computation.
In March 2008, the FASB issued Statement of Financial Accounting Standards No. 161,
"
Disclosures About Derivative Instruments and Hedging Activities, an amendment of FASB Statement
No. 133
(SFAS 161). SFAS 161 amends and expands the disclosure requirements of SFAS 133 with
the intent to provide users of financial statements with an enhanced understanding of: (a) how and
why an
57
entity uses derivative instruments; (b) how derivative instruments and related hedged items are
accounted for under SFAS 133 and its related interpretations; and (c) how derivative instruments
and related hedged items affect an entitys financial position, financial performance and cash
flows. This statement is effective for financial statements issued for fiscal years and interim
periods beginning after November 15, 2008, with early application encouraged. Since SFAS 161
requires only additional disclosures concerning derivatives and hedging activities, adoption of the
statement will not affect the Companys financial condition, results of operations or cash flows.
In December 2007, the FASB issued Statement of Financial Accounting Standards No. 141(R),
Business Combinations
(SFAS 141(R)) and Statement of Financial Accounting Standards No. 160,
Noncontrolling Interests in Consolidated Financial Statements an Amendment of ARB No. 51
(SFAS
160). These new standards will significantly change the financial accounting and reporting for
future business combination transactions and noncontrolling (or minority) interests in consolidated
financial statements on a prospective basis. The Company will be required to adopt SFAS 141(R) and
SFAS 160 for periods beginning on or after December 15, 2008. Adoption of SFAS 141(R) and SFAS 160
will not affect the Companys financial condition, results of operations or cash flows, but may
have an effect on accounting for future business combinations.
2. Acquisitions
In June 2008, the Company purchased the 20% ownership of the minority shareholder of Garlock
Pty Limited in Australia. Subsequent to the share purchase, the Company owns 100% of Garlock Pty
Limited, which is in the Sealing Products segment. In May 2008, the Company acquired certain
assets and assumed certain liabilities of Air Perfection, Inc., a privately-held business which
audits, sells and services compressed air systems. This acquisition is included in the Companys
Engineered Products segment. In February 2008, the Company acquired V.W. Kaiser Engineering, a
privately-held manufacturer of pins, bushings and suspension kits for the commercial vehicle
aftermarket. In January 2008, the Company acquired certain assets and assumed certain liabilities
of Sinflex Sealing Technologies, a distributor and manufacturer of industrial sealing products,
located in Shanghai, China. These acquisitions are included in the Companys Sealing Products
segment. The Company also purchased several small product lines during 2008.
The acquisitions completed during 2008 were paid for with $43.4 million in cash. They
resulted in increases in working capital of $6.7 million, property, plant and equipment of $1.9
million, goodwill of $18.3 million, other intangible assets of $20.8 million, other noncurrent
assets of $0.3 million and debt of $0.4 million, as well as decreases in long-term deferred tax
assets of $6.6 million and other noncurrent liabilities of $2.4 million. The purchase price
allocations of recently acquired businesses are subject to the completion of the valuation of
certain assets and liabilities.
In June 2007, the Company acquired Texflo Machining Ltd., a privately-held company that
services and repairs reciprocating compressors, primarily for the natural gas market in western
Canada. In July 2007, the Company acquired Compressor Products International Limited, a
privately-held manufacturer of critical sealing components for reciprocating compressors, gas
engines and related equipment. These acquisitions are included in the Companys Engineered
Products segment. The Company also purchased the remaining ownership interest in one of its
subsidiaries and two small product lines during 2007.
The acquisitions completed during 2007 were paid for with $77.0 million in cash. They
resulted in increases in property, plant and equipment of $4.5 million, goodwill of $42.3 million,
other intangible assets of $40.3 million and debt of $2.2 million, decreases in long-term deferred
tax assets of $7.6 million, other noncurrent liabilities of $4.1 million and working capital of
$0.3 million, as well as an
58
extraordinary gain of $4.1 million related to the purchase of the remaining ownership interest
in one of the Companys subsidiaries. The gain was recorded net of $1.6 million of income taxes.
In May 2006, the Company acquired Allwest Compressor Services (Allwest), a privately-held
manufacturer of compressor components primarily for the natural gas and oil production industries
in Western Canada. Allwest, along with Southwest Compressor Services and H.A.R. Compressor
Products, which were also acquired during the year, are included in the Companys Engineered
Products segment. In July 2006, the Company acquired Amicon Plastics, a privately-held company
that manufactures and sells customized fluoropolymer and engineered plastic components to
semiconductor, pump and valve, oilfield and other industries. This acquisition is included in the
Companys Sealing Products segment.
The acquisitions completed during 2006 were paid for with $27.3 million in cash, and a $1.0
million note payable to one of the sellers.
3. Other Operating Expense (Income)
The Company incurred $4.6 million, $6.0 million and $2.3 million of restructuring costs during
the years ended December 31, 2008, 2007 and 2006, respectively.
In 2005, the Company approved a plan to modernize the Palmyra, New York facilities of Garlock
Sealing Technologies, included within the Sealing Products segment. Garlock Sealing Technologies
has been on its current site since the early 1900s, with the buildings dating from 1907 to 1956.
The project will reduce the number of buildings on the site from 26 to 7 and eliminate 350,000
square feet of space, or approximately half of the space currently under roof. Work on the project
began in the second half of 2005. The modernization will be completed over six years at an
expected cost, including expenses and capital expenditures, of approximately $45 million, excluding
the impact of grants, tax abatements and tax credits. Through 2008, the Company has recorded
expenses, primarily demolition of existing structures, site remediation and equipment relocation of
$8.0 million and capital expenditures of $22.5 million, offset by $8.6 million of grants, tax
abatements and tax credits. It is currently anticipated that an additional $8.5 million of
expenses and $6.4 million of capital expenditures will be incurred to complete the project, offset
by an additional $13.4 million of tax abatements and tax credits.
During 2007, the Company announced the planned consolidation of facilities for a unit within
the Sealing Products segment. Approximately $0.6 million of costs were incurred during 2007 of the
total $2.3 million for the entire initiative. Workforce reductions announced totaled 34, primarily
hourly manufacturing positions, all of which took place during 2008. The project was completed in
2008. In connection with this facilities consolidation, the Company sold a building for $3.0
million, resulting in a pre-tax gain of $2.2 million. This gain is included in other operating
expense (income) for the year ended December 31, 2008.
Several smaller restructuring initiatives were begun and completed during 2008, primarily the
consolidation of two small facilities. Approximately $0.9 million of costs were incurred.
59
Restructuring reserves at December 31, 2008, as well as activity during the year, consisted
of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance
|
|
|
|
|
|
|
|
|
|
|
Balance
|
|
|
|
December 31,
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
Provision
|
|
|
Payments
|
|
|
2008
|
|
|
|
|
|
|
|
(in millions)
|
|
|
|
|
|
Personnel-related costs
|
|
$
|
0.4
|
|
|
$
|
1.6
|
|
|
$
|
(0.8
|
)
|
|
$
|
1.2
|
|
Facility demolition and
relocation costs
|
|
|
|
|
|
|
3.0
|
|
|
|
(3.0
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
0.4
|
|
|
$
|
4.6
|
|
|
$
|
(3.8
|
)
|
|
$
|
1.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring reserves at December 31, 2007, as well as activity during the year, consisted
of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct
|
|
|
|
|
|
|
Balance
|
|
|
|
|
|
|
|
|
|
|
Credits to
|
|
|
Balance
|
|
|
|
December 31,
|
|
|
|
|
|
|
|
|
|
|
Environmental
|
|
|
December 31,
|
|
|
|
2006
|
|
|
Provision
|
|
|
Payments
|
|
|
Liabilities
|
|
|
2007
|
|
|
|
|
|
|
|
|
|
|
|
(in millions)
|
|
|
|
|
|
|
|
|
|
Personnel-related costs
|
|
$
|
0.1
|
|
|
$
|
0.7
|
|
|
$
|
(0.4
|
)
|
|
$
|
|
|
|
$
|
0.4
|
|
Facility demolition and
relocation costs
|
|
|
|
|
|
|
5.3
|
|
|
|
(3.0
|
)
|
|
|
(2.3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
0.1
|
|
|
$
|
6.0
|
|
|
$
|
(3.4
|
)
|
|
$
|
(2.3
|
)
|
|
$
|
0.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring reserves at December 31, 2006, as well as activity during the year, consisted
of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Direct
|
|
|
|
|
|
|
Balance
|
|
|
|
|
|
|
|
|
|
|
Credits to
|
|
|
Balance
|
|
|
|
December 31,
|
|
|
|
|
|
|
|
|
|
|
Environmental
|
|
|
December 31,
|
|
|
|
2005
|
|
|
Provision
|
|
|
Payments
|
|
|
Liabilities
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
|
(in millions)
|
|
|
|
|
|
|
|
|
|
Personnel-related costs
|
|
$
|
0.1
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
0.1
|
|
Facility demolition and
relocation costs
|
|
|
|
|
|
|
2.3
|
|
|
|
(0.9
|
)
|
|
|
(1.4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
0.1
|
|
|
$
|
2.3
|
|
|
$
|
(0.9
|
)
|
|
$
|
(1.4
|
)
|
|
$
|
0.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring costs by reportable segment are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(in millions)
|
|
Sealing Products
|
|
$
|
3.7
|
|
|
$
|
6.0
|
|
|
$
|
2.3
|
|
Engineered Products
|
|
|
0.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
4.6
|
|
|
$
|
6.0
|
|
|
$
|
2.3
|
|
|
|
|
|
|
|
|
|
|
|
Also included in other operating expense (income) for the year ended December 31, 2008 was
$2.5 million received related to the favorable settlement of a warranty claim against a supplier.
60
4. Other Income (Expense)
Included in other non-operating expense for the year ended December 31, 2008, were $3.4
million of incremental costs for legal, financial and strategic advice and proxy solicitation in
connection with the contested election of directors initiated by one of the Companys shareholders.
On April 11, 2008, an agreement with the shareholder was entered into that resolved the contested
election.
5. Income Taxes
Income (loss) before income taxes and extraordinary items as shown in the Consolidated
Statements of Operations consists of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(in millions)
|
|
Domestic
|
|
$
|
32.5
|
|
|
$
|
12.4
|
|
|
$
|
(285.7
|
)
|
Foreign
|
|
|
48.2
|
|
|
|
45.6
|
|
|
|
31.5
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
80.7
|
|
|
$
|
58.0
|
|
|
$
|
(254.2
|
)
|
|
|
|
|
|
|
|
|
|
|
A summary of income tax benefit (expense) in the Consolidated Statements of Operations before
extraordinary items is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(in millions)
|
|
Current:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
(10.2
|
)
|
|
$
|
(10.6
|
)
|
|
$
|
2.0
|
|
Foreign
|
|
|
(14.9
|
)
|
|
|
(17.3
|
)
|
|
|
(10.6
|
)
|
State
|
|
|
(0.9
|
)
|
|
|
(0.8
|
)
|
|
|
(0.6
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(26.0
|
)
|
|
|
(28.7
|
)
|
|
|
(9.2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
(0.1
|
)
|
|
|
6.5
|
|
|
|
99.2
|
|
Foreign
|
|
|
(1.1
|
)
|
|
|
1.5
|
|
|
|
(2.4
|
)
|
State
|
|
|
|
|
|
|
0.4
|
|
|
|
7.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1.2
|
)
|
|
|
8.4
|
|
|
|
104.5
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
(27.2
|
)
|
|
$
|
(20.3
|
)
|
|
$
|
95.3
|
|
|
|
|
|
|
|
|
|
|
|
Significant components of deferred income tax assets and liabilities at December 31, 2008 and
2007 are as follows:
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(in millions)
|
|
Deferred income tax assets:
|
|
|
|
|
|
|
|
|
Accrual for post-retirement benefits other than pensions
|
|
$
|
3.1
|
|
|
$
|
3.0
|
|
Environmental reserves
|
|
|
8.3
|
|
|
|
10.4
|
|
Retained liabilities of previously owned businesses
|
|
|
12.3
|
|
|
|
12.1
|
|
Call options
|
|
|
16.8
|
|
|
|
18.7
|
|
Inventories
|
|
|
|
|
|
|
1.9
|
|
Accruals and reserves
|
|
|
18.3
|
|
|
|
18.0
|
|
Minimum pension liability
|
|
|
33.1
|
|
|
|
10.1
|
|
Asbestos accrual
|
|
|
153.1
|
|
|
|
143.4
|
|
|
|
|
|
|
|
|
Total deferred income tax assets
|
|
|
245.0
|
|
|
|
217.6
|
|
|
|
|
|
|
|
|
61
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(in millions)
|
|
Deferred income tax liabilities:
|
|
|
|
|
|
|
|
|
Pensions
|
|
|
(3.2
|
)
|
|
|
(4.8
|
)
|
Tax depreciation and amortization in excess of book
|
|
|
(44.5
|
)
|
|
|
(37.1
|
)
|
Payments in excess of insurance recoveries
|
|
|
(78.1
|
)
|
|
|
(62.5
|
)
|
Inventories
|
|
|
(0.8
|
)
|
|
|
|
|
Other
|
|
|
|
|
|
|
(0.8
|
)
|
|
|
|
|
|
|
|
Total deferred income tax liabilities
|
|
|
(126.6
|
)
|
|
|
(105.2
|
)
|
|
|
|
|
|
|
|
Net deferred income taxes
|
|
$
|
118.4
|
|
|
$
|
112.4
|
|
|
|
|
|
|
|
|
The Company concluded that a valuation allowance on its deferred tax assets at December 31,
2008 and 2007, was not required. The Companys methodology for determining the realizability of
deferred tax assets involves estimates of future taxable income from its operations. These
estimates are projected through the life of the related deferred tax assets based on assumptions
that the Company believes to be reasonable and consistent with current operating results. Changes
in future operating results not currently forecasted may have a significant impact on the
realization of deferred tax assets.
The effective income tax rate from operations varied from the statutory federal income tax
rate as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percent of Pretax Income
|
|
|
Years Ended December 31,
|
|
|
2008
|
|
2007
|
|
2006
|
Statutory federal income tax rate
|
|
|
35.0
|
%
|
|
|
35.0
|
%
|
|
|
(35.0
|
)%
|
Credits
|
|
|
(0.3
|
)
|
|
|
(1.6
|
)
|
|
|
|
|
State and local taxes
|
|
|
1.2
|
|
|
|
0.7
|
|
|
|
(2.8
|
)
|
Domestic manufacturers deduction
|
|
|
(1.0
|
)
|
|
|
(0.5
|
)
|
|
|
(0.1
|
)
|
Foreign tax rate differences
|
|
|
(2.0
|
)
|
|
|
(2.6
|
)
|
|
|
0.2
|
|
Uncertain tax positions
|
|
|
1.3
|
|
|
|
2.7
|
|
|
|
|
|
Audit settlements
|
|
|
(2.1
|
)
|
|
|
(0.7
|
)
|
|
|
|
|
Other items
|
|
|
1.6
|
|
|
|
2.0
|
|
|
|
0.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effective income tax rate
|
|
|
33.7
|
%
|
|
|
35.0
|
%
|
|
|
(37.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
At December 31, 2008, the Company had undistributed earnings of approximately $73.6 million
from subsidiaries in Australia, Canada, Mexico and Brazil that are not considered to be permanently
reinvested. Based on current income tax rates, the Company believes the tax effect on any
distribution will be immaterial due to the Companys foreign tax credit position. Accordingly, no
deferred taxes have been provided for these undistributed foreign earnings.
The Company has not provided for the federal and foreign withholding taxes on $140.9 million
of the remaining foreign subsidiaries undistributed earnings as of December 31, 2008, because such
earnings are intended to be reinvested indefinitely. On repatriation, certain foreign countries
impose withholding taxes. The amount of withholding tax that would be payable on remittance of the
entire amount would approximate $12.0 million. Based on current income tax rates, the Company
believes the tax effect of any distribution will be immaterial due to the Companys foreign tax
credit position.
The Company adopted FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes
(FIN 48) on January 1, 2007. As of December 31, 2008 and 2007, the Company had $5.6 million and
$19.1 million, respectively, of liabilities recorded for unrecognized tax benefits. These amounts
included interest of $0.5 million and $1.9 million, respectively. The unrecognized tax benefit
62
balances as of December 31, 2008 and 2007, also included $1.6 million and $13.2 million,
respectively, for tax positions for which the ultimate deductibility was highly certain but for
which there was uncertainty about the timing of such deductibility. Included in the unrecognized
tax benefits as of December 31, 2008 and 2007, were cumulative amounts of $4.0 million and $5.9
million, respectively, for uncertain tax positions that would affect the Companys effective tax
rate if recognized. The Company records interest and penalties related to unrecognized tax
benefits in income tax expense. A reconciliation of the beginning and ending amount of the
unrecognized tax benefits (excluding interest) is as follows:
|
|
|
|
|
|
|
|
|
(in millions)
|
|
2008
|
|
|
2007
|
|
Balance at beginning of year
|
|
$
|
17.2
|
|
|
$
|
21.8
|
|
Additions based on tax positions related to the current year
|
|
|
2.5
|
|
|
|
0.7
|
|
Additions for tax positions of prior years
|
|
|
0.7
|
|
|
|
0.1
|
|
Reductions for tax positions of prior years
|
|
|
|
|
|
|
(4.5
|
)
|
Reductions as a result of audit settlements
|
|
|
(15.3
|
)
|
|
|
(0.9
|
)
|
|
|
|
|
|
|
|
Balance at end of year
|
|
$
|
5.1
|
|
|
$
|
17.2
|
|
|
|
|
|
|
|
|
During the year ending December 31, 2008, the Company recorded a net non-cash benefit of $1.8
million to income tax expense related to the reversal of reserves for uncertain tax benefits
resulting from the completion of the U.S. federal income tax return examination for 2003 to 2006.
The Company and its subsidiaries are subject to U.S. federal income tax as well as income tax
in multiple state and foreign jurisdictions. Substantially all state, local and foreign income tax
returns for the years 2003 through 2007 are open to examination. The U.S. federal income tax
return for 2007 is also open to examination. Various foreign and state tax returns are currently
under examination and may conclude within the next twelve months. The final outcomes of these
audits are not yet determinable; however, management believes that any assessments that may arise
will not be material to the Companys financial condition or results of operations.
6. Earnings (Loss) Per Share
Basic earnings (loss) per share is computed by dividing the applicable net income (loss) by
the weighted-average number of common shares outstanding for the period. Diluted earnings (loss)
per share is calculated using the weighted-average number of shares of common stock as adjusted for
any potentially dilutive shares as of the balance sheet date. The computation of basic and diluted
earnings (loss) per share is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
(in millions, except per share amounts)
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
Numerator (basic and diluted):
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
53.5
|
|
|
$
|
40.2
|
|
|
$
|
(158.9
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares basic
|
|
|
20.2
|
|
|
|
21.3
|
|
|
|
20.9
|
|
Share-based awards
|
|
|
0.5
|
|
|
|
0.5
|
|
|
|
|
|
Convertible debentures
|
|
|
0.3
|
|
|
|
0.5
|
|
|
|
|
|
Other
|
|
|
0.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares diluted
|
|
|
21.1
|
|
|
|
22.3
|
|
|
|
20.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
2.64
|
|
|
$
|
1.89
|
|
|
$
|
(7.60
|
)
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
2.54
|
|
|
$
|
1.80
|
|
|
$
|
(7.60
|
)
|
|
|
|
|
|
|
|
|
|
|
63
As discussed further in Note 10, the Company has issued convertible debentures. Under the
terms of the debentures, the Company would settle the par amount of its obligations in cash and the
remaining obligations, if any, in common shares. In accordance with the current applicable
accounting guidelines, the Company includes the conversion option effect in diluted earnings per
share during such periods when the Companys stock price exceeds the initial conversion price of
$33.79 per share.
In 2006, there was a loss attributable to common shares. Potentially dilutive share-based
awards of 0.6 million shares and convertible debentures of 0.1 million shares were excluded from
the calculation of diluted earnings per share as they were antidilutive.
7. Inventories
Inventories consists of the following:
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(in millions)
|
|
Finished products
|
|
$
|
53.5
|
|
|
$
|
45.7
|
|
Costs relating to long-term contracts and programs
|
|
|
41.5
|
|
|
|
19.4
|
|
Work in process
|
|
|
16.1
|
|
|
|
23.0
|
|
Raw materials and supplies
|
|
|
36.9
|
|
|
|
30.8
|
|
|
|
|
|
|
|
|
|
|
|
148.0
|
|
|
|
118.9
|
|
Reserve to reduce certain inventories to LIFO basis
|
|
|
(16.9
|
)
|
|
|
(16.2
|
)
|
Progress payments
|
|
|
(46.3
|
)
|
|
|
(32.4
|
)
|
|
|
|
|
|
|
|
Total
|
|
$
|
84.8
|
|
|
$
|
70.3
|
|
|
|
|
|
|
|
|
8. Property, Plant and Equipment
Property, plant and equipment consists of the following:
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(in millions)
|
|
Land
|
|
$
|
3.5
|
|
|
$
|
4.0
|
|
Buildings and improvements
|
|
|
115.0
|
|
|
|
107.7
|
|
Machinery and equipment
|
|
|
369.7
|
|
|
|
344.1
|
|
Construction in progress
|
|
|
23.8
|
|
|
|
33.1
|
|
|
|
|
|
|
|
|
|
|
|
512.0
|
|
|
|
488.9
|
|
Less accumulated depreciation
|
|
|
(305.9
|
)
|
|
|
(295.4
|
)
|
|
|
|
|
|
|
|
Total
|
|
$
|
206.1
|
|
|
$
|
193.5
|
|
|
|
|
|
|
|
|
Construction in progress was reduced by $1.5 million as of December 31, 2008, for grants and
credits receivable from governmental agencies to reimburse the Company for expenditures made on the
Palmyra, New York modernization project.
9. Goodwill and Other Intangible Assets
The changes in the net carrying value of goodwill by reportable segment for the years ended
December 31, 2008 and 2007 are as follows:
64
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Engine
|
|
|
|
|
|
|
Sealing
|
|
|
Engineered
|
|
|
Products and
|
|
|
|
|
|
|
Products
|
|
|
Products
|
|
|
Services
|
|
|
Total
|
|
|
|
(in millions)
|
|
Goodwill, net as of December 31, 2006
|
|
$
|
48.6
|
|
|
$
|
105.9
|
|
|
$
|
7.1
|
|
|
$
|
161.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation
|
|
|
1.2
|
|
|
|
8.7
|
|
|
|
|
|
|
|
9.9
|
|
Acquisitions
|
|
|
|
|
|
|
42.3
|
|
|
|
|
|
|
|
42.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill, net as of December 31, 2007
|
|
|
49.8
|
|
|
|
156.9
|
|
|
|
7.1
|
|
|
|
213.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation
|
|
|
(1.3
|
)
|
|
|
(12.7
|
)
|
|
|
|
|
|
|
(14.0
|
)
|
Acquisitions
|
|
|
17.9
|
|
|
|
0.4
|
|
|
|
|
|
|
|
18.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill, net as of December 31, 2008
|
|
$
|
66.4
|
|
|
$
|
144.6
|
|
|
$
|
7.1
|
|
|
$
|
218.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The gross carrying amount and accumulated amortization of identifiable intangible assets is as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2008
|
|
|
As of December 31, 2007
|
|
|
|
Gross
|
|
|
|
|
|
Gross
|
|
|
|
|
|
|
Carrying
|
|
|
Accumulated
|
|
|
Carrying
|
|
|
Accumulated
|
|
|
|
Amount
|
|
|
Amortization
|
|
|
Amount
|
|
|
Amortization
|
|
|
|
|
|
|
|
(in millions)
|
|
|
|
|
|
Customer relationships
|
|
$
|
77.3
|
|
|
$
|
27.1
|
|
|
$
|
68.4
|
|
|
$
|
20.9
|
|
Existing technology
|
|
|
22.4
|
|
|
|
5.0
|
|
|
|
21.0
|
|
|
|
3.8
|
|
Trademarks
|
|
|
36.5
|
|
|
|
6.4
|
|
|
|
38.4
|
|
|
|
5.8
|
|
Other
|
|
|
14.1
|
|
|
|
8.4
|
|
|
|
13.3
|
|
|
|
7.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
150.3
|
|
|
$
|
46.9
|
|
|
$
|
141.1
|
|
|
$
|
37.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization expense for the years ended December 31, 2008, 2007 and 2006 was $10.8 million,
$7.8 million and $6.1 million, respectively. Amortization expense for these intangible assets for
the years 2009 through 2013 is estimated to be $10.3 million, $10.1 million, $9.7 million, $9.1
million and $8.4 million, respectively. The Company has trademarks with indefinite lives that were
included in the table above with a carrying amount of approximately $23 million as of December 31,
2008 that were not amortized.
10. Long-Term Debt
The Companys long-term debt at December 31, 2008 and 2007 is summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(in millions)
|
|
Convertible Debentures
|
|
$
|
172.5
|
|
|
$
|
172.5
|
|
Coltec Senior Notes
|
|
|
|
|
|
|
3.1
|
|
Industrial revenue bonds
|
|
|
9.6
|
|
|
|
9.6
|
|
Other notes payable
|
|
|
0.1
|
|
|
|
0.5
|
|
|
|
|
|
|
|
|
|
|
|
182.2
|
|
|
|
185.7
|
|
Less current maturities of long-term debt
|
|
|
9.6
|
|
|
|
3.6
|
|
|
|
|
|
|
|
|
|
|
$
|
172.6
|
|
|
$
|
182.1
|
|
|
|
|
|
|
|
|
The Companys primary U.S. operating subsidiaries have a senior secured revolving credit
facility with a group of banks. The credit agreement for this facility was originally executed on
May 16,
65
2002. On April 26, 2006, the Company and its primary U.S. operating subsidiaries amended and
extended the facility. As amended, the maximum initial amount available for borrowings under the
facility is $75 million. Under certain conditions, the borrowers may request that the facility be
increased by up to $25 million, to $100 million total. The facility matures on April 21, 2011.
Borrowings are available at LIBOR plus a margin of 1.00% to 1.75%. The Company pays an annual
unused line fee of 0.25%.
There have been no borrowings under this credit facility since its inception. Borrowings
under the credit facility would be collateralized by receivables, inventories, intellectual
property, insurance receivables and all other personal property assets (other than fixed assets) of
the Company and its U.S. subsidiaries, and by pledges of 65% of the capital stock of its foreign
subsidiaries and 100% of the capital stock of its domestic subsidiaries. The credit facility
contains customary restrictions, covenants and events of default for financings of this type,
including but not limited to limitations on the ability to pay dividends, limitations on the
incurrence and repayment of additional debt and maintenance of a fixed charge coverage financial
ratio. Certain of the covenants and restrictions apply only if availability under the facility
falls below certain levels.
In 2005, the Company issued $172.5 million in aggregate principal amount of Convertible Senior
Debentures (the Debentures). The Debentures bear interest at the annual rate of 3.9375%, with
interest due on April 15 and October 15 of each year. The Debentures will mature on October 15,
2015 unless they are converted prior to that date. The Debentures are the Companys direct,
unsecured and unsubordinated obligations and would rank equal in priority with all unsecured and
unsubordinated indebtedness and senior in right of payment to all subordinated indebtedness. They
would effectively rank junior to all secured indebtedness to the extent of the value of the assets
securing such indebtedness. The Debentures do not contain any financial covenants.
Holders may convert the Debentures into cash and shares of the Companys common stock, under
certain circumstances. The initial conversion rate, which is subject to adjustment, is 29.5972
shares of common stock per $1,000 principal amount of Debentures. This is equal to an initial
conversion price of $33.79 per share. The debentures may be converted under the following
circumstances:
|
|
|
during any fiscal quarter (and only during such fiscal quarter), if the closing
price of the Companys common stock for at least 20 trading days in the 30 consecutive
trading-day period ending on the last trading day of the preceding fiscal quarter was
130% or more of the then current conversion price per share of common stock on that
30
th
trading day;
|
|
|
|
|
during the five business day period after any five consecutive trading-day period
(which is referred to as the measurement period) in which the trading price per
debenture for each day of the measurement period was less than 98% of the product of
the closing price of the Companys common stock and the applicable conversion rate for
the debentures;
|
|
|
|
|
on or after September 15, 2015;
|
|
|
|
|
upon the occurrence of specified corporate transactions; or
|
|
|
|
|
in connection with a transaction or event constituting a change of control.
|
The conditions that permit conversion were not satisfied at December 31, 2008.
Upon conversion of any Debentures, the principal amount would be settled in cash.
Specifically, in connection with any conversion, the Company will satisfy its obligations under the
Debentures by
66
delivering to holders, in respect of each $1,000 aggregate principal amount of Debentures
being converted:
|
|
|
cash equal to the lesser of $1,000 or the Conversion Value, and
|
|
|
|
|
to the extent the Conversion Value exceeds $1,000, a number of shares equal to the
sum of, for each day of the Cash Settlement Period (defined below), (1) 5% of the
difference between (A) the product of the conversion rate (plus any additional shares
as an adjustment upon a change of control) and the closing price of the Companys
common stock for such date and (B) $1,000, divided by (2) the closing price of the
Companys common stock for such day.
|
Conversion Value means the product of (1) the conversion rate in effect (plus any additional
shares as an adjustment upon a change of control) and (2) the average of the closing prices of the
Companys common stock for the 20 consecutive trading days beginning on the second trading day
after the conversion date for those Debentures.
The industrial revenue bonds are payable in full in 2009 and bear interest at rates ranging
from 6.4% to 6.55%.
Future principal payments on long-term debt are as follows:
|
|
|
|
|
|
|
(in millions)
|
|
2009
|
|
$
|
9.6
|
|
2010
|
|
|
0.1
|
|
2011
|
|
|
|
|
2012
|
|
|
|
|
2013
|
|
|
|
|
Thereafter
|
|
|
172.5
|
|
|
|
|
|
|
|
$
|
182.2
|
|
|
|
|
|
11. Fair Value Measurements
Assets and liabilities measured at fair value on a recurring basis are summarized as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value Measurements as of
|
|
|
|
December 31, 2008
|
|
|
|
Total
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
|
|
|
|
|
(in millions)
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash equivalents
|
|
$
|
65.8
|
|
|
$
|
65.8
|
|
|
$
|
|
|
|
$
|
|
|
Crucible back-up trust assets
|
|
|
22.4
|
|
|
|
22.4
|
|
|
|
|
|
|
|
|
|
Cash management fund
|
|
|
7.1
|
|
|
|
|
|
|
|
7.1
|
|
|
|
|
|
Foreign currency derivatives
|
|
|
1.8
|
|
|
|
|
|
|
|
1.8
|
|
|
|
|
|
Deferred compensation assets
|
|
|
2.6
|
|
|
|
2.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
99.7
|
|
|
$
|
90.8
|
|
|
$
|
8.9
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred compensation liabilities
|
|
$
|
4.1
|
|
|
$
|
4.1
|
|
|
$
|
|
|
|
$
|
|
|
Foreign currency derivatives
|
|
|
0.7
|
|
|
|
|
|
|
|
0.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
4.8
|
|
|
$
|
4.1
|
|
|
$
|
0.7
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
67
The Companys cash equivalents, Crucible back-up trust assets and deferred compensation assets
and liabilities are classified within Level 1 of the fair value hierarchy because they are valued
using quoted market prices. For further discussion of the Crucible back-up trust, see Note 17,
Commitments and Contingencies Crucible Materials Corporation. The fair values for foreign
currency derivatives are based on quoted market prices from various banks for similar instruments.
In December 2007, the Company was notified that the cash management fund held at a financial
institution would be closed and liquidated. In addition, (1) cash redemptions were temporarily
suspended, although redemptions could be filled through a pro-rata distribution of the underlying
securities, consisting principally of high-quality corporate debt, mortgage-backed securities and
asset-backed securities; (2) the funds valuation would be based on the market value of the
underlying securities, whereas historically the funds valuation was based on amortized cost; and
(3) interest would continue to accrue. Due to this event, the Company re-evaluated the nature of
the investment and determined that it should be reclassified as an investment rather than as a cash
equivalent in its Consolidated Financial Statements. The Company has been advised by the fund
manager that the intention is to make an orderly liquidation of the cash management fund with the
goal of preserving and distributing as much of the original investment values as possible to the
fund investors. The fair value of the cash management fund assets is determined through a
combination of broker quotations, alternative pricing sources with reasonable levels of price
transparency and review of management, and is reflected in the net asset value of the fund. In the
years ended December 31, 2008 and 2007, the Company recorded expense of $2.0 million and $0.4
million, respectively, related to decreases in the value of the cash management fund which is
included in other income (expense) in the accompanying Consolidated Statements of Operations.
The carrying values of the Companys significant financial instruments reflected in the
Consolidated Balance Sheets approximate their respective fair values at December 31, 2008 and 2007,
except for the following instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
2007
|
|
|
Carrying
|
|
Fair
|
|
Carrying
|
|
Fair
|
|
|
Value
|
|
Value
|
|
Value
|
|
Value
|
|
|
(in millions)
|
Long-term debt
|
|
$
|
182.2
|
|
|
$
|
145.1
|
|
|
$
|
185.7
|
|
|
$
|
215.9
|
|
The fair values for long-term debt are based on quoted market prices or on rates available to
the Company for debt with similar terms and maturities.
12. Pensions and Postretirement Benefits
The Company and its subsidiaries have several non-contributory defined benefit pension plans
covering eligible employees in the United States, Canada, Mexico and several European countries.
Salaried employees benefit payments are generally determined using a formula that is based on an
employees compensation and length of service. The Company closed its defined benefit pension plan
for new salaried employees in the United States who joined the Company after January 1, 2006, and
effective January 1, 2007, benefits were frozen for all salaried employees who were not age 40 or
older as of December 31, 2006, and other employees who chose to freeze their benefits. Hourly
employees benefit payments are generally determined using stated amounts for each year of service.
The Companys employees also participate in voluntary contributory retirement savings plans for
salaried and hourly employees maintained by the Company and its subsidiaries. Under these plans,
eligible employees can receive matching contributions up to the first 6% of their eligible
earnings. Effective January 1, 2007, those employees whose defined benefit pension plan benefits
were frozen receive an additional 2%
68
Company contribution each year. The Company recorded $6.9 million, $6.2 million and $5.2
million in expenses in 2008, 2007 and 2006, respectively, for matching contributions under these
plans.
The Companys general funding policy for qualified defined benefit pension plans is to
contribute amounts that are at least sufficient to satisfy regulatory funding standards. In both
2007 and 2006, the Company contributed discretionary amounts of $10.0 million to the U.S. pension
plans. The Company anticipates that there will be a required funding of $6.4 million in 2009. The
Company expects to make total contributions of approximately $0.9 million in 2009 to the foreign
pension plans. The projected benefit obligation, accumulated benefit obligation and fair value of
plan assets for the defined benefit pension plans with accumulated benefit obligations in excess of
plan assets were $190.0 million, $177.6 million and $109.7 million at December 31, 2008, and $186.7
million, $172.5 million and $167.5 million at December 31, 2007, respectively.
The Company amortizes prior service cost and unrecognized gains and losses using the
straight-line basis over the average future service life of active participants.
The Company provides, through non-qualified plans, supplemental pension benefits to a limited
number of employees. Certain of the Companys subsidiaries also sponsor unfunded defined benefit
postretirement plans that provide certain health-care and life insurance benefits to eligible
employees. The health-care plans are contributory, with retiree contributions adjusted
periodically, and contain other cost-sharing features, such as deductibles and coinsurance. The
life insurance plans are generally noncontributory. The amounts included in Other Benefits in
the following tables include the non-qualified plans and the other defined benefit postretirement
plans discussed above.
Domestic Plans
The following table sets forth the changes in projected benefit obligations and plan assets of
the Companys U.S. defined benefit pension and other non-qualified and postretirement plans as of
and for the years ended December 31, 2008 and 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Benefits
|
|
|
Other Benefits
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
(in millions)
|
|
Change in Projected Benefit Obligations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Projected benefit obligations at
beginning of year
|
|
$
|
168.6
|
|
|
$
|
155.8
|
|
|
$
|
12.9
|
|
|
$
|
11.9
|
|
Service cost
|
|
|
5.8
|
|
|
|
5.8
|
|
|
|
1.0
|
|
|
|
1.5
|
|
Interest cost
|
|
|
10.4
|
|
|
|
9.7
|
|
|
|
0.7
|
|
|
|
0.7
|
|
Actuarial loss
|
|
|
1.7
|
|
|
|
3.0
|
|
|
|
0.7
|
|
|
|
|
|
Amendments
|
|
|
0.5
|
|
|
|
0.4
|
|
|
|
|
|
|
|
0.5
|
|
Administrative expenses
|
|
|
(1.2
|
)
|
|
|
(1.3
|
)
|
|
|
|
|
|
|
|
|
Benefits paid
|
|
|
(5.5
|
)
|
|
|
(4.8
|
)
|
|
|
(1.2
|
)
|
|
|
(1.7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Projected benefit obligations at end of year
|
|
|
180.3
|
|
|
|
168.6
|
|
|
|
14.1
|
|
|
|
12.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in Plan Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets
at beginning of year
|
|
|
157.1
|
|
|
|
143.2
|
|
|
|
|
|
|
|
|
|
Actual return on plan assets
|
|
|
(44.2
|
)
|
|
|
10.0
|
|
|
|
|
|
|
|
|
|
Administrative expenses
|
|
|
(1.2
|
)
|
|
|
(1.3
|
)
|
|
|
|
|
|
|
|
|
Company contributions
|
|
|
|
|
|
|
10.0
|
|
|
|
|
|
|
|
|
|
Benefits paid
|
|
|
(5.5
|
)
|
|
|
(4.8
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets at end of year
|
|
|
106.2
|
|
|
|
157.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Funded Status at End of Year
|
|
$
|
(74.1
|
)
|
|
$
|
(11.5
|
)
|
|
$
|
(14.1
|
)
|
|
$
|
(12.9
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Benefits
|
|
|
Other Benefits
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
(in millions)
|
|
Amounts Recognized in the
Consolidated Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
$
|
|
|
|
$
|
|
|
|
$
|
(4.2
|
)
|
|
$
|
(0.8
|
)
|
Noncurrent liabilities
|
|
|
(74.1
|
)
|
|
|
(11.5
|
)
|
|
|
(9.9
|
)
|
|
|
(12.1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(74.1
|
)
|
|
$
|
(11.5
|
)
|
|
$
|
(14.1
|
)
|
|
$
|
(12.9
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recent volatility in the equity and fixed income markets has caused a significant decline in
the value of the U.S. pension plan assets and an increase in plan liabilities. The resulting
decline in the plans funded status has created the requirement of significant charges to
accumulated other comprehensive income during the year ended December 31, 2008. Pre-tax charges
recognized in accumulated other comprehensive income as of December 31, 2008 and 2007 consist of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Benefits
|
|
|
Other Benefits
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
(in millions)
|
|
Net actuarial loss
|
|
$
|
78.9
|
|
|
$
|
20.3
|
|
|
$
|
3.0
|
|
|
$
|
2.5
|
|
Prior service cost
|
|
|
3.7
|
|
|
|
4.5
|
|
|
|
1.4
|
|
|
|
1.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
82.6
|
|
|
$
|
24.8
|
|
|
$
|
4.4
|
|
|
$
|
4.1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accumulated benefit obligation for all domestic defined benefit pension plans was $169.0
million and $156.7 million at December 31, 2008 and 2007, respectively.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Benefits
|
|
|
Other Benefits
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(in millions)
|
|
Net Periodic Benefit Cost
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost
|
|
$
|
5.8
|
|
|
$
|
5.8
|
|
|
$
|
7.4
|
|
|
$
|
1.0
|
|
|
$
|
1.5
|
|
|
$
|
0.9
|
|
Interest cost
|
|
|
10.4
|
|
|
|
9.7
|
|
|
|
8.9
|
|
|
|
0.7
|
|
|
|
0.7
|
|
|
|
0.7
|
|
Expected return on plan assets
|
|
|
(13.1
|
)
|
|
|
(12.5
|
)
|
|
|
(10.5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of prior service cost
|
|
|
1.2
|
|
|
|
1.2
|
|
|
|
2.5
|
|
|
|
0.2
|
|
|
|
0.2
|
|
|
|
(0.1
|
)
|
Recognized net actuarial loss
|
|
|
0.5
|
|
|
|
0.1
|
|
|
|
1.8
|
|
|
|
0.2
|
|
|
|
0.2
|
|
|
|
0.2
|
|
Curtailment loss
|
|
|
|
|
|
|
|
|
|
|
0.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit cost
|
|
|
4.8
|
|
|
|
4.3
|
|
|
$
|
10.3
|
|
|
|
2.1
|
|
|
|
2.6
|
|
|
$
|
1.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Changes in Plan Assets and
Benefit Obligations Recognized in
Other Comprehensive Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
59.1
|
|
|
|
5.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prior service cost
|
|
|
0.4
|
|
|
|
0.3
|
|
|
|
|
|
|
|
0.7
|
|
|
|
0.7
|
|
|
|
|
|
Amortization of net loss
|
|
|
(0.5
|
)
|
|
|
(0.1
|
)
|
|
|
|
|
|
|
(0.2
|
)
|
|
|
(0.2
|
)
|
|
|
|
|
Amortization of prior service cost
|
|
|
(1.2
|
)
|
|
|
(1.2
|
)
|
|
|
|
|
|
|
(0.2
|
)
|
|
|
(0.2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
recognized in other comprehensive income
|
|
|
57.8
|
|
|
|
4.6
|
|
|
|
|
|
|
|
0.3
|
|
|
|
0.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Recognized in Net Periodic Benefit
Cost and Other Comprehensive
Income
|
|
$
|
62.6
|
|
|
$
|
8.9
|
|
|
|
|
|
|
$
|
2.4
|
|
|
$
|
2.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
70
The estimated net loss and prior service cost for the defined benefit pension plans that will
be amortized from accumulated other comprehensive income into net periodic benefit cost over the
next fiscal year are $6.4 million and $0.9 million, respectively. The estimated net loss and prior
service cost for the other defined benefit postretirement plans that will be amortized from
accumulated other comprehensive income into net periodic benefit cost over the next fiscal year is
$0.2 million and $0.2 million, respectively.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Benefits
|
|
Other Benefits
|
|
|
2008
|
|
2007
|
|
2006
|
|
2008
|
|
2007
|
|
2006
|
Weighted-Average Assumptions Used to
Determine Benefit Obligations at
December 31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate
|
|
|
6.25
|
%
|
|
|
6.25
|
%
|
|
|
6.25
|
%
|
|
|
6.25
|
%
|
|
|
6.25
|
%
|
|
|
6.25
|
%
|
Rate of compensation increase
|
|
|
4.0
|
%
|
|
|
4.0
|
%
|
|
|
4.0
|
%
|
|
|
4.0
|
%
|
|
|
4.0
|
%
|
|
|
4.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-Average Assumptions Used to
Determine Net Periodic Benefit Cost for
Years Ended December 31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate
|
|
|
6.25
|
%
|
|
|
6.25
|
%
|
|
|
5.75
|
%
|
|
|
6.25
|
%
|
|
|
6.25
|
%
|
|
|
5.75
|
%
|
Expected long-term return
on plan assets
|
|
|
8.5
|
%
|
|
|
8.5
|
%
|
|
|
8.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Rate of compensation increase
|
|
|
4.0
|
%
|
|
|
4.0
|
%
|
|
|
4.0
|
%
|
|
|
4.0
|
%
|
|
|
4.0
|
%
|
|
|
4.0
|
%
|
The discount rate reflects the current rate at which the pension liabilities could be
effectively settled at the end of the year. The discount rate was determined by matching the
Companys expected benefit payments, taking into account the plans demographics, to the Citigroup
Pension Discount Curve. This produced a discount rate of 6.25% at December 31, 2008. As of the
date of these financial statements, there are no known or anticipated changes in our discount rate
assumption that will impact our pension expense in 2009. A 25 basis point decrease (increase) in
our discount rate, holding constant our expected long-term return on plan assets and other
assumptions, would increase (decrease) pension expense by approximately $0.7 million per year.
The overall expected long-term rate of return on assets was determined based upon
weighted-average historical returns over an extended period of time for the asset classes in which
the plans invest according to the Companys current investment policy.
The Company uses the RP-2000 mortality table to value its domestic pension liabilities.
|
|
|
|
|
|
|
|
|
Assumed Health Care Cost Trend Rates at December 31
|
|
2008
|
|
2007
|
Health care cost trend rate assumed for next year
|
|
|
10.0
|
%
|
|
|
9.0
|
%
|
Rate to which the cost trend rate is assumed to
decline (the ultimate rate)
|
|
|
5.0
|
%
|
|
|
5.0
|
%
|
Year that the rate reaches the ultimate trend rate
|
|
|
2013
|
|
|
|
2013
|
|
A one percentage point change in the assumed health-care cost trend rate would have an impact
of not more than $0.1 million on net periodic benefit cost and $0.8 million on benefit obligations.
Plan Assets
The asset allocation for pension plans at the end of 2008 and 2007, and the target allocation
for 2009, by asset category are as follows:
71
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Target
|
|
|
|
|
Allocation
|
|
Plan Assets at December 31,
|
Asset Category
|
|
2009
|
|
2008
|
|
2007
|
Equity securities
|
|
|
65
|
%
|
|
|
65
|
%
|
|
|
65
|
%
|
Fixed income
|
|
|
35
|
%
|
|
|
35
|
%
|
|
|
35
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Companys investment goal is to maximize the return on assets, over the long term, by
investing in equities and fixed income investments while diversifying investments within each asset
class to reduce the impact of losses in individual securities. Equity investments include a mix of
U.S. large capitalization equities, U.S. small capitalization equities and non-U.S. equities.
Fixed income investments include a mix of corporate bonds, treasury obligations and mortgage backed
securities. The asset allocation policy is reviewed periodically and any variation from the target
asset allocation mix greater than 2% is rebalanced on a monthly basis. The plans have no direct
investments in the Companys common stock.
Estimated Future Benefit Payments
The following benefit payments, which reflect expected future service, as appropriate, are
expected to be paid:
|
|
|
|
|
|
|
|
|
|
|
Pension
|
|
|
Other
|
|
|
|
Benefits
|
|
|
Benefits
|
|
|
|
(in millions)
|
|
2009
|
|
$
|
6.5
|
|
|
$
|
4.9
|
|
2010
|
|
|
7.0
|
|
|
|
1.3
|
|
2011
|
|
|
7.7
|
|
|
|
1.1
|
|
2012
|
|
|
8.5
|
|
|
|
1.1
|
|
2013
|
|
|
9.4
|
|
|
|
1.1
|
|
Years 2014 2018
|
|
|
62.2
|
|
|
|
5.5
|
|
|
|
|
|
|
|
|
|
|
$
|
101.3
|
|
|
$
|
15.0
|
|
|
|
|
|
|
|
|
Foreign Plans
The following table sets forth the changes in projected benefit obligations and plan assets of
the Companys foreign defined benefit pension and other postretirement plans as of and for the
years ended December 31, 2008 and 2007.
72
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Benefits
|
|
|
Other Benefits
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
(in millions)
|
|
Change in Projected Benefit Obligations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Projected benefit obligations at
beginning of year
|
|
$
|
19.3
|
|
|
$
|
18.2
|
|
|
$
|
1.4
|
|
|
$
|
1.5
|
|
Service cost
|
|
|
0.7
|
|
|
|
0.7
|
|
|
|
|
|
|
|
0.1
|
|
Interest cost
|
|
|
1.0
|
|
|
|
0.9
|
|
|
|
|
|
|
|
0.1
|
|
Curtailments and settlements
|
|
|
|
|
|
|
|
|
|
|
(1.4
|
)
|
|
|
|
|
Actuarial gain
|
|
|
(2.8
|
)
|
|
|
(1.1
|
)
|
|
|
|
|
|
|
(0.3
|
)
|
Benefits paid
|
|
|
(1.2
|
)
|
|
|
(1.8
|
)
|
|
|
|
|
|
|
|
|
Other, primarily exchange
rate adjustment
|
|
|
(2.3
|
)
|
|
|
2.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Projected benefit obligations at end of year
|
|
|
14.7
|
|
|
|
19.3
|
|
|
|
|
|
|
|
1.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in Plan Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets
at beginning of year
|
|
|
12.4
|
|
|
|
10.6
|
|
|
|
|
|
|
|
|
|
Actual return on plan assets
|
|
|
(1.9
|
)
|
|
|
0.1
|
|
|
|
|
|
|
|
|
|
Company contributions
|
|
|
1.3
|
|
|
|
1.9
|
|
|
|
|
|
|
|
|
|
Benefits paid
|
|
|
(1.2
|
)
|
|
|
(1.8
|
)
|
|
|
|
|
|
|
|
|
Other, primarily exchange rate adjustment
|
|
|
(2.0
|
)
|
|
|
1.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value of plan assets at end of year
|
|
|
8.6
|
|
|
|
12.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Funded Status
|
|
$
|
(6.1
|
)
|
|
$
|
(6.9
|
)
|
|
$
|
|
|
|
$
|
(1.4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts Recognized in the
Consolidated Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Noncurrent assets
|
|
$
|
0.4
|
|
|
$
|
0.8
|
|
|
$
|
|
|
|
$
|
|
|
Current liabilities
|
|
|
(0.3
|
)
|
|
|
(0.3
|
)
|
|
|
|
|
|
|
|
|
Noncurrent liabilities
|
|
|
(6.2
|
)
|
|
|
(7.4
|
)
|
|
|
|
|
|
|
(1.4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
(6.1
|
)
|
|
$
|
(6.9
|
)
|
|
$
|
|
|
|
$
|
(1.4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pre-tax charges (credits) recognized in accumulated other comprehensive income as of December
31, 2008 and 2007 consist of:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Benefits
|
|
|
Other Benefits
|
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
|
(in millions)
|
|
Net actuarial loss (gain)
|
|
$
|
1.5
|
|
|
$
|
2.4
|
|
|
$
|
|
|
|
$
|
(0.6
|
)
|
Net transition asset
|
|
|
(0.2
|
)
|
|
|
(0.3
|
)
|
|
|
|
|
|
|
|
|
Prior service cost
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
1.3
|
|
|
$
|
2.1
|
|
|
$
|
|
|
|
$
|
0.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accumulated benefit obligations for all foreign defined benefit pension plans was $12.7
million and $16.9 million at December 31, 2008 and 2007, respectively.
73
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Benefits
|
|
|
Other Benefits
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(in millions)
|
|
Net Periodic Benefit Cost
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost
|
|
$
|
0.7
|
|
|
$
|
0.7
|
|
|
$
|
0.6
|
|
|
$
|
|
|
|
$
|
0.1
|
|
|
$
|
0.1
|
|
Interest cost
|
|
|
1.0
|
|
|
|
0.9
|
|
|
|
0.8
|
|
|
|
|
|
|
|
0.1
|
|
|
|
0.1
|
|
Expected return on plan assets
|
|
|
(0.8
|
)
|
|
|
(0.8
|
)
|
|
|
(0.7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
Recognized net actuarial loss
|
|
|
0.1
|
|
|
|
0.1
|
|
|
|
0.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Curtailment and settlement loss (gain)
|
|
|
|
|
|
|
|
|
|
|
0.1
|
|
|
|
(1.1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit cost
|
|
|
1.0
|
|
|
|
0.9
|
|
|
$
|
1.1
|
|
|
|
(1.1
|
)
|
|
|
0.2
|
|
|
$
|
0.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Changes in Plan Assets and
Benefit Obligations Recognized in
Other Comprehensive Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) gain
|
|
|
(0.1
|
)
|
|
|
(0.4
|
)
|
|
|
|
|
|
|
0.6
|
|
|
|
(0.4
|
)
|
|
|
|
|
Amortization of transition asset
|
|
|
(0.1
|
)
|
|
|
(0.1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Curtailment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(0.9
|
)
|
|
|
|
|
|
|
|
|
Other, primarily exchange rate
adjustment
|
|
|
(0.6
|
)
|
|
|
0.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
recognized in other comprehensive income
|
|
|
(0.8
|
)
|
|
|
(0.1
|
)
|
|
|
|
|
|
|
(0.3
|
)
|
|
|
(0.4
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Recognized in Net Periodic Benefit
Cost and Other Comprehensive
Income
|
|
$
|
0.2
|
|
|
$
|
0.8
|
|
|
|
|
|
|
$
|
(1.4
|
)
|
|
$
|
(0.2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The estimated net loss for the defined benefit pension plans that will be amortized from
accumulated other comprehensive income into net periodic benefit cost over the next fiscal year is
$0.1 million.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pension Benefits
|
|
Other Benefits
|
|
|
2008
|
|
2007
|
|
2006
|
|
2008
|
|
2007
|
|
2006
|
Weighted-Average Assumptions Used to
Determine Benefit Obligations at
December 31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate
|
|
|
7.0
|
%
|
|
|
5.6
|
%
|
|
|
5.0
|
%
|
|
|
6.25
|
%
|
|
|
5.5
|
%
|
|
|
4.5
|
%
|
Rate of compensation increase
|
|
|
3.0
|
%
|
|
|
3.0
|
%
|
|
|
3.0
|
%
|
|
|
3.0
|
%
|
|
|
3.0
|
%
|
|
|
3.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-Average Assumptions Used to
Determine Net Periodic Benefit Cost for
Years Ended December 31
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discount rate
|
|
|
5.6
|
%
|
|
|
5.0
|
%
|
|
|
4.7
|
%
|
|
|
5.5
|
%
|
|
|
4.5
|
%
|
|
|
4.0
|
%
|
Expected long-term
return on plan assets
|
|
|
6.8
|
%
|
|
|
7.0
|
%
|
|
|
7.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
Rate of compensation increase
|
|
|
3.0
|
%
|
|
|
3.0
|
%
|
|
|
3.0
|
%
|
|
|
3.0
|
%
|
|
|
3.0
|
%
|
|
|
3.0
|
%
|
74
Assumed Health Care Cost Trend Rates
The assumed health care cost trend rate at December 31, 2008 and 2007 was 4%.
Plan Assets
The asset allocation for the Canadian pension plan at the end of 2008 and 2007 and the target
allocation for 2009 is 60% equity securities, 35% fixed income, and 5% other. The asset allocation
for the Mexican pension plan at the end of 2008 and 2007 and the target allocation for 2009 is 100%
fixed income. The European plans are generally unfunded.
Estimated Future Benefit Payments
The following benefit payments, which reflect expected future service, as appropriate, are
expected to be made:
|
|
|
|
|
|
|
|
|
|
|
Pension
|
|
|
Other
|
|
|
|
Benefits
|
|
|
Benefits
|
|
|
|
(in millions)
|
|
2009
|
|
$
|
1.0
|
|
|
$
|
|
|
2010
|
|
|
0.8
|
|
|
|
|
|
2011
|
|
|
0.8
|
|
|
|
|
|
2012
|
|
|
0.9
|
|
|
|
|
|
2013
|
|
|
1.1
|
|
|
|
|
|
Years 2014 2018
|
|
|
6.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
11.1
|
|
|
$
|
|
|
|
|
|
|
|
|
|
13. Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss) consists of the following:
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(in millions)
|
|
Unrealized translation adjustments
|
|
$
|
37.1
|
|
|
$
|
68.7
|
|
Pension and other postretirement plans
|
|
|
(55.1
|
)
|
|
|
(19.5
|
)
|
Accumulated net gain on cash flow hedges
|
|
|
0.6
|
|
|
|
0.7
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive income
(loss)
|
|
$
|
(17.4
|
)
|
|
$
|
49.9
|
|
|
|
|
|
|
|
|
The unrealized translation adjustments are net of deferred taxes of $1.0 million in 2008. The
pension and other postretirement plans are net of deferred taxes of $33.2 million and $11.8
million, in 2008 and 2007, respectively. The accumulated net gain on cash flow hedges is net of
deferred taxes of $0.4 million and $0.5 million in 2008 and 2007, respectively.
75
14. Shareholders Equity
On March 3, 2008, pursuant to a $100 million share repurchase authorization approved by the
Companys board of directors, the Company entered into an accelerated share repurchase (ASR)
agreement with a financial institution to provide for the immediate retirement of $50 million of
the Companys common stock. Under the ASR agreement, the Company purchased approximately 1.7
million shares of its common stock from a financial institution at an initial price of $29.53 per
share. The financial institution borrowed these shares from third parties. Total consideration
paid to the financial institution at initial settlement to repurchase these shares, including
commissions and other fees, was approximately $50.2 million and was recorded in shareholders
equity as a reduction of common stock and additional paid-in capital.
The price adjustment period under the ASR terminated in August 2008. During the term of the
ASR, the financial institution purchased shares of the Companys common stock in the open market to
settle its obligation related to shares borrowed from third parties and sold to the Company. The
Company was required to remit a final settlement adjustment of $11.9 million based on an average of
the reported daily volume weighted average price of its common stock during the term of the ASR.
The final settlement adjustment was remitted in cash and was recorded in shareholders equity as a
reduction of additional paid-in capital.
Pursuant to the share repurchase authorization and in accordance with the terms of a plan to
repurchase shares announced on September 8, 2008, the Company acquired 252,400 shares of its common
stock in open-market transactions at an average price of about $28.00 per share, resulting in total
repurchases of approximately $7.1 million, including commissions and fees, from October 1, 2008 to
October 29, 2008. On October 29, 2008, in light of the volatility in the financial and credit
markets, the board of directors terminated the share repurchase plan.
15. Equity Compensation Plan
The Company has an equity compensation plan (the Plan) that initially provided for the
delivery of up to 3.6 million shares pursuant to various market and performance-based incentive
awards. As of December 31, 2008, there are 0.7 million shares available for future awards. The
Companys policy is to issue new shares to satisfy share option exercises.
Under the terms of the Plan, performance share awards were granted to executives and other key
employees during 2008, 2007 and 2006. Each grant will vest if the Company achieves specific
financial objectives at the end of a three-year performance period. Additional shares may be
awarded if objectives are exceeded, but some or all shares may be forfeited if objectives are not
met. Performance shares earned at the end of a performance period, if any, will be paid in actual
shares of Company common stock, less the number of shares equal in value to applicable withholding
taxes if the employee chooses. During the performance period, a grantee receives dividend
equivalents accrued in cash (if any), and shares are forfeited if a grantee terminates employment.
A summary of the performance share activity during the year ended December 31, 2008, is
presented below. The number of performance share awards shown in the table below represents the
maximum number that could be issued.
76
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-Average
|
|
|
|
|
|
|
|
Grant-Date
|
|
|
|
Shares
|
|
|
Fair Value
|
|
Nonvested at January 1, 2008
|
|
|
377,195
|
|
|
$
|
32.57
|
|
Granted
|
|
|
357,644
|
|
|
|
30.66
|
|
Vested
|
|
|
(175,115
|
)
|
|
|
28.71
|
|
Forfeited
|
|
|
(72,384
|
)
|
|
|
31.19
|
|
Achievement level adjustment
|
|
|
(1,246
|
)
|
|
|
28.71
|
|
|
|
|
|
|
|
|
Nonvested at December 31, 2008
|
|
|
486,094
|
|
|
$
|
32.73
|
|
|
|
|
|
|
|
|
The performance share awards granted had a fair value, which approximated market value, at the
grant date of $5.5 million, $5.0 million and $4.3 million or $30.66, $36.69 and $28.71 per share in
2008, 2007 and 2006, respectively. Compensation expense related to the performance shares is
recorded over the applicable performance period and amounted to $3.1 million, $4.8 million and $5.0
million in 2008, 2007 and 2006, respectively. The related income tax benefit was $1.2 million,
$1.8 million and $1.9 million, respectively. The 2006 performance share awards vested as of
December 31, 2008 and were paid in February 2009.
As of December 31, 2008, there was $2.3 million of unrecognized compensation cost related to
nonvested performance share awards that is expected to be recognized over a period of two years.
Non-qualified and incentive stock options were granted in 2008, 2003 and 2002. No stock
option has a term exceeding 10 years from the date of grant. All stock options were granted at not
less than 100% of fair market value (as defined) on the date of grant. Compensation expense
related to the stock options amounted to $0.3 million in 2008, with a related income tax benefit of
$0.1 million. As of December 31, 2008, there was $1.0 million of unrecognized compensation cost
related to nonvested stock options that is expected to be recognized over a period of two years.
The following table provides certain information with respect to stock options as of December
31, 2008:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average
|
|
Range of
|
|
Stock Options
|
|
|
Stock Options
|
|
|
Weighted Average
|
|
|
Remaining
|
|
Exercise Price
|
|
Outstanding
|
|
|
Exercisable
|
|
|
Exercise Price
|
|
|
Contractual Life
|
|
Under $20.00
|
|
|
581,374
|
|
|
|
581,374
|
|
|
$
|
5.01
|
|
|
2.35 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Over $20.00
|
|
|
100,000
|
|
|
|
|
|
|
$
|
34.55
|
|
|
9.28 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
681,374
|
|
|
|
581,374
|
|
|
$
|
9.35
|
|
|
3.59 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company determines the fair value of stock options using the Black-Scholes option-pricing
formula. Key inputs into this formula include expected term, expected volatility, expected
dividend yield and the risk-free interest rate. Each assumption is discussed below. This fair
value is amortized on a straight-line basis over the vesting period.
The expected term represents the period that the Companys stock options are expected to be
outstanding, and is determined based on historical experience of similar awards, giving
consideration to contractual terms of the awards, vesting schedules and expectations of future
employee behavior. The fair value of stock options reflects a volatility factor calculated using
historical market data for the Companys common stock. The time frame used was approximately three
years prior to the grant date for
77
awards in 2008. The dividend assumption is based on the Companys current expectations about
its dividend policy. The Company bases the risk-free interest rate on the yield to maturity at the
time of the stock option grant on zero-coupon U.S. government bonds having a remaining life equal
to the options expected life. When estimating forfeitures, the Company considers voluntary
termination behavior as well as analysis of actual option forfeitures.
The following assumptions were used to estimate the fair value of the 2008 option awards:
|
|
|
|
|
Average expected term
|
|
6 years
|
Expected volatility
|
|
|
33.0
|
%
|
Risk-free interest rate
|
|
|
2.8
|
%
|
Expected dividend yield
|
|
|
0.0
|
%
|
A summary of option activity under the Plan as of December 31, 2008, and changes during the
year then ended, is presented below:
|
|
|
|
|
|
|
|
|
|
|
Share
|
|
|
Weighted
|
|
|
|
Options
|
|
|
Average
|
|
|
|
Outstanding
|
|
|
Exercise Price
|
|
Balance at December 31, 2007
|
|
|
668,820
|
|
|
$
|
4.97
|
|
Granted
|
|
|
100,000
|
|
|
|
34.55
|
|
Exercised
|
|
|
(87,446
|
)
|
|
|
4.71
|
|
|
|
|
|
|
|
|
Balance at December 31, 2008
|
|
|
681,374
|
|
|
$
|
9.35
|
|
|
|
|
|
|
|
|
As of December 31, 2008, the aggregate intrinsic value of the outstanding and exercisable
shares was $9.6 million. The total intrinsic value of options exercised during the years ended
December 31, 2008, 2007 and 2006, was $2.7 million, $8.3 million and $5.7 million, respectively.
All outstanding share options granted in 2003 and 2002 were fully vested by December 31, 2006
and none of the share options granted in 2008 have vested. The total fair value of share options
vested during the year ended December 31, 2006 was $0.5 million.
Cash received from option exercises under the Plan for the years ended December 31, 2008, 2007
and 2006 was $0.4 million, $1.0 million and $0.7 million, respectively. The tax benefit realized
for the tax deductions from option exercises totaled $0.7 million, $2.5 million and $1.3 million
for the years ended December 31, 2008, 2007 and 2006, respectively.
During 2008, 133,103 shares of restricted stock were issued with restriction periods ranging
from one to six years from the initial grant date. Compensation expense related to all restricted
shares of $1.0 million in 2008 is based upon the market price of the underlying common stock as of
the date of the grant and is amortized over the applicable restriction period using the
straight-line method. All restricted stock awards were nonvested at the end of the year with a
weighted-average grant date fair value of $32.57 per share. As of December 31, 2008, there was
$3.4 million of unrecognized compensation cost related to restricted stock that is expected to be
recognized over a weighted average period of 3.37 years.
Each non-employee director receives a one-time initial grant of phantom shares equal in value
to $30,000 upon election to the board of directors. Each non-employee director also receives an
annual grant of phantom shares equal in value to $75,000, beginning in the year following the
directors election to the board of directors and continuing through the tenth year of service as a
director. The Company will pay each non-employee director in cash the fair market value of certain
of the directors phantom shares
78
granted, subject to applicable withholding taxes, upon termination of service as a member of the
board of directors. The remaining phantom shares granted will be paid out in the form of one share
of Company common stock for each phantom share, with the value of any fractional phantom shares
paid in cash. Expense (income) recognized in the years ended December 31, 2008, 2007 and 2006
related to these phantom share grants was $(0.1) million, $0.1 million and $0.6 million,
respectively. Cash payments of $0.4 million were used to settle phantom shares during 2007. No
cash was used to settle any phantom shares in 2006.
16. Business Segment Information
The Company has three reportable segments. The Sealing Products segment manufactures sealing
and PTFE products. The Engineered Products segment manufactures metal polymer and solid polymer
bearings and filament wound products, air compressor systems and vacuum pumps, and reciprocating
compressor components. The Engine Products and Services segment manufactures and services
heavy-duty, medium-speed diesel, natural gas and dual fuel reciprocating engines. The Companys
reportable segments are managed separately based on differences in their products and services and
their end-customers. Segment profit is total segment revenue reduced by operating expenses and
restructuring and other costs identifiable with the segment. Corporate expenses include general
corporate administrative costs. Expenses not directly attributable to the segments, corporate
expenses, net interest expense, asbestos-related expenses, gains/losses or impairments related to
the sale of assets and income taxes are not included in the computation of segment profit. The
accounting policies of the reportable segments are the same as those for the Company.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(in millions)
|
|
Sales
|
|
|
|
|
|
|
|
|
|
|
|
|
Sealing Products
|
|
$
|
503.5
|
|
|
$
|
457.3
|
|
|
$
|
432.5
|
|
Engineered Products
|
|
|
524.1
|
|
|
|
445.5
|
|
|
|
391.7
|
|
Engine Products and Services
|
|
|
142.1
|
|
|
|
128.1
|
|
|
|
105.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,169.7
|
|
|
|
1,030.9
|
|
|
|
929.4
|
|
Intersegment sales
|
|
|
(1.9
|
)
|
|
|
(0.9
|
)
|
|
|
(1.0
|
)
|
|
|
|
|
|
|
|
|
|
|
Total sales
|
|
$
|
1,167.8
|
|
|
$
|
1,030.0
|
|
|
$
|
928.4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Profit
|
|
|
|
|
|
|
|
|
|
|
|
|
Sealing Products
|
|
$
|
90.4
|
|
|
$
|
78.0
|
|
|
$
|
76.5
|
|
Engineered Products
|
|
|
68.1
|
|
|
|
69.4
|
|
|
|
61.5
|
|
Engine Products and Services
|
|
|
20.8
|
|
|
|
15.3
|
|
|
|
4.9
|
|
|
|
|
|
|
|
|
|
|
|
Total segment profit
|
|
|
179.3
|
|
|
|
162.7
|
|
|
|
142.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate expenses
|
|
|
(34.5
|
)
|
|
|
(34.1
|
)
|
|
|
(31.6
|
)
|
Asbestos-related expenses
|
|
|
(52.1
|
)
|
|
|
(68.4
|
)
|
|
|
(359.4
|
)
|
Interest income (expense), net
|
|
|
(5.3
|
)
|
|
|
0.2
|
|
|
|
(3.2
|
)
|
Other expense, net
|
|
|
(6.7
|
)
|
|
|
(2.4
|
)
|
|
|
(2.9
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes
|
|
$
|
80.7
|
|
|
$
|
58.0
|
|
|
$
|
(254.2
|
)
|
|
|
|
|
|
|
|
|
|
|
No customer accounted for 10% or more of net sales in 2008, 2007 or 2006.
79
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
|
(in millions)
|
|
Capital Expenditures
|
|
|
|
|
|
|
|
|
|
|
|
|
Sealing Products
|
|
$
|
24.8
|
|
|
$
|
27.4
|
|
|
$
|
22.3
|
|
Engineered Products
|
|
|
20.4
|
|
|
|
16.8
|
|
|
|
14.5
|
|
Engine Products and Services
|
|
|
3.7
|
|
|
|
2.2
|
|
|
|
4.4
|
|
Corporate
|
|
|
0.2
|
|
|
|
0.4
|
|
|
|
0.1
|
|
|
|
|
|
|
|
|
|
|
|
Total capital expenditures
|
|
$
|
49.1
|
|
|
$
|
46.8
|
|
|
$
|
41.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and Amortization Expense
|
|
|
|
|
|
|
|
|
|
|
|
|
Sealing Products
|
|
$
|
15.9
|
|
|
$
|
14.8
|
|
|
$
|
13.5
|
|
Engineered Products
|
|
|
24.3
|
|
|
|
20.6
|
|
|
|
17.2
|
|
Engine Products and Services
|
|
|
3.9
|
|
|
|
4.0
|
|
|
|
3.7
|
|
Corporate
|
|
|
0.7
|
|
|
|
0.8
|
|
|
|
0.8
|
|
|
|
|
|
|
|
|
|
|
|
Total depreciation and amortization
|
|
$
|
44.8
|
|
|
$
|
40.2
|
|
|
$
|
35.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Sales
by Geographic Area
|
|
|
|
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
610.6
|
|
|
$
|
565.7
|
|
|
$
|
543.0
|
|
Europe
|
|
|
329.7
|
|
|
|
277.8
|
|
|
|
222.8
|
|
Other foreign
|
|
|
227.5
|
|
|
|
186.5
|
|
|
|
162.6
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
1,167.8
|
|
|
$
|
1,030.0
|
|
|
$
|
928.4
|
|
|
|
|
|
|
|
|
|
|
|
Net sales are attributed to countries based on location of the customer.
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(in millions)
|
|
Assets
|
|
|
|
|
|
|
|
|
Sealing Products
|
|
$
|
291.4
|
|
|
$
|
246.8
|
|
Engineered Products
|
|
|
484.9
|
|
|
|
464.3
|
|
Engine Products and Services
|
|
|
72.4
|
|
|
|
72.2
|
|
Corporate
|
|
|
503.8
|
|
|
|
687.0
|
|
|
|
|
|
|
|
|
|
|
$
|
1,352.5
|
|
|
$
|
1,470.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-Lived Assets
|
|
|
|
|
|
|
|
|
United States
|
|
$
|
274.4
|
|
|
$
|
231.6
|
|
Germany
|
|
|
71.9
|
|
|
|
74.5
|
|
France
|
|
|
69.2
|
|
|
|
71.2
|
|
United Kingdom
|
|
|
47.8
|
|
|
|
67.4
|
|
Other foreign
|
|
|
64.3
|
|
|
|
66.1
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
527.6
|
|
|
$
|
510.8
|
|
|
|
|
|
|
|
|
Corporate assets include all of the Companys cash and cash equivalents, asbestos insurance
receivables and noncurrent deferred income taxes. Long-lived assets consist of property, plant and
equipment, goodwill and other intangible assets.
80
17. Commitments and Contingencies
General
Various claims, lawsuits and administrative proceedings, all arising in the ordinary course of
business with respect to commercial, product liability, asbestos and environmental matters, are
pending or threatened against the Company or its subsidiaries and seek monetary damages and/or
other remedies. The Company believes that any liability that may finally be determined with
respect to commercial and non-asbestos product liability claims should not have a material effect
on the Companys consolidated financial condition or results of operations. From time to time, the
Company and its subsidiaries are also involved as plaintiffs in legal proceedings involving
contract, patent protection, environmental, insurance and other matters.
Environmental
The Companys facilities and operations are subject to federal, state and local environmental
and occupational health and safety requirements of the U.S. and foreign countries. The Company
takes a proactive approach in its efforts to comply with environmental, health and safety laws as
they relate to its manufacturing operations and in proposing and implementing any remedial plans
that may be necessary. The Company also regularly conducts comprehensive environmental, health and
safety audits at its facilities to maintain compliance and improve operational efficiency.
Although the Company believes past operations were in substantial compliance with the then
applicable regulations, the Company or one of its subsidiaries has been named as a potentially
responsible party or is otherwise involved at 21 sites where the costs to it are expected to exceed
$100,000. Investigations have been completed for 15 sites and are in progress at the other six
sites. The majority of these sites relate to remediation projects at former operating facilities
that were sold or closed and primarily deal with soil and groundwater contamination.
The Companys policy is to accrue environmental investigation and remediation costs when it is
probable that a liability has been incurred and the amount can be reasonably estimated. The
measurement of the liability is based on an evaluation of currently available facts with respect to
each individual situation and takes into consideration factors such as existing technology,
presently enacted laws and regulations and prior experience in remediation of contaminated sites.
Liabilities are established for all sites based on the factors discussed above. As assessments and
remediation progress at individual sites, these liabilities are reviewed periodically and adjusted
to reflect additional technical data and legal information. As of December 31, 2008 and 2007,
EnPro had accrued liabilities of $22.1 million and $27.7 million, respectively, for estimated
future expenditures relating to environmental contingencies. The amounts recorded in the
Consolidated Financial Statements have been recorded on an undiscounted basis.
The Company believes that its reserves for environmental contingencies are adequate based on
currently available information. Actual costs to be incurred for identified situations in future
periods may vary from estimates because of the inherent uncertainties in evaluating environmental
exposures due to unknown conditions, changing government regulations and legal standards regarding
liability. Subject to the imprecision in estimating future environmental costs, the Company
believes that maintaining compliance with current environmental laws and government regulations
will not require significant capital expenditures or have a material adverse effect on its
financial condition, but could be material to its results of operations or cash flows in a given
period.
81
Colt Firearms and Central Moloney
The Company has contingent liabilities related to divested businesses for which certain of its
subsidiaries retained liability or are obligated under indemnity agreements. These contingent
liabilities include, but are not limited to, potential product liability and associated claims
related to firearms manufactured prior to 1990 by Colt Firearms, a former operation of Coltec, and
for electrical transformers manufactured prior to 1994 by Central Moloney, another former Coltec
operation. No product liability claims are currently pending against the Company related to Colt
Firearms or Central Moloney. The Company also has ongoing obligations, which are included in
retained liabilities of previously owned businesses in the Consolidated Balance Sheets, with regard
to workers compensation, retiree medical and other retiree benefit matters that relate to the
Companys periods of ownership of these operations.
Crucible Materials Corporation
Crucible Materials Corporation (Crucible), which is engaged primarily in the manufacture and
distribution of specialty metal products, was a wholly owned subsidiary of Coltec until 1985 when a
majority of the outstanding shares were sold. Coltec divested its remaining minority interest in
2004.
In conjunction with the closure of a Crucible plant in the early 1980s, Coltec was required to
fund two trusts for retiree medical benefits for union employees at the plant. The first trust
(the Benefits Trust) pays for these retiree medical benefits on an ongoing basis. Coltec has no
ownership interest in the Benefits Trust, and thus the assets and liabilities of this trust are not
included in the Companys Consolidated Balance Sheets. Under the terms of the Benefits Trust
agreement, the trustees retained an actuary to assess the adequacy of the assets in the Benefits
Trust in 1995, another actuarial report was completed in 2005, and a third report will be required
in 2015. The actuarial reports in 1995 and 2005 determined that there were adequate assets to fund
the payment of future benefits. If it is determined in 2015 that the trust assets are not adequate
to fund the payment of future medical benefits, Coltec will be required to contribute additional
amounts to the Benefits Trust. In the event there are ever excess assets in the Benefits Trust,
those excess assets will not revert to Coltec.
Because of the possibility that Coltec could be required to make additional contributions to
the Benefits Trust to cover potential shortfalls, Coltec was required to establish a second trust
(the Back-Up Trust). The trust assets and a corresponding liability of the Back-Up Trust are
reflected in the Companys Consolidated Balance Sheets in other non-current assets and in retained
liabilities of previously owned businesses, respectively, and amounted to $22.4 million each at
December 31, 2008. As noted above, based on the valuation completed in early 2005, the actuary
determined that there were adequate assets in the Benefits Trust to fund the estimated payments by
the trust until the next valuation date. Until such time as a payment is required or the remaining
excess trust assets revert to the Company, the trust assets and liabilities will be kept equal to
each other on the Companys Consolidated Balance Sheets.
The Company also has ongoing obligations, which are included in retained liabilities of
previously owned businesses in the Consolidated Balance Sheets, with regard to workers
compensation, retiree medical and other retiree benefit matters, in addition to those mentioned
previously, that relate to the Companys period of ownership of this operation.
82
Debt and Capital Lease Guarantees
As of December 31, 2008, the Company had contingent liabilities for potential payments on
guarantees of certain debt and lease obligations totaling $6.2 million. These guarantees arose
from the divestitures of Crucible and Central Moloney and expire at various dates through 2010.
There is no liability for these guarantees reflected in the Companys Consolidated Balance Sheets.
In the event that the other parties do not fulfill their obligations under the debt or lease
agreements, the Company could be responsible for these obligations.
Other Contingent Liability Matters
The Company provides warranties on many of its products. The specific terms and conditions of
these warranties vary depending on the product and the market in which the product is sold. The
Company records a liability based upon estimates of the costs that may be incurred under its
warranties after a review of historical warranty experience and information about specific warranty
claims. Adjustments are made to the liability as claims data and historical experience warrant.
Changes in the carrying amount of the product warranty liability for the years ended December
31, 2008 and 2007, are as follows:
|
|
|
|
|
|
|
|
|
|
|
2008
|
|
|
2007
|
|
|
|
(in millions)
|
|
Balance at beginning of year
|
|
$
|
3.6
|
|
|
$
|
4.0
|
|
Charges to expense
|
|
|
4.5
|
|
|
|
2.7
|
|
Charges to the accrual
|
|
|
(4.0
|
)
|
|
|
(3.1
|
)
|
|
|
|
|
|
|
|
Balance at end of year
|
|
$
|
4.1
|
|
|
$
|
3.6
|
|
|
|
|
|
|
|
|
Asbestos
History
. Certain of the Companys subsidiaries, primarily Garlock Sealing
Technologies LLC (Garlock) and The Anchor Packing Company (Anchor), are among a large number of
defendants in actions filed in various states by plaintiffs alleging injury or death as a result of
exposure to asbestos fibers. Among the products at issue in these actions are industrial sealing
products, including gaskets and packing products. The damages claimed vary from action to action,
and in some cases plaintiffs seek both compensatory and punitive damages. To date, neither Garlock
nor Anchor has been required to pay any punitive damage awards, although there can be no assurance
that they will not be required to do so in the future. Liability for compensatory damages has
historically been allocated among responsible defendants. Since the first asbestos-related
lawsuits were filed against Garlock in 1975, Garlock and Anchor have processed more than 900,000
asbestos claims to conclusion (including judgments, settlements and dismissals) and, together with
their insurers, have paid almost $1.4 billion in settlements and judgments and over $400 million in
fees and expenses.
Claims Mix
. Of those claims resolved, approximately 3% have been claims of plaintiffs
alleging the disease mesothelioma, approximately 7% have been claims of plaintiffs with lung or
other cancers, and approximately 90% have been claims of plaintiffs alleging asbestosis, pleural
plaques or other non-malignant impairment of the respiratory system. The mix of cases filed in
2008 contains approximately 27% mesothelioma claims and 17% lung or other cancer claims. In the
remaining 56% of the new cases, either the plaintiffs alleged non-malignant impairment or the
disease or condition is not alleged and remains unknown to us. Of the 104,100 open cases at
December 31, 2008, the Company is aware of approximately 4,600 (4.4%) that involve claimants
alleging mesothelioma.
83
New Filings
. The number of new actions filed against the Companys subsidiaries in
2008 (5,500) was about 5% higher than the number filed in 2007 (5,200) but was significantly lower
than the number filed in 2006 (7,700). The number filed against our subsidiaries in each of the
three years was much lower than the number filed in the peak filing year, 2003, when 44,700 new
claims were filed. Factors in the decline include, but are not limited to, tort reform in some
high profile states, especially Mississippi, Texas and Ohio; tort reform in Florida, Georgia, South
Carolina, Kansas and Tennessee; actions taken and rulings by some judges and court administrators
that have had the effect of limiting access to their courts for claimants without sufficient ties
to the jurisdiction or claimants with no discernible disease; acceleration of claims into past
years; and declining incidence of asbestos-related disease. The trend of declining new filings has
been principally in non-malignant claims; however, the number of new filings of claims alleging
mesothelioma, lung and other cancers has declined only modestly since 2005 and was essentially flat
for the two-year period 2006 through 2007. While we believe that the number of new mesothelioma
filings was actually higher for 2008 than for 2007, the exact mix of 2008 claims is not yet fully
known.
Product Defenses
. The asbestos in products formerly sold by Garlock and Anchor was
encapsulated, which means the asbestos fibers were incorporated into the products during the
manufacturing process and sealed in a binder. The products were also nonfriable, which means they
could not be crumbled by hand pressure. The U.S. Occupational Safety and Health Administration,
which began generally requiring warnings on asbestos-containing products in 1972, has never
required that a warning be placed on products such as Garlocks gaskets. Even though no warning
label was required, Garlock included one on all of its asbestos-containing products beginning in
1978. Further, gaskets such as those previously manufactured and sold by Garlock are one of the
few asbestos-containing products still permitted to be manufactured under regulations of the U.S.
Environmental Protection Agency. Nevertheless, Garlock discontinued all manufacture and
distribution of asbestos-containing products in the U.S. during 2000 and worldwide in mid-2001.
From the mid-1980s until 2000, U.S. sales of asbestos-containing industrial sealing products were
not a material part of Garlocks sales and were predominantly to sophisticated purchasers such as
the U.S. Navy and large petrochemical facilities.
Garlocks product defenses have enabled it to be successful more often than not at trial.
Garlock won defense verdicts in three of the six cases tried to verdict in 2008, and in seven of 12
cases tried to verdict in the three-year period 2006 through 2008. In the successful jury trials,
the juries determined that either Garlocks products were not defective, that Garlock was not
negligent, or that the claimant was not exposed to Garlocks products.
Recent Trial Results
. In 2008, Garlock began eleven trials involving thirteen
plaintiffs. Garlock received three jury verdicts in its favor, one in an Ohio case and two in a
Pennsylvania trial involving two plaintiffs. In a Kentucky lung cancer case, the jury awarded the
plaintiff $1.52 million. Garlocks share of this verdict was approximately $682,000; Garlock will
appeal. In a Pennsylvania lung cancer case the jury awarded the plaintiff $400,000. Garlocks
share was $200,000, 50% of the total verdict. In an Illinois case the jury awarded $500,000
against Garlock to a plaintiff with asbestosis. Garlock will appeal. Also in Pennsylvania, four
lawsuits involving five plaintiffs settled during trial before the jury reached a verdict. A
lawsuit in California also dismissed during trial. In South Carolina, Garlock obtained a dismissal
in one case during trial because there was insufficient evidence of exposure to Garlock products.
In 2007, Garlock began nine trials involving twelve plaintiffs. A Massachusetts jury returned
a defense verdict in favor of Garlock. In a Kentucky case, the jury awarded the plaintiff $145,000
against Garlock. Garlock plans to appeal this verdict. Four lawsuits in Pennsylvania settled
during trial before the juries had reached a verdict. Garlock also settled cases during trial in
Louisiana, Maryland and Washington.
84
In 2006, Garlock began ten trials involving eleven plaintiffs. Garlock received jury verdicts
in its favor in Oakland, California; Easton, Pennsylvania; and Louisville, Kentucky. In
Pennsylvania, three other lawsuits involving four plaintiffs settled during trial before the juries
reached verdict. Garlock also settled cases in Massachusetts, California and Texas during trial.
In a retrial of a Kentucky case, the jury awarded the plaintiff $900,000 against Garlock. The
award was significantly less than the $1.75 million award against Garlock in the previous trial,
which Garlock successfully appealed. Garlock has also appealed the new verdict. In addition,
Garlock obtained dismissals in two cases in Philadelphia after the juries were selected but before
the trials began because there was insufficient evidence of exposure to Garlock products.
Appeals
. Garlock has historically enjoyed success in a majority of its appeals. The
Company believes that Garlock will continue to be successful in the appellate process, although
there can be no assurance of success in any particular pending or future appeal. In June 2007, the
New York Court of Appeals, in a unanimous decision, overturned an $800,000 verdict that was entered
against Garlock in 2004, granting a new trial. In March 2006, a three-judge panel of the Ohio
Court of Appeals, in a unanimous decision, overturned a $6.4 million verdict that was entered
against Garlock in 2003, granting a new trial. The case subsequently settled. On the other hand,
the Maryland Court of Appeals denied Garlocks appeal from a 2005 verdict in a mesothelioma case in
Baltimore, and Garlock paid that verdict, with post-judgment interest, in the fourth quarter of
2006. In a separate Baltimore case in the fourth quarter of 2006, the Maryland Court of Special
Appeals denied Garlocks appeal from another 2005 verdict. The subsequent appeal of that decision
was also denied and Garlock paid that verdict in the second quarter of 2007. At December 31, 2008,
four Garlock appeals were pending from adverse verdicts totaling $2.2 million, up from $1.4 million
at December 31, 2007 and down from $6.8 million at December 31, 2006.
In some cases, appeals require the provision of security in the form of appeal bonds,
potentially in amounts greater than the verdicts. The Company is required to provide cash
collateral or letters of credit to secure the full amount of the bonds, which can restrict the use
of a significant amount of the Companys cash for the periods of such appeals. At December 31,
2008, the Company had approximately $1.7 million of appeal bonds secured by letters of credit
rather than cash collateral. This amount securing appeal bonds compares to $1.1 million at
December 31, 2007 and $1.3 million at December 31, 2006. In 2007 and 2006, the cash collateral
relating to appeal bonds was recorded as restricted cash on the Companys Consolidated Balance
Sheet.
Settlements
. Garlock settles and disposes of actions on a regular basis. Garlocks
historical settlement strategy was to settle only cases in advanced stages of litigation. In 1999
and 2000, however, Garlock employed a more aggressive settlement strategy. The purpose of this
strategy was to achieve a permanent reduction in the number of overall asbestos claims through the
settlement of a large number of claims, including some early-stage claims and some claims not yet
filed as lawsuits. Due to this short-term aggressive settlement strategy and a significant overall
increase in claims filings, the settlement amounts paid in those years and several subsequent years
were greater than the amounts paid in any year prior to 1999. In 2001, Garlock resumed its
historical settlement strategy and focused on reducing settlement commitments to match insurance
recoveries. As a result, Garlock reduced new settlement commitments from $180 million in 2000 to
$94 million in 2001 and $86 million in 2002. New settlement commitments totaled $84 million in
2006, $76 million in 2007 and $71 million in 2008. Approximately $15 million of the 2006 amount
and approximately $5 million of the 2007 amount were committed in settlements to pay verdicts that
had been rendered in the years 2003 2005.
Settlements are made without any admission of liability. Settlement amounts vary depending
upon a number of factors, including the jurisdiction where the action was brought, the nature and
extent of the disease alleged and the associated medical evidence, the age and occupation of the
plaintiff, the
85
presence or absence of other possible causes of the plaintiffs alleged illness, alternative
sources of payment available to the plaintiff, the availability of legal defenses, and whether the
action is an individual one or part of a group.
Before any payment on a settled claim is made, the claimant is required to submit a medical
report acceptable to Garlock substantiating the asbestos-related illness and meeting specific
criteria of disability. In addition, sworn testimony or other evidence that the claimant worked
with or around Garlock asbestos-containing products is required. The claimant is also required to
sign a full and unconditional release of Garlock, its subsidiaries, parent, officers, directors,
affiliates and related parties from any liability for asbestos-related injuries or claims.
Status of Anchor
. Anchor is an inactive and insolvent indirect subsidiary of Coltec.
There is no remaining insurance coverage available to Anchor. Anchor has no remaining assets and
has not committed to settle any actions since 1998. As cases reach the trial stage, Anchor is
typically dismissed without payment.
Insurance Coverage
. At December 31, 2008, Garlock had available $307.4 million of
insurance and trust coverage that the Company believes will be
available to cover current and future asbestos
claims and certain expense payments. The Company believes that
Garlock may also recover some additional insurance from insolvent
carriers over time. Garlock collected approximately $0.1 million
and $1.0 million, respectively, from insolvent carriers in 2008 and 2007. There can be no
assurance that Garlock will collect any additional insurance from
insolvent carriers.
Of the $307.4 million of collectible insurance and trust assets, the Company considers $295.8
million (96%) to be of high quality because (a) the insurance policies are written or guaranteed by
U.S.-based carriers whose credit rating by S&P is investment grade (BBB) or better, and whose AM
Best rating is excellent (A-) or better, or (b) in the form of cash or liquid investments held in
insurance trusts resulting from commutation agreements. The Company considers $11.6 million (4%)
to be of moderate quality because the insurance policies are written with (a) other solvent U.S.
carriers who are unrated or below investment grade ($7.8 million) or (b) with various London market
carriers ($3.8 million). Of the $307.4 million, $228.7 million is allocated to claims that have
been paid by Garlock and submitted to its insurance companies for reimbursement and the remainder
is allocated to pending and estimated future claims as described later in this section.
Arrangements with Garlocks insurance carriers limit the amount of insurance proceeds that
Garlock is entitled to receive in any one year. Based on these arrangements, which include
settlement agreements in place with most of the carriers involved, the Company anticipates that its
remaining solvent insurance will be collected during the period 2009 through 2018 in approximately
the following annual amounts: 2009 and 2010 $67 million per year; 2011 $40 million; 2012 and
2013 $25 million per year; 2014 through 2016 $20 million per year; and 2017 and 2018 $12
million per year. The Company collected $73 million of insurance in 2008.
During the fourth quarter of 2006, the Company reached an agreement with a significant group
of related U.S. insurers. These insurers had withheld payments pending resolution of a dispute.
The agreement provides for the payment of the full amount of the insurance policies ($194 million)
in various annual payments to be made from 2007 through 2018. Under the agreement, Garlock
received $20 million in 2008 and $22 million in 2007.
86
In May 2006, the Company reached agreement with a U.S. insurer that resolved two lawsuits and
an arbitration proceeding. Pursuant to the settlement, Garlock received $3 million in 2008, $3
million in 2007 and $4 million in 2006 and is scheduled to receive another $11 million in the
future.
In the second quarter of 2004, the Company reached agreement with Equitas, the London-based
entity responsible for the pre-1993 Lloyds of London policies in the Companys insurance block,
concerning settlement of its exposure to the Companys subsidiaries asbestos claims. As a result
of the settlement, $88 million was placed in an independent trust. In the fourth quarter of 2004,
the Company reached agreement with a group of London market carriers (other than Equitas) and one
of its U.S. carriers that has some policies reinsured through the London market. As a result of
the settlement, $55.5 million was placed in an independent trust. At December 31, 2008, the
aggregate market value of the funds remaining in the two trusts was $20.6 million, which was
included in the $307.4 million of insurance and trust coverage available to pay future
asbestos-related claims and expenses.
Insurance coverage for asbestos claims is not available to cover exposures initially occurring
on and after July 1, 1984. Although Garlock and Anchor continue to be named as defendants in new
actions, only a few allege initial exposure after July 1, 1984. To date, no payments have been
made with respect to these few claims, pursuant to a settlement or otherwise. Garlock and Anchor
believe that they have substantial defenses to these claims and therefore automatically reject them
for settlement. However, there can be no assurance that any or all of these defenses will be
successful in the future.
The Companys Liability Estimate
. Prior to mid-2004, the Company maintained that its
subsidiaries liability for unasserted claims was not reasonably estimable. The Company estimated
and recorded liabilities only for pending claims in advanced stages of processing, for which it
believed it had a basis for making a reasonable estimate. The Company disclosed the significance
of the total potential liability for unasserted claims in considerable detail. During 2004, the
Company authorized counsel to retain Bates White to assist in estimating the Companys
subsidiaries liability for pending and future asbestos claims.
Bates Whites first report, dated February 17, 2005, provided an estimate of the liability as
of December 31, 2004 for the following ten years, which represented a time horizon within which
Bates White believed such liability was both probable and estimable within a range of values.
Bates White has updated its estimate every quarter since the end of 2004.
Each quarter until the fourth quarter of 2006, the Company adopted the Bates White estimate
and adjusted the liability to equal the low end of the then-current range. Until the second
quarter of 2006, the additional liability was recorded with a corresponding increase in the
Companys insurance receivable, and thus did not affect net income. During the second quarter of
2006, however, the Companys
87
insurance was fully allocated to past, present and future claims, and therefore subsequent
changes to the Bates White estimate were recorded as charges to income.
The estimated range of potential liabilities provided by Bates White at December 31, 2008 was
$431 million to $627 million. According to Bates White, increases in the range over time have been
attributable primarily to (1) the propensity to sue Garlock, (2) an increase in settlement values
of mesothelioma claims, (3) an increase in claims filings and values in some jurisdictions, most
notably California, and (4) the delay in, and uncertain impact of, the funding and implementation
of trusts formed under Section 524(g) of the United States Bankruptcy Code to pay asbestos claims
against numerous defendants in Chapter 11 reorganization cases. Because the 524(g) trusts are
estimated by some, including Bates White, to have billions of dollars available for the payment of
asbestos claims, they could have a significant impact on the Companys future settlement payments
and could therefore significantly affect its liability.
The Company has independently developed internal estimates for asbestos-related liabilities.
It has used those estimates for a variety of purposes, including guidance for settlement
negotiations and trial strategy, in its strategic planning, budgeting and cash flow planning
processes, and in setting targets for annual and long-term incentive compensation. The Companys
internal estimate has been within the Bates White range of equally likely estimates and has proven
to be a more precise predictor of the actual amounts spent on settlements and verdicts than the low
end of the Bates White range. As a result, while the low end of the Bates White range still
provides a reasonable lower boundary of possible outcomes, Bates White and management believe that
the Companys internal estimate for the next ten years represents the most likely point within the
range. Accordingly, the Company adjusted the recorded liability from the low end of the Bates
White estimate to its point estimate in the fourth quarter of 2006 and has adjusted the liability
in each subsequent quarter consistent with its internal estimate.
The Company focuses on future cash flows to prepare its estimate. It makes assumptions about
future asbestos spending based on (1) past trends, (2) publicly available epidemiological data, (3)
current agreements with plaintiff firms and managements judgment about the current and future
litigation environment, (4) the availability to claimants of other payment sources, both
co-defendants and the 524(g) trusts, (5) the Companys remaining available insurance; (6) general
developments in the asbestos litigation; and (7) the input and insight provided to the Company by
Bates White. The Company adjusts its estimate when current cash flow results and long-term trends
suggest that its targets cannot be met. As a result, the Company has a process that it believes
produces the best estimate of the future liability for the ten-year time period within the Bates
White range.
The Company currently estimates that the liability of its subsidiaries for the indemnity cost
of resolving asbestos claims for the next ten years will be $458.7 million. The estimated
liability of $458.7 million is before any tax benefit and is not discounted to present value, and
it does not include fees and expenses, which are recorded as incurred. The recorded liability will
continue to be impacted by actual claims and settlement experience and any change in the legal
environment that could cause a significant increase or decrease in the long-term expectations of
management and Bates White. The Company expects the recorded liability to fluctuate, perhaps
significantly. Any significant change in the estimated liability could have a material effect on
the Companys consolidated financial position and results of operations.
The Companys estimate is within the Bates White range, developed independently, and the
Company believes that its estimate is the best estimate within the Bates White range of reasonable
and probable estimates of Garlocks future obligation.
Bates White also indicated a broader range of potential estimates from $189 million to $711
million. The Company cautions that points within that broader range remain possible outcomes.
Also, while the Company agrees with Bates White that beyond two to four years for Garlocks
economically-driven non-malignant claims and beyond ten years for Garlocks cancer claims and
medically-driven non-malignant claims, there are reasonable scenarios in which the [asbestos]
expenditure is
de minimus
, it cautions that the process of estimating future liabilities is highly
uncertain. Adjusting the Companys liability to the best estimate within the range does not change
that fact. In the words of the Bates White report, the reliability of estimates of future
probable expenditures of Garlock for asbestos-related personal injury claims declines significantly
for each year further into the future. Scenarios continue to exist that could result in a total
future asbestos liability for Garlock in excess of $1 billion.
As previously mentioned, the liability estimate does not include legal fees and expenses,
which add considerably to the costs each year. Over the last two years, these expenses have
averaged
88
approximately $7 million per quarter. In addition to these legal fees and expenses, the
Company expects to continue to record charges to income in future quarters for:
|
|
|
Increases or decreases, if any, in the Companys estimate of Garlocks potential
liability, plus
|
|
|
|
|
Increases, if any, that result from additional quarters added to maintain the
ten-year estimation period (increases of this type have averaged approximately $6 7
million per quarter for the last two years), plus
|
|
|
|
|
Amounts, if any, of solvent insurance lost or commuted, offset by insolvent
recoveries and earnings from insurance settlement trusts.
|
In 2008, the Company recorded a pre-tax charge of $52.1 million to reflect net cash outlays of
$26.2 million for legal fees and expenses paid during the year and a $25.9 million non-cash charge.
The non-cash charge included $23.8 million, primarily to add an estimate of the liability for 2018
to maintain a ten-year estimate and $2.1 million to reduce the remaining insurance estimated to be
available from remaining policies with various London market carriers.
In 2007, the Company recorded a pre-tax charge to income of $68.4 million to reflect net cash
outlays of $25.8 million for legal fees and expenses incurred during the year, and a $42.6 million
non-cash charge. The non-cash charge included $23.2 million related to the addition of periods to
maintain a ten-year liability estimate and $19.4 million to adjust the liability based on revisions
to managements estimate in the fourth quarter of 2007. The Company made this adjustment based on
its review of negotiations and payment trends and its belief that it is more likely that, in the
future, a higher percentage of settlement commitments made in any year will also be paid in that
same year.
Quantitative Claims and Insurance Information
. The Companys liability as of December
31, 2008 was $465.5 million (the Companys estimate of the liability described above of $458.7
million plus $6.8 million of accrued legal and other fees already incurred but not yet paid). The
liability included $85.3 million classified as a current liability and $380.2 million classified as
a noncurrent liability. The recorded amounts do not include legal fees and expenses to be incurred
in the future.
As of December 31, 2008, the Company had remaining insurance and trust coverage of $307.4
million which is reflected on its balance sheet as a receivable ($67.9 million classified in
current assets and $239.5 classified in non-current assets), which it believes will be available
for the payment of asbestos-related claims. Included in the receivable is $228.7 million in
insured claims and expenses that our subsidiaries have paid out in excess of amounts recovered from
insurance. These amounts are recoverable under the terms of the Companys insurance policies and
have been billed to the insurance carriers. The remaining $78.7 million will be available for
pending and future claims.
The table below quantitatively depicts the number of pending cases, asbestos-related cash
flows, the amount that the Company expects Garlock to recover from insurance related to this
liability, and an analysis of the liability.
89
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of and for the
|
|
|
|
Year Ended
|
|
|
|
December 31,
|
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
Pending Cases (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
New actions filed during period
|
|
|
5,500
|
|
|
|
5,200
|
|
|
|
7,700
|
|
Open actions at period-end
|
|
|
104,100
|
|
|
|
105,700
|
|
|
|
106,500
|
|
Cash Flow (dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
Payments (2)
|
|
$
|
(109.7
|
)
|
|
$
|
(115.1
|
)
|
|
$
|
(125.7
|
)
|
Insurance recoveries (3)
|
|
|
72.7
|
|
|
|
90.2
|
|
|
|
87.7
|
|
|
|
|
|
|
|
|
|
|
|
Net cash flow
|
|
$
|
(37.0
|
)
|
|
$
|
(24.9
|
)
|
|
$
|
(38.0
|
)
|
|
|
|
|
|
|
|
|
|
|
Solvent Insurance and Trust Assets (dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
Insurance receivable for previously paid claims (4)
|
|
$
|
228.7
|
|
|
$
|
252.0
|
|
|
$
|
251.2
|
|
Insurance available for pending and future claims
|
|
|
78.7
|
|
|
|
129.5
|
|
|
|
216.9
|
|
|
|
|
|
|
|
|
|
|
|
Remaining solvent insurance and trust assets
|
|
$
|
307.4
|
|
|
$
|
381.5
|
|
|
$
|
468.1
|
|
|
|
|
|
|
|
|
|
|
|
Liability Analysis (dollars in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
Liability for pending and future claims (5)(6)
|
|
$
|
465.5
|
|
|
$
|
524.4
|
|
|
$
|
567.9
|
|
Insurance available for pending and future claims
|
|
|
78.7
|
|
|
|
129.5
|
|
|
|
216.9
|
|
|
|
|
|
|
|
|
|
|
|
Liability in excess of insurance coverage (6)
|
|
|
386.8
|
|
|
|
394.9
|
|
|
|
351.0
|
|
Insurance receivable for previously paid claims
|
|
|
228.7
|
|
|
|
252.0
|
|
|
|
251.2
|
|
|
|
|
|
|
|
|
|
|
|
Liability in excess of anticipated insurance collections (6)
|
|
$
|
158.1
|
|
|
$
|
142.9
|
|
|
$
|
99.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
Includes actions actually filed with a court of competent jurisdiction. Each action in which
both Garlock and one or more other of our subsidiaries is named as a defendant is shown as a
single action. Multiple actions filed on behalf of the same plaintiff in multiple
jurisdictions are also counted as one action. Claims not filed as actions in court but that
are submitted and paid as part of previous settlements (approximately 800 in 2008, 900 in 2007
and 700 in 2006) are not included.
|
|
(2)
|
|
Includes all payments for judgments, settlements, fees and expenses made in the period.
|
|
(3)
|
|
Includes all recoveries from insurance received in the period.
|
|
(4)
|
|
Includes previous payments for which Garlock is entitled to receive corresponding insurance
recoveries but has not received payment, in large part due to annual limits imposed under
insurance arrangements.
|
|
(5)
|
|
The liability represents managements best estimate of the future payments for the following
ten-year period. Amounts shown include $6.8 million, $5.4 million and $6.9 million at
December 31, 2008, 2007 and 2006, respectively, of accrued fees and expenses for services
previously rendered but unpaid.
|
|
(6)
|
|
Does not include fees and expenses to be incurred in the future, which are recorded as a
charge to income when incurred.
|
90
Other Commitments
The Company has several operating leases primarily for real estate, equipment and vehicles.
Operating lease arrangements are generally utilized to secure the use of assets if the terms and
conditions of the lease or the nature of the asset makes the lease arrangement more favorable than
a purchase. Future minimum lease payments by year and in the aggregate, under noncancelable
operating leases with initial or remaining noncancelable lease terms in excess of one year,
consisted of the following at December 31, 2008:
|
|
|
|
|
|
|
(in millions)
|
|
|
|
|
|
2009
|
|
$
|
13.0
|
|
2010
|
|
|
10.7
|
|
2011
|
|
|
9.5
|
|
2012
|
|
|
7.9
|
|
2013
|
|
|
6.6
|
|
Thereafter
|
|
|
9.6
|
|
|
|
|
|
Total minimum payments
|
|
$
|
57.3
|
|
|
|
|
|
Net rent expense was $15.5 million, $12.0 million and $10.8 million for the years ended
December 31, 2008, 2007 and 2006, respectively.
18. Subsequent Event
In February the Company purchased PTM (UK) Limited, a privately-owned manufacturer and
distributor of sealing products with two locations in the United Kingdom. The acquisition was paid
for in cash and will be included in the Companys Sealing Products segment.
91
19. Selected Quarterly Financial Data (Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First Quarter
|
|
|
Second Quarter
|
|
|
Third Quarter
|
|
|
Fourth Quarter
|
|
(in millions, except per share data)
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
|
Net sales
|
|
$
|
283.1
|
|
|
$
|
247.3
|
|
|
$
|
316.8
|
|
|
$
|
254.4
|
|
|
$
|
278.6
|
|
|
$
|
252.7
|
|
|
$
|
289.3
|
|
|
$
|
275.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
$
|
103.5
|
|
|
$
|
88.5
|
|
|
$
|
115.0
|
|
|
$
|
91.4
|
|
|
$
|
98.9
|
|
|
$
|
89.5
|
|
|
$
|
89.9
|
|
|
$
|
90.6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before extraordinary
Item
|
|
$
|
13.2
|
|
|
$
|
12.3
|
|
|
$
|
21.1
|
|
|
$
|
13.8
|
|
|
$
|
13.1
|
|
|
$
|
12.3
|
|
|
$
|
6.1
|
|
|
$
|
(0.7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Extraordinary item, net of taxes
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
2.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
13.2
|
|
|
$
|
12.3
|
|
|
$
|
21.1
|
|
|
$
|
13.8
|
|
|
$
|
13.1
|
|
|
$
|
12.3
|
|
|
$
|
6.1
|
|
|
$
|
1.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before
extraordinary item
|
|
$
|
0.63
|
|
|
$
|
0.58
|
|
|
$
|
1.05
|
|
|
$
|
0.65
|
|
|
$
|
0.66
|
|
|
$
|
0.58
|
|
|
$
|
0.31
|
|
|
$
|
(0.04
|
)
|
Extraordinary item
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
0.63
|
|
|
$
|
0.58
|
|
|
$
|
1.05
|
|
|
$
|
0.65
|
|
|
$
|
0.66
|
|
|
$
|
0.58
|
|
|
$
|
0.31
|
|
|
$
|
0.08
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before
extraordinary item
|
|
$
|
0.61
|
|
|
$
|
0.56
|
|
|
$
|
0.99
|
|
|
$
|
0.61
|
|
|
$
|
0.62
|
|
|
$
|
0.54
|
|
|
$
|
0.30
|
|
|
$
|
(0.04
|
)
|
Extraordinary item
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.12
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$
|
0.61
|
|
|
$
|
0.56
|
|
|
$
|
0.99
|
|
|
$
|
0.61
|
|
|
$
|
0.62
|
|
|
$
|
0.54
|
|
|
$
|
0.30
|
|
|
$
|
0.08
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
92
SCHEDULE II
Valuation and Qualifying Accounts
For the Years Ended December 31, 2008, 2007 and 2006
(In millions)
Allowance
for Doubtful Accounts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance,
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning
|
|
Charge
|
|
Write-off of
|
|
|
|
|
|
Balance,
|
|
|
of Year
|
|
to Expense
|
|
Receivables
|
|
Other (1)
|
|
End of Year
|
2008
|
|
$
|
3.6
|
|
|
$
|
1.8
|
|
|
$
|
(0.7
|
)
|
|
$
|
0.2
|
|
|
$
|
4.9
|
|
2007
|
|
$
|
2.8
|
|
|
$
|
0.8
|
|
|
$
|
(0.6
|
)
|
|
$
|
0.6
|
|
|
$
|
3.6
|
|
2006
|
|
$
|
2.8
|
|
|
$
|
1.2
|
|
|
$
|
(1.4
|
)
|
|
$
|
0.2
|
|
|
$
|
2.8
|
|
|
|
|
(1)
|
|
Consists primarily of acquisitions and the effect of changes in currency rates.
|
93
Exhibit 10.13
MANAGEMENT CONTINUITY AGREEMENT
THIS AGREEMENT
dated as of this 14
th
day of April 2008 between Stephen E. Macadam
(the Executive) and EnPro Industries, Inc., a North Carolina corporation (the Company).
WHEREAS,
the Company considers it essential to the best interests of its shareholders to
foster the continuous employment of key management personnel in the event there is, or is
threatened, a change in control of the Company; and
WHEREAS
, the Company recognizes that the uncertainty and questions which may arise among key
management in connection with the possibility of a change in control may result in the departure or
distraction of key management personnel to the detriment of the Company and its shareholders; and
WHEREAS
, the Company desires to provide certain protection to Executive in the event of a
change in control of the Company as set forth in this Agreement in order to induce Executive to
remain in the employ of the Company notwithstanding any risks and uncertainties created by the
possibility of a change in control of the Company;
WITNESSETH:
NOW, THEREFORE
, in consideration of the foregoing and the mutual promises herein contained,
the parties agree as follows:
1.
Term
. The Term of this Agreement shall mean the period commencing on the date
hereof and ending thirty-six (36) months after such date; provided, however, that commencing on the
date one year after the date hereof, and on each annual anniversary of such date (such date and
each annual anniversary thereof shall be hereinafter referred to as the Renewal Date), the Term
shall be automatically extended so as to terminate thirty-six (36) months from such Renewal Date,
unless at least sixty (60) days prior to the Renewal Date the Company shall give notice to the
Executive that the Term shall not be so extended.
2.
Period of Employment
. Executives Period of Employment shall commence on the
date on which a Change in Control occurs during the Term and shall end on the date that is
thirty-six (36) months after the date on which such Change in Control occurs (subject to the
provisions of Section 20 below pursuant to which the Period of Employment may be deemed to have
commenced prior to the date of a Change in Control in certain circumstances).
3.
Certain Definitions
. For purposes of this Agreement:
Board shall mean the Board of Directors of the Company.
Cause shall mean Executives termination of employment with the Company due to (A)
the willful and continued failure by Executive to substantially perform Executives duties
with the Company, which failure causes material and demonstrable injury to the Company
(other than any such failure resulting from Executives incapacity due to physical or mental
illness), after a demand for substantial performance is delivered
to Executive by the Board which specifically identifies the manner in which the Board
believes that Executive has not substantially performed Executives duties, and after
Executive has been given a period (hereinafter known as the Cure Period) of at least
thirty (30) days to correct Executives performance, or (B) the willful engaging by
Executive in other gross misconduct materially and demonstrably injurious to the Company.
For purposes hereof, no act, or failure to act, on Executives part shall be considered
willful unless conclusively demonstrated to have been done, or omitted to be done, by
Executive not in good faith and without reasonable belief that Executives action or
omission was in the best interests of the Company. Notwithstanding the foregoing, Executive
shall not be deemed to have been terminated for Cause unless and until there shall have been
delivered to Executive a Notice of Termination which shall include a copy of a resolution
duly adopted by the affirmative vote of not less than three-quarters of the entire
membership of the Board at a meeting of the Board called and held for the purpose (after
reasonable notice to Executive and an opportunity for Executive, together with Executives
counsel, to be heard before the Board), finding that in the good faith opinion of the Board
Executive was guilty of conduct set forth above in clause (A) (including the expiration of
the Cure Period without the correction of Executives performance) or clause (B) above and
specifying the particulars thereof in detail.
Change in Control shall mean:
(i) The acquisition by any individual, entity or group (within the meaning of Section
13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the Exchange
Act)), of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the
Exchange Act) of 20% or more of either (A) the then outstanding shares of common stock of
the Company (the Outstanding Company Common Stock) or (B) the combined voting power of the
then outstanding voting securities of the Company entitled to vote generally in the election
of directors (the Outstanding Company Voting Securities); provided, however, that the
following acquisitions shall not constitute a Change in Control: (A) any acquisition
directly from the Company (other than by exercise of a conversion privilege), (B) any
acquisition by the Company or any of its subsidiaries, (C) any acquisition by any employee
benefit plan (or related trust) sponsored or maintained by the Company or any of its
subsidiaries or (D) any acquisition by any company with respect to which, following such
acquisition, more than 70% of, respectively, the then outstanding shares of common stock of
such company and the combined voting power of the then outstanding voting securities of such
company entitled to vote generally in the election of directors is then beneficially owned,
directly or indirectly, by all or substantially all of the individuals and entities who were
the beneficial owners, respectively, of the Outstanding Company Common Stock and Outstanding
Company Voting Securities immediately prior to such acquisition in substantially the same
proportions as their ownership, solely in their capacity as shareholders of the Company,
immediately prior to such acquisition, of the Outstanding Company Common Stock and
Outstanding Company Voting Securities, as the case may be; or (ii) individuals who, as of
the Distribution Date (as such term is defined in the Distribution Agreement among Goodrich
Corporation, EnPro Industries, Inc. and Coltec Industries Inc.), constitute the Board (the
Incumbent Board) cease for any reason to constitute at least a majority of the Board;
provided, however, that any individual becoming a director subsequent to the Distribution
Date whose election, or nomination for election by the Companys shareholders, was approved
by a vote of at least a majority of the directors then comprising the Incumbent Board shall
be considered as though such
2
individual were a member of the Incumbent Board, but excluding, for this purpose, any
such individual whose initial assumption of office occurs as a result of either an actual or
threatened election contest; or (iii) consummation of a reorganization, merger or
consolidation, in each case, with respect to which all or substantially all of the
individuals and entities who were the beneficial owners, respectively, of the Outstanding
Company Common Stock and Outstanding Company Voting Securities immediately prior to such
reorganization, merger or consolidation, do not, following such reorganization, merger or
consolidation, beneficially own, directly or indirectly, solely in their capacity as
shareholders of the Company, more than 70% of, respectively, the then outstanding shares of
common stock and the combined voting power of the then outstanding voting securities
entitled to vote generally in the election of directors, as the case may be, of the company
resulting from such reorganization, merger or consolidation in substantially the same
proportions as their ownership, immediately prior to such reorganization, merger or
consolidation of the Outstanding Company Common Stock and Outstanding Company Voting
Securities, as the case may be; or (iv) consummation of (A) a complete liquidation or
dissolution of the Company or (B) a sale or other disposition of all or substantially all of
the assets of the Company, other than to a company, with respect to which following such
sale or other disposition, more than 70% of, respectively, the then outstanding shares of
common stock of such company and the combined voting power of the then outstanding voting
securities of such company entitled to vote generally in the election of directors is then
beneficially owned, directly or indirectly, by all or substantially all of the individuals
and entities, solely in their capacity as shareholders of the Company, who were the
beneficial owners, respectively, of the Outstanding Company Common Stock and Outstanding
Company Voting Securities immediately prior to such sale or other disposition in
substantially the same proportion as their ownership, immediately prior to such sale or
other disposition, of the Outstanding Company Common Stock and Outstanding Company Voting
Securities, as the case may be.
Date of Termination is as defined in Section 8 below.
Good Reason shall mean:
(i) without Executives express written consent, (A) the assignment to Executive of any
new duties or responsibilities substantially inconsistent in character with Executives
duties and responsibilities within the Company immediately prior to a Change in Control, (B)
any substantial adverse change in Executives duties and responsibilities as in effect
immediately prior to a Change in Control, including, but not limited to, a reduction in
duties or responsibilities which occurs because the Company is no longer an independent
publicly-held entity, (C) any removal of Executive from or any failure to re-elect Executive
to any director position of the Company, (D) a change in the annual or long term incentive
plan in which Executive currently participates such that Executives opportunity to earn
incentive compensation is impaired, (E) a material reduction in the aggregate value of
Company perquisites made available to Executive, (F) an elimination or material impairment
of Executives ability to participate in retirement plans comparable to those in which
Executive currently participates, (G) any substantial increase in Executives obligation to
travel on the Companys business over Executives present business travel obligations, or
(H) an elimination or material impairment of Executives ability to receive stock options
with values comparable to those Executive was granted within the one year period preceding
the commencement of the Period of Employment; (ii) the failure of the Company to comply
with any other of its obligations
3
under Section 4 herein; (iii) the relocation of the offices of the Company at which
Executive was employed immediately prior to the Change in Control to a location which is
more than fifty (50) miles from such prior location, or the failure of the Company to (A)
pay or reimburse Executive, in accordance with the Companys relocation policy for its
employees in existence immediately prior to a Change in Control, for all reasonable costs
and expenses; plus gross ups referred to in such policy incurred by Executive relating to
a change of Executives principal residence in connection with any relocation of the
Companys offices to which Executive consents, and (B) indemnify Executive against any loss
(defined as the difference between the actual sale price of such residence and the higher of
(1) Executives aggregate investment in such residence or (2) the fair market value of such
residence as determined by the relocation management organization used by the Company
immediately prior to the Change in Control (or other real estate appraiser designated by
Executive and reasonably satisfactory to the Company)) realized in the sale of Executives
principal residence in connection with any such change of residence; (iv) the failure of
the Company to obtain the assumption of and the agreement to perform this Agreement by any
successor as contemplated in Section 11 hereof; or (v) any purported termination of
Executives employment during the Period of Employment which is not effected pursuant to a
Notice of Termination satisfying the requirements of Section 7 hereof.
Incapacity Discharge means Executives termination of employment with the Company if,
as a result of Executives incapacity due to physical or mental illness, Executive shall
have been absent from Executives duties with the Company on a full-time basis for
one-hundred twenty (120) consecutive business days, and within thirty (30) days after a
written Notice of Termination is given, Executive shall not have returned to the full-time
performance of Executives duties.
Mandatory Retirement Date shall mean the compulsory retirement date, if any,
established by the Company for those executives of the Company who, by reason of their
positions and the size of their nonforfeitable annual retirement benefits under the
Companys pension, profit-sharing, and deferred compensation plans, are exempt from, the
provisions of the Age Discrimination in Employment Act, 29 U.S.C. Sections 621, et seq.,
which date shall not in any event be earlier for any executive than the last day of the
month in which such Executive reaches age 65.
Notice of Termination is as defined in Section 7 below.
Payment Period shall mean thirty-six (36) months, provided that the Payment Period
shall not exceed the number of whole calendar months between the Executives Date of
Termination and Mandatory Retirement Date (if applicable).
4.
Compensation During Period of Employment
. For so long during Executives Period of
Employment as Executive is an employee of the Company, the Company shall be obligated to compensate
Executive as follows:
(a) Executive shall continue to receive Executives full base salary at the rate in
effect immediately prior to the Change in Control. Executives base salary shall be
increased annually, with each such increase due on the anniversary date of Executives most
recent previous increase. Each such increase shall be no less than an amount which
4
at least equals on a percentage basis the mean of the annualized percentage increases
in base salary for all elected officers of the Company during the two full calendar years
immediately preceding the Change in Control.
(b) Executive shall continue to participate in all benefit and compensation plans
(including but not limited to the Equity Compensation Plan, Long-Term Incentive Program,
Performance Share Deferred Compensation Plan, Annual Performance Plan, Executive Life
Insurance Program, Deferred Compensation Plan, 401(K) plan, savings plan, flexible benefits
plan, life insurance plan, health and accident plan or disability plan) in which Executive
was participating immediately prior to the Change in Control, or in plans providing
substantially similar benefits, in either case upon terms and conditions and at levels at
least as favorable as those provided to Executive under the plans in which Executive was
participating immediately prior to the Change in Control;
(c) Executive shall continue to receive all fringe benefits, perquisites, and similar
arrangements which Executive was entitled to receive immediately prior to the Change in
Control; and
(d) Executive shall continue to receive annually the number of paid vacation days and
holidays Executive was entitled to receive immediately prior to the Change in Control.
5.
Compensation Upon Termination of Employment
. The following provisions set forth
the benefits that may become payable to Executive upon termination of employment with the Company
during the Period of Employment in accordance with, and subject to, the provisions of Section 6
below:
(a) By not later than the fifth business day following the Date of Termination, the
Company shall pay Executive in a lump sum an amount equal to the sum of the following:
(i) any base salary that is earned but unpaid as of the Date of Termination;
(ii) a pro rata portion of the target incentive amount under the Annual
Performance Plan for the calendar year in which the Date of Termination occurs
(based on the number of calendar days in such calendar year completed through the
Date of Termination); and
(iii) a pro rata portion of the calculated market value of the phantom
Performance Shares, if any, awarded to Executive under the Companys Long-Term
Incentive Program (the LTIP) for each Plan Cycle under the LTIP that has not been
completed as of the Date of Termination, determined as follows:
(A) The performance for each such Plan Cycle under the applicable LTIP
award agreement shall be determined based on (x) for any completed calendar
year of the Plan Cycle as of the Date of Termination, actual performance for
the calendar year, (y) for the calendar year in which the Date of
Termination occurs if at least one calendar quarter has been completed
during such calendar year, the greater of target
5
performance for the calendar year or actual performance for the
completed calendar quarter(s) for the calendar year annualized for the year,
and (z) for any other calendar years of the Plan Cycle, target performance
for the calendar year.
(B) The number of phantom Performance Shares for each such Plan Cycle
shall be adjusted in accordance with the formula set forth in the applicable
LTIP award agreement based on the performance for the Plan Cycle determined
under paragraph (A) above.
(C) The pro rata portion of the calculated market value of the
number of phantom Performance Shares adjusted in accordance with paragraph
(B) above shall be based on the number of calendar days in the Plan Cycle
completed through the Date of Termination.
Section 5(c) below sets for the method for determining the target incentive amount under
the Annual Performance Plan and the calculated market value of phantom Performance Shares
under the LTIP. Any amounts payable under Sections 5(a)(ii) or (iii) above shall be offset
dollar-for-dollar by any pro rata payments otherwise provided for under the Annual
Performance Plan or the LTIP.
(b) In lieu of any salary payments that Executive would have received if he had
continued in the employment of the Company during the Payment Period, the Company shall pay
to Executive in a lump sum, by not later than the fifth business day following the Date of
Termination, an amount equal to one-twelfth of Executives annualized base salary in effect
immediately prior to the Date of Termination, multiplied by the number of months in the
Payment Period.
(c) By not later than the fifth day following the Date of Termination, the Company
shall pay Executive in a lump sum an amount equal to the sum of:
(i) under the Annual Performance Plan (and in lieu of any further awards under
the Annual Performance Plan that Executive would have received if he had continued
in the employment of the Company during the Payment Period), the number of months in
the Payment Period multiplied by the greatest of one-twelfth of: (A) the amount most
recently paid to Executive for a full calendar year; (B) Executives target
incentive amount for the calendar year in which his Date of Termination occurs; or
(C) Executives target incentive amount in effect prior to the Change in Control
for the calendar year in which the Change in Control occurs; plus, if applicable,
(ii) under the LTIP (and in lieu of any further grants under the LTIP that
Executive would have received if he had continued in the employment of the Company
during the Payment Period), twenty-four (24) multiplied by the greatest of: (A) with
respect to the most recently completed Plan Cycle as of the Date of Termination,
one-twelfth of the calculated market value of the Performance Shares actually
awarded Executive (including the value of any Performance Shares Executive may have
elected to defer under the Performance Share Deferred Compensation Program); (B)
with respect to the most recently
6
commenced Plan Cycle under the LTIP (if Executive is a participant in such Plan
Cycle) prior to Executives Date of Termination, one-twelfth of the calculated
market value of the phantom Performance Shares, if any, awarded to Executive; or
(C) with respect to the most recently commenced Plan Cycle prior to the date of the
occurrence of the Change in Control, one-twelfth of the calculated market value of
the phantom Performance Shares, if any, awarded to Executive.
For purposes of this Section 5, Executives target incentive amount under the
Annual Performance Plan for a given calendar year (i.e., the calendar year in which
the Date of Termination occurs or the Change in Control occurs, as applicable) is
determined by multiplying (i) Executives annualized total gross base salary for the
calendar year by (ii) the incentive target percentage which is applicable to
Executives incentive category under the Annual Performance Plan for the calendar
year. For purposes of this Section 5, the calculated market value of each
Performance Share actually awarded upon completion of a Plan Cycle, Performance
Share deferred under the Performance Share Deferred Compensation Program or phantom
Performance Share granted under the LTIP shall be the mean of the high and low
prices of the Companys common stock on the relevant date as reported on the New
York Stock Exchange Composite Transactions listing (or similar report), or, if no
sale was made on such date, then on the next preceding day on which a sale was made
multiplied by the number of shares involved in the calculation. The relevant date
for Section 5(a)(iii) and clauses 5(c)(ii)(B) and 5(c)(ii)(C) is the date upon which
the Compensation Committee (Committee) of the Board of Directors awarded the
phantom Performance Shares in question; for clause 5(c)(ii)(A) the relevant date is
the date on which the Committee made a determination of attainment of financial
objectives and awarded Performance Shares (including any Performance Shares
Executive may have elected to defer under the Performance Share Deferred
Compensation Program).
Any payments received pursuant to Sections 5(c)(i) or (ii) above shall be in
addition to, and not in lieu of, any payments required to be made to Executive as
the result of the happening of an event that would constitute a change in control
pursuant to the provisions of the Annual Performance Plan or LTIP, as applicable.
(d) By not later than the fifth day following the Date of Termination, the Company
shall pay Executive in a lump sum an amount equal to the sum of:
(i) If Executive is under age 55, or over the age of 55 but not eligible to
retire, at the Date of Termination the present value of all health and welfare
benefits the Executive would have been entitled to had the Executive continued as an
employee of the Company during the Payment Period and been entitled to or
participated in the same health and welfare benefits during the Payment Period as
immediately prior to the Date of Termination plus an amount in cash equal to the
amount necessary to cause the amount of the aggregate after-tax lump sum payment the
Executive receives pursuant to this provision to be equal to the aggregate after-tax
value of the benefits which Executive would have received if Executive continued to
receive such benefits as an employee; or
7
(ii) If Executive is age 55 or over and eligible to retire on the Date of
Termination, the present value of the health and welfare benefits to which Executive
would have been entitled under the Companys general retirement policies if
Executive retired on the Date of Termination with the Company paying that percentage
of the premium cost of the plans which it would have paid under the terms of the
plans in effect immediately prior to the Change of Control with respect to
individuals who retire at age 65, regardless of Executives actual age on the
Termination Date, provided such lump sum value would be at least equal to the lump
sum value of the benefits which would have been payable if Executive had been
eligible to retire and had retired immediately prior to the Change in Control.
(e) By not later than the fifth day following the Date of Termination, the Company
shall pay Executive in a lump sum an amount equal to the sum of the present value of the
fringe benefit programs, perquisites (if any), and similar arrangements the Executive would
have been entitled to receive had the Executive continued in employment with the Company for
the Payment Period and been entitled to or participated in the same such benefits during the
Payment Period as immediately prior to the Date of Termination. In addition and
notwithstanding any provision of the Companys 2002 Equity Compensation Plan (or any
comparable equity award plan of the Company) or any applicable award agreement thereunder to
the contrary, Executive may exercise any of Executives stock options that are vested as of
Executives Date of Termination at any time during the Payment Period (but not exceeding the
original expiration date of the options).
(f) The Company shall, in addition to the benefits to which Executive is entitled under
the retirement plans or programs sponsored by the Company or its affiliates in which
Executive participates (including without limitation any Supplemental Executive Retirement
Plan in which Executive participates, if applicable), pay Executive in a lump sum in cash by
no later than the fifth day following the Date of Termination an amount equal to the
actuarial equivalent of the retirement pension to which Executive would have been entitled
under the terms of such retirement plans or programs had Executive accumulated additional
years of continuous service under such plans equal in length to Executives Payment Period.
The length of the Payment Period will be added to total years of continuous service for
determining vesting, the amount of benefit accrual, to the age which Executive will be
considered to be for the purposes of determining eligibility for normal or early retirement
calculations and the age used for determining the amount of any actuarial reduction. For the
purposes of calculating the additional benefit accrual under this paragraph, the amount of
compensation Executive will be deemed to have received during each month of Executives
Payment Period shall be equal to the sum of Executives annual base salary prorated on a
monthly basis as provided for under Section 4(a) immediately prior to the Date of
Termination (including salary increases), plus under the Companys Annual Performance Plan
the greatest of one-twelfth of:
(i) the amount most recently paid to Executive for a full calendar year,
(ii) Executives target incentive amount for the calendar year in which
Executives Date of Termination occurs, or
8
(iii) Executives target incentive amount in effect prior to the Change in
Control for the calendar year in which the Change in Control occurs. Attached as
Exhibit 1 is an illustration, not intending to be exhaustive, of examples of how
inclusion of the Payment Period may affect the calculation of Executives retirement
benefit.
(g) In no event shall any amount payable to Executive described in this Section 5 be
considered compensation or earnings under any pension, savings or other retirement plan of
the Company.
6.
Termination
.
(a)
Termination Without Compensation.
If Executives employment is terminated for any
of the following reasons, Executive shall not be entitled by virtue of this Agreement to any
of the benefits provided in the foregoing Section 5:
(i) If, prior to the commencement of the Period of Employment, Executives
employment with the Company is terminated at any time for any reason, including
without limitation due to (A) Executives death, (B) an Incapacity Discharge, (C) a
termination initiated by the Company with or without Cause or (D) resignation,
retirement or other termination initiated by Executive with or without Good Reason,
subject, however, to the provisions of Section 20 below.
(ii) If Executives employment with the Company is terminated during the
Period of Employment with Cause.
(iii) If Executive resigns, retires or otherwise voluntarily terminates
employment with the Company during the Period of Employment without Good Reason.
(b)
Termination with Compensation.
If Executives employment is terminated for any of
the following reasons, Executive shall be entitled by virtue of this Agreement to the
benefits provided in the foregoing Section 5 as follows:
(i) If, during the Period of Employment, the Company discharges Executive
other than for Cause, Executive shall receive all of the benefits and payments
provided in Section 5.
(ii) Executive may terminate his employment with the Company at any time
during the Period of Employment for Good Reason (Good Reason Termination) and
shall receive all of the benefits and payments provided in Section 5.
(iii) If, during the Period of Employment, Executive either (A) retires from
employment with the Company or (B) if the Company discharges Executive due to an
Incapacity Discharge, in either case while Executive has cause to terminate his
employment as a Good Reason Termination (whether or not Executive has provided
Notice of Termination to the Company pursuant to
9
Section 7), Executive shall receive all of the benefits and payments provided
in Section 5.
(iv) If Executive dies while employed by the Company during the Period of
Employment while having cause to terminate his employment as a Good Reason
Termination (whether or not Executive has provided Notice of Termination to the
Company pursuant to Section 7), Executives beneficiary or beneficiaries named on
Exhibit 2 to this Agreement (or Executives estate if he has not named a
beneficiary) shall be entitled to receive those payments provided under Sections
5(a), 5(b) and 5(c) of this Agreement in addition to any benefits that such
beneficiaries would be entitled under any other plan, program or policy of the
Company as a result of Executives employment with the Company.
(v) Executive may become eligible for the benefits and payments under Section
5 for termination of employment prior to a Change in Control in accordance with, and
subject to, the provisions of Section 20 below.
7.
Notice of Termination.
Any termination of Executives employment by the Company or
any termination by Executive as a Good Reason Termination shall be communicated by written notice
to the other party hereto. For purposes of this Agreement, such notice shall be referred to as a
Notice of Termination. Such notice shall, to the extent applicable, set forth the specific reason
for termination, and shall set forth in reasonable detail the facts and circumstances claimed to
provide a basis for termination of Executives employment under the provision so indicated.
8.
Date of Termination.
Date of Termination shall mean:
(a) If Executive terminates Executives employment as a Good Reason Termination, the
date specified in the Notice of Termination, but in no event more than sixty (60) days after
Notice of Termination is given.
(b) If Executives employment is terminated with Cause, the date on which a Notice of
Termination is given, except that the Date of Termination shall not be any date prior to the
date on which the Cure Period expires without the correction of Executives performance (if
applicable).
(c) If Executives employment pursuant to this Agreement is terminated following
absence due to physical incapacity as an Incapacity Discharge, then the Date of Termination
shall be thirty (30) days after Notice of Termination is given (provided that Executive
shall not have returned to the performance of Executives duties on a full-time basis during
such thirty (30) day period).
(d) A termination of employment by either the Company or by Executive shall not affect
any rights Executive or Executives surviving spouse or beneficiaries may have pursuant to
any other agreement or plan of the Company providing benefits to Executive, except as
provided in such agreement or plan.
10
9.
Certain Additional Payments
.
(a) Anything in this Agreement to the contrary notwithstanding, in the event it shall
be determined that any payment or distribution by the Company to Executive or for
Executives benefit (whether paid or payable or distributed or distributable pursuant to the
terms of this Agreement or otherwise, but determined without regard to any additional
payments required under this Section 9) (a Payment) would be subject to the excise tax
imposed by Section 4999 (or any successor provisions) of the Internal Revenue Code of 1986,
as amended (the Code), or any interest or penalty is incurred by Executive with respect to
such excise tax (such excise tax, together with any such interest and penalties, is
hereinafter collectively referred to as the Excise Tax), then Executive shall be entitled
to receive an additional payment (a Gross-Up Payment) in an amount such that after payment
by Executive of all taxes (including any interest or penalties imposed with respect to such
taxes), including, without limitation, any income taxes (and any interest and penalties
imposed with respect thereto) and Excise Tax imposed on the Gross-Up Payment, Executive
retains an amount of the Gross-Up Payment equal to the Excise Tax imposed upon the Payments.
(b) Subject to the provisions of Section 9(c), all determinations required to be made
under this Section 9, including whether and when such a Gross-Up Payment is required and the
amount of such Gross-Up Payment and the assumptions to be utilized in arriving at such
determination, shall be made by Ernst & Young (or their successors) (the Accounting Firm)
which shall provide detailed supporting calculations both to the Company and to Executive
within fifteen (15) business days of the receipt of notice from Executive that there has
been a Payment, or such earlier time as is requested by the Company. In the event that the
Accounting Firm is serving as accountant or auditor for the individual, entity or group
effecting the Change in Control, Executive shall appoint another nationally recognized
accounting firm to make the determinations required hereunder (which accounting firm shall
then be referred to as the Accounting Firm hereunder). All fees and expenses of the
Accounting Firm shall be borne solely by the Company. Any Gross-Up Payment as determined
pursuant to this Section 9, shall be paid by the Company to Executive within five (5) days
of the receipt of the Accounting Firms determination. If the Accounting Firm determines
that no Excise Tax is payable by Executive, it shall furnish Executive with a written
opinion that failure to report the Excise Tax on Executives applicable federal income tax
return would not result in the imposition of a negligence or similar penalty. Any
determination by the Accounting Firm shall be binding upon the Company and Executive. As a
result of the uncertainty of the application of Section 4999 of the Code at the time of the
initial determination by the Accounting Firm hereunder, it is possible that Gross-Up
Payments which will not have been made by the Company should have been made
(Underpayment). In the event that the Company exhausts its remedies pursuant to Section
9(c) and Executive thereafter is required to make a payment of any Excise Tax, the
Accounting Firm shall determine the amount of the Underpayment that has occurred and any
such Underpayment shall be promptly paid by the Company to Executive or for Executives
benefit.
(c) Executive shall notify the Company in writing of any claim by the Internal Revenue
Service that, if successful, would require the payment by the Company of the Gross-Up
Payment. Such notification shall be given as soon as practicable but no later than ten (10)
business days after Executive or his representative is informed in writing of
11
such claim and shall apprise the Company of the nature of such claim and the date on
which such claim is requested to be paid. Executive shall not pay such claim prior to the
expiration of the thirty (30) day period following the date on which Executive gives such
notice to the Company (or such shorter period ending on the date that any payment of taxes
with respect to such claim is due). If the Company notifies Executive in writing prior to
the expiration of such period that it desires to contest such claim, Executive shall:
(i) give the Company any information reasonably requested by the Company
relating to such claim,
(ii) take such action in connection with contesting such claim as the Company
shall reasonably request in writing from time to time, including, without
limitation, accepting legal representation with respect to such claim by an attorney
reasonably selected by the Company,
(iii) cooperate with the Company in good faith in order effectively to contest
such claim, and
(iv) permit the Company to participate in any proceedings relating to such
claim; however, that the Company shall bear and pay directly all costs and expenses
(including additional interest and penalties) incurred in connection with such
contest and shall indemnify and hold Executive harmless, on an after-tax basis, for
any Excise Tax or income tax (including interest and penalties with respect thereto)
imposed as a result of such representation and payment of costs and expenses.
Without limitation on the foregoing provisions of this Section 9(c), the Company
shall control all proceedings taken in connection with such contest and, at its sole
option, may pursue or forego any and all administrative appeals, proceedings,
hearings and conferences with the taxing authority in respect of any such claim and
may, at its sole option, either direct Executive to pay the tax claimed and sue for
a refund or contest the claim in any permissible manner, and Executive agree to
prosecute such contest to a determination before any administrative tribunal, in a
court of initial jurisdiction and in one or more appellate courts, as the Company
shall determine; provided, however, that if the Company directs Executive to pay
such claim and sue for a refund, the Company shall advance the amount of such
payment to Executive, on an interest-free basis and shall indemnify and hold
Executive harmless, on an after-tax basis, from any Excise Tax or income tax
(including interest or penalties with respect thereto) imposed with respect to such
advance or with respect to any imputed income with respect to such advance; and
further provided that any extension of the statute of limitations relating to
payment of taxes for Executives taxable year with respect to which such contested
amount is claimed to be due is limited solely to such contested amount. Furthermore,
the Companys control of the contest shall be limited to issues with respect to
which a Gross-Up Payment would be payable hereunder and Executive shall be entitled
to settle or contest, as the case may be, any other issue raised by the Internal
Revenue Service or any other taxing authority.
(d) If, after the receipt by Executive of an amount advanced by the Company pursuant to
Section 9(c), Executive become entitled to receive any refund with respect to
12
such claim, Executive shall (subject to the Companys complying with the requirements
of Section 9(c)) promptly pay to the Company the amount of such refund (together with any
interest paid or credited thereon after taxes applicable thereto). If, after the receipt by
Executive of an amount advanced by the Company pursuant to Section 9(c), a determination is
made that Executive shall not be entitled to any refund with respect to such claim and the
Company does not notify Executive in writing of its intent to contest such denial of refund
prior to the expiration of thirty (30) days after such determination, then such advance
shall be forgiven and shall not be required to be repaid and the amount of such advance
shall offset, to the extent thereof, the amount of Gross-Up Payment required to be paid.
(e) Notwithstanding the provisions of this Section 9 to the contrary, in no event shall
any payments made to Executive under this Section 9 be made later than the end of the
calendar year following the calendar year in which Executive remits the Excise Tax.
10.
No Obligation to Mitigate Damages, No Effect on Other Contractual Rights.
Executive
shall not be required to refund the amount of any payment or employee benefit provided for or
otherwise mitigate damages under this Agreement by seeking or accepting other employment or
otherwise, nor shall the amount of any payment required to be made under this Agreement be reduced
by any compensation earned by Executive as the result of any employment by another employer after
the date of termination of Executives employment with the Company, or otherwise. Upon receipt of
written notice from Executive that Executive has been reemployed by another company or entity on a
full-time basis, benefits, fringe benefits and perquisites otherwise receivable by Executive
pursuant to Sections 5(d) or 5(e) related to life, health, disability and accident insurance plans
and programs and other similar benefits, company cars, financial planning, country club
memberships, and the like (but not incentive compensation, LTIP, pension plans or other similar
plans and programs) shall be reduced to the extent comparable benefits are made available to
Executive at his new employment and any such benefits actually received by Executive shall be
reported to the Company by Executive.
The provisions of the Agreement, and any payment or benefit provided for hereunder shall not
reduce any amount otherwise payable, or in any way diminish Executives existing rights, or rights
which would occur solely as a result of the passage of time, under any other agreement, contract,
plan or arrangement with the Company.
11.
Successors and Binding Agreement.
(a) The Company shall require any successor (whether direct or indirect, by purchase,
merger, consolidation or otherwise) to all or substantially all of the business or assets of
the Company, by agreement in form and substance satisfactory to Executive, to assume and
agree to perform this Agreement.
(b) This Agreement shall be binding upon the Company and any successor of or to the
Company, including, without limitation, any person acquiring directly or indirectly all or
substantially all of the assets of the Company whether by merger, consolidation, sale or
otherwise (and such successor shall thereafter be deemed the Company for the purposes of
this Agreement), but shall not otherwise be assignable by the Company.
13
(c) This Agreement shall inure to the benefit of and be enforceable by Executive and
Executives personal or legal representatives, executors, administrators, successors, heirs,
distributees, devisees and legatees. If Executive should die while any amounts would still
be payable to Executive pursuant to Sections 5 and 6 hereunder if Executive had continued to
live, all such amounts, unless otherwise provided herein, shall be paid in accordance with
the terms of this Agreement to Executives devisee, legatee, or other designee or, if there
be no such designee, to Executives estate.
12.
Notices
. For the purposes of this Agreement, notices and all other communications
provided for in the Agreement shall be in writing and shall be deemed to have been duly given when
delivered or mailed by United States registered mail, return receipt requested, postage prepaid,
addressed to the respective addresses set forth on the first page of this Agreement, provided that
all notices to the Company shall be directed to the attention of the Chief Executive Officer of the
Company with a copy to the Secretary of the Company, or to such other address as either party may
have furnished to the other in writing, except that notices of change of address shall be effective
only upon receipt.
13.
Governing Law.
The validity, interpretation, construction and performance of this
Agreement shall be governed by the laws of the State of North Carolina, without giving effect to
the principles of conflict of laws of such State.
14.
Miscellaneous.
No provisions of this Agreement may be modified, waived or
discharged, and this Agreement may not be terminated before the end of the Term, unless such
waiver, modification, discharge or termination is agreed to in a writing signed by Executive and
the Company. No waiver by either party hereto at any time of any breach by the other party hereto
or compliance with, any condition or provision of this Agreement to be performed by such other
party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at
any prior or subsequent time. No agreements or representations, oral or otherwise, express or
implied, with respect to the subject matter hereof, have been made by either party which is not set
forth expressly in this Agreement.
15.
Validity.
The invalidity or unenforceability of any provisions of this Agreement
shall not affect the validity or enforceability of any other provision of this Agreement, which
shall remain in full force and effect.
16.
Counterparts.
This Agreement may be executed in one or more counterparts, each of
which shall be deemed to be an original, but all of which together will constitute one and the same
agreement.
17.
Withholding of Taxes.
The Company may withhold from any amounts payable under
this Agreement all federal, state, city or other taxes as shall be required pursuant to any law or
government regulation or ruling.
18.
Nonassignability.
This Agreement is personal in nature and neither of the parties
hereto shall, without the consent of the other, assign or transfer this Agreement or any rights or
obligations hereunder, except as provided in Section 11 above. Without limiting the foregoing,
Executives right to receive payments hereunder shall not be assignable or transferable, whether by
pledge, creation of a security interest or otherwise, other than by a transfer by Executives will
14
or by the laws of descent and distribution and in the event of any attempted assignment or
transfer contrary to this Section 18 the Company shall have no liability to pay any amounts so
attempted to be assigned or transferred.
19.
Legal Fees and Expenses.
If a Change in Control shall have occurred, thereafter
the Company shall pay and be solely responsible for any and all attorneys and related fees and
expenses incurred by Executive to successfully (in whole or in part and whether by modification of
the Companys position, agreement, compromise, settlement, or administrative or judicial
determination) enforce this Agreement or any provision hereof or as a result of the Company or any
Shareholder of the Company contesting the validity or enforceability of this Agreement or any
provision hereof. To secure the foregoing obligation, the Company shall, within 90 days after being
requested by Executive to do so, enter into a contract with an insurance company, open a letter of
credit or establish an escrow in a form satisfactory to Executive. Notwithstanding the provisions
of this Section 19 to the contrary, in no event shall any payments made to Executive under this
Section 19 be made for expenses incurred by Executive following the end of the second calendar year
following the calendar year in which Executives Date of Termination occurs, provided that the
period during which reimbursement for such expenses may be made may extend to the end of the third
calendar year in which Executives Date of Termination occurs.
20.
Employment Rights
. Nothing expressed or implied in this Agreement shall create
any right or duty on Executives part or on the part of the Company to have Executive remain in the
employment of the Company prior to the commencement of the Period of Employment; provided, however,
that any termination or purported termination of Executives employment by the Company without
Cause, or termination of Executives employment by Executive under circumstances that would
constitute Good Reason had a Change in Control occurred, in either case following the commencement
of any discussion with a third party, or the announcement by a third party of the commencement of,
or the intention to commence a tender offer, or other intention to acquire all or a portion of the
equity securities of the Company that ultimately results in a Change in Control shall be deemed to
be a termination of Executives employment after a Change in Control for purposes of (i) this
Agreement and both the Period of Employment and the Payment Period shall be deemed to have begun on
the day prior to such termination and (ii) the Companys Equity Compensation Plan as if the Change
in Control had occurred on the day prior to such termination (resulting in the full vesting and
extended exercisability of the Executives outstanding stock options under, and in accordance with,
the provisions of the Equity Compensation Plan).
21.
Right of Setoff.
There shall be no right of setoff or counterclaim against, or
delay in, any payment by the Company to Executive or Executives designated beneficiary or
beneficiaries provided for in this Agreement in respect of any claim against Executive or any debt
or obligation owed by Executive, whether arising hereunder or otherwise.
22.
Rights to Other Benefits.
The existence of the Agreement and Executives rights
hereunder shall be in addition to, and not in lieu of, Executives rights under any other of the
Companys compensation and benefit plans and programs, and under any other contract or agreement
between Executive and the Company.
23.
Prior Agreements.
This Agreement supersedes and replaces any and all prior
agreements and understandings between the Company and the Executive with respect to the
15
subject matter hereof. Any such prior agreements and understandings are no longer in force or
effect.
24.
Compliance with Section 409A of the Internal Revenue Code
.
Any payments under
this Agreement that are deemed to be deferred compensation subject to the requirements of Section
409A (Section 409A) of the Internal Revenue Code of 1986, as amended, are intended to comply with
the requirements of Section 409A. To this end and notwithstanding any other provision of this
Agreement to the contrary, if at the time of Executives termination of employment with the
Company, (i) the Companys securities are publicly traded on an established securities market; (ii)
Executive is a specified employee (as defined in Section 409A); and (iii) the deferral of the
commencement of any payments or benefits otherwise payable pursuant to this Agreement as a result
of such termination of employment is necessary in order to prevent any accelerated or additional
tax under Section 409A, then the Company will defer the commencement of such payments (without any
reduction in amount ultimately paid or provided to Executive) that are not paid within the
short-term deferral rule under Section 409A (and any regulations thereunder) or within the
involuntary separation exemption of Treasury Regulation § 1.409A-1(b)(9)(iii). Such deferral
shall last until the date that is six (6) months following Executives termination of employment
with the Company (or the earliest date as is permitted under Section 409A). Any amounts the
payment of which are so deferred shall be paid in a lump sum payment within ten (10) days after the
end of such deferral period. If Executive dies during the deferral period prior to the payment of
any deferred amount, then the unpaid deferred amount shall be paid to the personal representative
of Executives estate within sixty (60) days after the date of Executives death. For purposes of
Section 409A, the right to a series of installment payments under this Agreement shall be treated
as a right to a series of separate payments.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective Date.
|
|
|
|
|
|
ENPRO INDUSTRIES, INC.
|
|
|
By:
|
/s/ Richard L. Magee
|
|
|
|
Name:
|
Richard L. Magee
|
|
|
|
Title:
|
Senior Vice President and General
Counsel
|
|
|
|
|
|
|
/s/ Stephen E. Macadam
|
|
|
Stephen E. Macadam
|
|
|
|
|
|
16
EXHIBIT 1
A. If as of Executives Date of Termination Executives years of continuous service under the
applicable retirement plans for purposes of determining eligibility for normal or early retirement
plus the length of Executives Payment Period is at least 5, then
1. If as of Executives Date of Termination Executives age plus the length of
Executives Payment Period is at least 65, Executives retirement benefit under Section 5(f)
will be calculated as a normal retirement benefit to which Executive would have been
entitled under the terms of the retirement plan in which Executive participates had
Executive accumulated benefit service under the retirement plan that included the Payment
Period; and
2. If as of Executives Date of Termination Executives age plus the length of
Executives Payment Period is at least 55 but less than 65, Executives retirement benefit
under Section 5(f) will be calculated as an early retirement benefit to which Executive
would have been entitled under the terms of the retirement plan in which Executive
participates had Executive accumulated benefit service under the retirement plan that
included the Payment Period. The actuarial reduction used shall be the actuarial reduction
factor for early retirement, calculated to Executives actual age plus the length of
Executives Payment Period, at Executives Date of Termination.
B. If as of Executives Date of Termination the sum of Executives years of continuous service
under the applicable retirement plans for purposes of determining eligibility for normal or early
retirement plus the length of Executives Payment Period is less than 5, or Executives age plus
the length of Executives Payment Period is less than 55, Executives retirement benefit under
Section 5(f) will be calculated as a deferred vested pension to which Executive would have been
entitled under the terms of the retirement plans in which Executive participates had Executive
accumulated benefit service under the retirement plan that included the Payment Period. The
actuarial reduction used shall be the actuarial reduction factor for a deferred vested pension,
calculated to Executives actual age at Executives Date of Termination plus the length of
Executives Payment Period.
C. For purposes of Section 5(f), actuarial equivalent shall be determined using the same
methods and assumptions as those utilized under the Companys retirement plans and programs
immediately prior to the Change in Control.
EXHIBIT 2
BENEFICIARY DESIGNATION
I hereby designate the following person(s) as a beneficiary for the purposes of Section
6(b)(iv) to the extent of the percentage interest listed next to their name:
|
|
|
NAME
|
|
PERCENTAGE INTEREST
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL (CANNOT EXCEED 100%)
|
|
|
|
|
|
Exhibit 10.19
MANAGEMENT CONTINUITY AGREEMENT
THIS AGREEMENT
dated as of this 11
th
day of February 2009 between Orville G.
Lunking (the Executive) and EnPro Industries, Inc., a North Carolina corporation (the Company).
WHEREAS,
the Company considers it essential to the best interests of its shareholders to
foster the continuous employment of key management personnel in the event there is, or is
threatened, a change in control of the Company; and
WHEREAS
, the Company recognizes that the uncertainty and questions which may arise among key
management in connection with the possibility of a change in control may result in the departure or
distraction of key management personnel to the detriment of the Company and its shareholders; and
WHEREAS
, the Company desires to provide certain protection to Executive in the event of a
change in control of the Company as set forth in this Agreement in order to induce Executive to
remain in the employ of the Company notwithstanding any risks and uncertainties created by the
possibility of a change in control of the Company;
WITNESSETH:
NOW, THEREFORE
, in consideration of the foregoing and the mutual promises herein contained,
the parties agree as follows:
1.
Term
. The Term of this Agreement shall mean the period commencing on the date
hereof and ending eighteen (18) months after such date; provided, however, that commencing on the
date one year after the date hereof, and on each annual anniversary of such date (such date and
each annual anniversary thereof shall be hereinafter referred to as the Renewal Date), the Term
shall be automatically extended so as to terminate eighteen (18) months from such Renewal Date,
unless at least sixty (60) days prior to the Renewal Date the Company shall give notice to the
Executive that the Term shall not be so extended.
2.
Period of Employment
. Executives Period of Employment shall commence on the
date on which a Change in Control occurs during the Term and shall end on the date that is eighteen
(18) months after the date on which such Change in Control occurs (subject to the provisions of
Section 20 below pursuant to which the Period of Employment may be deemed to have commenced prior
to the date of a Change in Control in certain circumstances).
3.
Certain Definitions
. For purposes of this Agreement:
Board shall mean the Board of Directors of the Company.
Cause shall mean Executives termination of employment with the Company due to (A)
the willful and continued failure by Executive to substantially perform Executives duties
with the Company, which failure causes material and demonstrable injury to the Company
(other than any such failure resulting from Executives incapacity due to physical or mental
illness), after a demand for substantial performance is delivered
to Executive by the Board which specifically identifies the manner in which the Board
believes that Executive has not substantially performed Executives duties, and after
Executive has been given a period (hereinafter known as the Cure Period) of at least
thirty (30) days to correct Executives performance, or (B) the willful engaging by
Executive in other gross misconduct materially and demonstrably injurious to the Company.
For purposes hereof, no act, or failure to act, on Executives part shall be considered
willful unless conclusively demonstrated to have been done, or omitted to be done, by
Executive not in good faith and without reasonable belief that Executives action or
omission was in the best interests of the Company. Notwithstanding the foregoing, Executive
shall not be deemed to have been terminated for Cause unless and until there shall have been
delivered to Executive a Notice of Termination which shall include a copy of a resolution
duly adopted by the affirmative vote of not less than three-quarters of the entire
membership of the Board at a meeting of the Board called and held for the purpose (after
reasonable notice to Executive and an opportunity for Executive, together with Executives
counsel, to be heard before the Board), finding that in the good faith opinion of the Board
Executive was guilty of conduct set forth above in clause (A) (including the expiration of
the Cure Period without the correction of Executives performance) or clause (B) above and
specifying the particulars thereof in detail.
Change in Control shall mean:
(i) The acquisition by any individual, entity or group (within the meaning of Section
13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the Exchange
Act)), of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the
Exchange Act) of 20% or more of either (A) the then outstanding shares of common stock of
the Company (the Outstanding Company Common Stock) or (B) the combined voting power of the
then outstanding voting securities of the Company entitled to vote generally in the election
of directors (the Outstanding Company Voting Securities); provided, however, that the
following acquisitions shall not constitute a Change in Control: (A) any acquisition
directly from the Company (other than by exercise of a conversion privilege), (B) any
acquisition by the Company or any of its subsidiaries, (C) any acquisition by any employee
benefit plan (or related trust) sponsored or maintained by the Company or any of its
subsidiaries or (D) any acquisition by any company with respect to which, following such
acquisition, more than 70% of, respectively, the then outstanding shares of common stock of
such company and the combined voting power of the then outstanding voting securities of such
company entitled to vote generally in the election of directors is then beneficially owned,
directly or indirectly, by all or substantially all of the individuals and entities who were
the beneficial owners, respectively, of the Outstanding Company Common Stock and Outstanding
Company Voting Securities immediately prior to such acquisition in substantially the same
proportions as their ownership, solely in their capacity as shareholders of the Company,
immediately prior to such acquisition, of the Outstanding Company Common Stock and
Outstanding Company Voting Securities, as the case may be; or (ii) individuals who, as of
the Distribution Date (as such term is defined in the Distribution Agreement among Goodrich
Corporation, EnPro Industries, Inc. and Coltec Industries Inc.), constitute the Board (the
Incumbent Board) cease for any reason to constitute at least a majority of the Board;
provided, however, that any individual becoming a director subsequent to the Distribution
Date whose election, or nomination for election by the Companys shareholders, was approved
by a vote of at least a majority of the directors then comprising the Incumbent Board shall
be considered as though such
2
individual were a member of the Incumbent Board, but excluding, for this purpose, any
such individual whose initial assumption of office occurs as a result of either an actual or
threatened election contest; or (iii) consummation of a reorganization, merger or
consolidation, in each case, with respect to which all or substantially all of the
individuals and entities who were the beneficial owners, respectively, of the Outstanding
Company Common Stock and Outstanding Company Voting Securities immediately prior to such
reorganization, merger or consolidation, do not, following such reorganization, merger or
consolidation, beneficially own, directly or indirectly, solely in their capacity as
shareholders of the Company, more than 70% of, respectively, the then outstanding shares of
common stock and the combined voting power of the then outstanding voting securities
entitled to vote generally in the election of directors, as the case may be, of the company
resulting from such reorganization, merger or consolidation in substantially the same
proportions as their ownership, immediately prior to such reorganization, merger or
consolidation of the Outstanding Company Common Stock and Outstanding Company Voting
Securities, as the case may be; or (iv) consummation of (A) a complete liquidation or
dissolution of the Company or (B) a sale or other disposition of all or substantially all of
the assets of the Company, other than to a company, with respect to which following such
sale or other disposition, more than 70% of, respectively, the then outstanding shares of
common stock of such company and the combined voting power of the then outstanding voting
securities of such company entitled to vote generally in the election of directors is then
beneficially owned, directly or indirectly, by all or substantially all of the individuals
and entities, solely in their capacity as shareholders of the Company, who were the
beneficial owners, respectively, of the Outstanding Company Common Stock and Outstanding
Company Voting Securities immediately prior to such sale or other disposition in
substantially the same proportion as their ownership, immediately prior to such sale or
other disposition, of the Outstanding Company Common Stock and Outstanding Company Voting
Securities, as the case may be.
Date of Termination is as defined in Section 8 below.
Good Reason shall mean:
(i) without Executives express written consent, (A) the assignment to Executive of any
new duties or responsibilities substantially inconsistent in character with Executives
duties and responsibilities within the Company immediately prior to a Change in Control, (B)
any substantial adverse change in Executives duties and responsibilities as in effect
immediately prior to a Change in Control, including, but not limited to, a reduction in
duties or responsibilities which occurs because the Company is no longer an independent
publicly-held entity, (C) any removal of Executive from or any failure to re-elect Executive
to any director position of the Company, (D) a change in the annual or long term incentive
plan in which Executive currently participates such that Executives opportunity to earn
incentive compensation is impaired, (E) a material reduction in the aggregate value of
Company perquisites made available to Executive, (F) an elimination or material impairment
of Executives ability to participate in retirement plans comparable to those in which
Executive currently participates, (G) any substantial increase in Executives obligation to
travel on the Companys business over Executives present business travel obligations, or
(H) an elimination or material impairment of Executives ability to receive stock options
with values comparable to those Executive was granted within the one year period preceding
the commencement of the Period of Employment; (ii) the failure of the Company to comply
with any other of its obligations
3
under Section 4 herein; (iii) the relocation of the offices of the Company at which
Executive was employed immediately prior to the Change in Control to a location which is
more than fifty (50) miles from such prior location, or the failure of the Company to (A)
pay or reimburse Executive, in accordance with the Companys relocation policy for its
employees in existence immediately prior to a Change in Control, for all reasonable costs
and expenses; plus gross ups referred to in such policy incurred by Executive relating to
a change of Executives principal residence in connection with any relocation of the
Companys offices to which Executive consents, and (B) indemnify Executive against any loss
(defined as the difference between the actual sale price of such residence and the higher of
(1) Executives aggregate investment in such residence or (2) the fair market value of such
residence as determined by the relocation management organization used by the Company
immediately prior to the Change in Control (or other real estate appraiser designated by
Executive and reasonably satisfactory to the Company)) realized in the sale of Executives
principal residence in connection with any such change of residence; (iv) the failure of
the Company to obtain the assumption of and the agreement to perform this Agreement by any
successor as contemplated in Section 11 hereof; or (v) any purported termination of
Executives employment during the Period of Employment which is not effected pursuant to a
Notice of Termination satisfying the requirements of Section 7 hereof.
Incapacity Discharge means Executives termination of employment with the Company if,
as a result of Executives incapacity due to physical or mental illness, Executive shall
have been absent from Executives duties with the Company on a full-time basis for
one-hundred twenty (120) consecutive business days, and within thirty (30) days after a
written Notice of Termination is given, Executive shall not have returned to the full-time
performance of Executives duties.
Mandatory Retirement Date shall mean the compulsory retirement date, if any,
established by the Company for those executives of the Company who, by reason of their
positions and the size of their nonforfeitable annual retirement benefits under the
Companys pension, profit-sharing, and deferred compensation plans, are exempt from, the
provisions of the Age Discrimination in Employment Act, 29 U.S.C. Sections 621, et seq.,
which date shall not in any event be earlier for any executive than the last day of the
month in which such Executive reaches age 65.
Notice of Termination is as defined in Section 7 below.
Payment Period shall mean eighteen (18) months, provided that the Payment Period
shall not exceed the number of whole calendar months between the Executives Date of
Termination and Mandatory Retirement Date (if applicable).
4.
Compensation During Period of Employment
. For so long during Executives Period of
Employment as Executive is an employee of the Company, the Company shall be obligated to compensate
Executive as follows:
(a) Executive shall continue to receive Executives full base salary at the rate in
effect immediately prior to the Change in Control. Executives base salary shall be
increased annually, with each such increase due on the anniversary date of Executives most
recent previous increase. Each such increase shall be no less than an amount which
4
at least equals on a percentage basis the mean of the annualized percentage increases
in base salary for all elected officers of the Company during the two full calendar years
immediately preceding the Change in Control.
(b) Executive shall continue to participate in all benefit and compensation plans
(including but not limited to the Equity Compensation Plan, Long-Term Incentive Program,
Performance Share Deferred Compensation Plan, Annual Performance Plan, Executive Life
Insurance Program, Deferred Compensation Plan, 401(K) plan, savings plan, flexible benefits
plan, life insurance plan, health and accident plan or disability plan) in which Executive
was participating immediately prior to the Change in Control, or in plans providing
substantially similar benefits, in either case upon terms and conditions and at levels at
least as favorable as those provided to Executive under the plans in which Executive was
participating immediately prior to the Change in Control;
(c) Executive shall continue to receive all fringe benefits, perquisites, and similar
arrangements which Executive was entitled to receive immediately prior to the Change in
Control; and
(d) Executive shall continue to receive annually the number of paid vacation days and
holidays Executive was entitled to receive immediately prior to the Change in Control.
5.
Compensation Upon Termination of Employment
. The following provisions set forth
the benefits that may become payable to Executive upon termination of employment with the Company
during the Period of Employment in accordance with, and subject to, the provisions of Section 6
below:
(a) By not later than the fifth business day following the Date of Termination, the
Company shall pay Executive in a lump sum an amount equal to the sum of the following:
(i) any base salary that is earned but unpaid as of the Date of Termination;
(ii) a pro rata portion of the target incentive amount under the Annual
Performance Plan for the calendar year in which the Date of Termination occurs
(based on the number of calendar days in such calendar year completed through the
Date of Termination); and
(iii) a pro rata portion of the calculated market value of the phantom
Performance Shares, if any, awarded to Executive under the Companys Long-Term
Incentive Program (the LTIP) for each Plan Cycle under the LTIP that has not been
completed as of the Date of Termination, determined as follows:
(A) The performance for each such Plan Cycle under the applicable LTIP
award agreement shall be determined based on (x) for any completed calendar
year of the Plan Cycle as of the Date of Termination, actual performance for
the calendar year, (y) for the calendar year in which the Date of
Termination occurs if at least one calendar quarter has been completed
during such calendar year, the greater of target
5
performance for the calendar year or actual performance for the
completed calendar quarter(s) for the calendar year annualized for the year,
and (z) for any other calendar years of the Plan Cycle, target performance
for the calendar year.
(B) The number of phantom Performance Shares for each such Plan Cycle
shall be adjusted in accordance with the formula set forth in the applicable
LTIP award agreement based on the performance for the Plan Cycle determined
under paragraph (A) above.
(C) The pro rata portion of the calculated market value of the
number of phantom Performance Shares adjusted in accordance with paragraph
(B) above shall be based on the number of calendar days in the Plan Cycle
completed through the Date of Termination.
Section 5(c) below sets for the method for determining the target incentive amount under
the Annual Performance Plan and the calculated market value of phantom Performance Shares
under the LTIP. Any amounts payable under Sections 5(a)(ii) or (iii) above shall be offset
dollar-for-dollar by any pro rata payments otherwise provided for under the Annual
Performance Plan or the LTIP.
(b) In lieu of any salary payments that Executive would have received if he had
continued in the employment of the Company during the Payment Period, the Company shall pay
to Executive in a lump sum, by not later than the fifth business day following the Date of
Termination, an amount equal to one-twelfth of Executives annualized base salary in effect
immediately prior to the Date of Termination, multiplied by the number of months in the
Payment Period.
(c) By not later than the fifth day following the Date of Termination, the Company
shall pay Executive in a lump sum an amount equal to the sum of:
(i) under the Annual Performance Plan (and in lieu of any further awards under
the Annual Performance Plan that Executive would have received if he had continued
in the employment of the Company during the Payment Period), the number of months in
the Payment Period multiplied by the greatest of one-twelfth of: (A) the amount most
recently paid to Executive for a full calendar year; (B) Executives target
incentive amount for the calendar year in which his Date of Termination occurs; or
(C) Executives target incentive amount in effect prior to the Change in Control
for the calendar year in which the Change in Control occurs; plus, if applicable,
(ii) under the LTIP (and in lieu of any further grants under the LTIP that
Executive would have received if he had continued in the employment of the Company
during the Payment Period), twelve (12) multiplied by the greatest of: (A) with
respect to the most recently completed Plan Cycle as of the Date of Termination,
one-twelfth of the calculated market value of the Performance Shares actually
awarded Executive (including the value of any Performance Shares Executive may have
elected to defer under the Performance Share Deferred Compensation Program); (B)
with respect to the most recently
6
commenced Plan Cycle under the LTIP (if Executive is a participant in such Plan
Cycle) prior to Executives Date of Termination, one-twelfth of the calculated
market value of the phantom Performance Shares, if any, awarded to Executive; or
(C) with respect to the most recently commenced Plan Cycle prior to the date of the
occurrence of the Change in Control, one-twelfth of the calculated market value of
the phantom Performance Shares, if any, awarded to Executive.
For purposes of this Section 5, Executives target incentive amount under the
Annual Performance Plan for a given calendar year (i.e., the calendar year in which
the Date of Termination occurs or the Change in Control occurs, as applicable) is
determined by multiplying (i) Executives annualized total gross base salary for the
calendar year by (ii) the incentive target percentage which is applicable to
Executives incentive category under the Annual Performance Plan for the calendar
year. For purposes of this Section 5, the calculated market value of each
Performance Share actually awarded upon completion of a Plan Cycle, Performance
Share deferred under the Performance Share Deferred Compensation Program or phantom
Performance Share granted under the LTIP shall be the mean of the high and low
prices of the Companys common stock on the relevant date as reported on the New
York Stock Exchange Composite Transactions listing (or similar report), or, if no
sale was made on such date, then on the next preceding day on which a sale was made
multiplied by the number of shares involved in the calculation. The relevant date
for Section 5(a)(iii) and clauses 5(c)(ii)(B) and 5(c)(ii)(C) is the date upon which
the Compensation Committee (Committee) of the Board of Directors awarded the
phantom Performance Shares in question; for clause 5(c)(ii)(A) the relevant date is
the date on which the Committee made a determination of attainment of financial
objectives and awarded Performance Shares (including any Performance Shares
Executive may have elected to defer under the Performance Share Deferred
Compensation Program).
Any payments received pursuant to Sections 5(c)(i) or (ii) above shall be in
addition to, and not in lieu of, any payments required to be made to Executive as
the result of the happening of an event that would constitute a change in control
pursuant to the provisions of the Annual Performance Plan or LTIP, as applicable.
(d) By not later than the fifth day following the Date of Termination, the Company
shall pay Executive in a lump sum an amount equal to the sum of:
(i) If Executive is under age 55, or over the age of 55 but not eligible to
retire, at the Date of Termination the present value of all health and welfare
benefits the Executive would have been entitled to had the Executive continued as an
employee of the Company during the Payment Period and been entitled to or
participated in the same health and welfare benefits during the Payment Period as
immediately prior to the Date of Termination plus an amount in cash equal to the
amount necessary to cause the amount of the aggregate after-tax lump sum payment the
Executive receives pursuant to this provision to be equal to the aggregate after-tax
value of the benefits which Executive would have received if Executive continued to
receive such benefits as an employee; or
7
(ii) If Executive is age 55 or over and eligible to retire on the Date of
Termination, the present value of the health and welfare benefits to which Executive
would have been entitled under the Companys general retirement policies if
Executive retired on the Date of Termination with the Company paying that percentage
of the premium cost of the plans which it would have paid under the terms of the
plans in effect immediately prior to the Change of Control with respect to
individuals who retire at age 65, regardless of Executives actual age on the
Termination Date, provided such lump sum value would be at least equal to the lump
sum value of the benefits which would have been payable if Executive had been
eligible to retire and had retired immediately prior to the Change in Control.
(e) By not later than the fifth day following the Date of Termination, the Company
shall pay Executive in a lump sum an amount equal to the sum of the present value of the
fringe benefit programs, perquisites (if any), and similar arrangements the Executive would
have been entitled to receive had the Executive continued in employment with the Company for
the Payment Period and been entitled to or participated in the same such benefits during the
Payment Period as immediately prior to the Date of Termination. In addition and
notwithstanding any provision of the Companys 2002 Equity Compensation Plan (or any
comparable equity award plan of the Company) or any applicable award agreement thereunder to
the contrary, Executive may exercise any of Executives stock options that are vested as of
Executives Date of Termination at any time during the Payment Period (but not exceeding the
original expiration date of the options).
(f) The Company shall, in addition to the benefits to which Executive is entitled under
the retirement plans or programs sponsored by the Company or its affiliates in which
Executive participates (including without limitation any Supplemental Executive Retirement
Plan in which Executive participates, if applicable), pay Executive in a lump sum in cash by
no later than the fifth day following the Date of Termination an amount equal to the
actuarial equivalent of the retirement pension to which Executive would have been entitled
under the terms of such retirement plans or programs had Executive accumulated additional
years of continuous service under such plans equal in length to Executives Payment Period.
The length of the Payment Period will be added to total years of continuous service for
determining vesting, the amount of benefit accrual, to the age which Executive will be
considered to be for the purposes of determining eligibility for normal or early retirement
calculations and the age used for determining the amount of any actuarial reduction. For the
purposes of calculating the additional benefit accrual under this paragraph, the amount of
compensation Executive will be deemed to have received during each month of Executives
Payment Period shall be equal to the sum of Executives annual base salary prorated on a
monthly basis as provided for under Section 4(a) immediately prior to the Date of
Termination (including salary increases), plus under the Companys Annual Performance Plan
the greatest of one-twelfth of:
(i) the amount most recently paid to Executive for a full calendar year,
(ii) Executives target incentive amount for the calendar year in which
Executives Date of Termination occurs, or
8
(iii) Executives target incentive amount in effect prior to the Change in
Control for the calendar year in which the Change in Control occurs. Attached as
Exhibit 1 is an illustration, not intending to be exhaustive, of examples of how
inclusion of the Payment Period may affect the calculation of Executives retirement
benefit.
(g) In no event shall any amount payable to Executive described in this Section 5 be
considered compensation or earnings under any pension, savings or other retirement plan of
the Company.
6.
Termination
.
(a)
Termination Without Compensation.
If Executives employment is terminated for any
of the following reasons, Executive shall not be entitled by virtue of this Agreement to any
of the benefits provided in the foregoing Section 5:
(i) If, prior to the commencement of the Period of Employment, Executives
employment with the Company is terminated at any time for any reason, including
without limitation due to (A) Executives death, (B) an Incapacity Discharge, (C) a
termination initiated by the Company with or without Cause or (D) resignation,
retirement or other termination initiated by Executive with or without Good Reason,
subject, however, to the provisions of Section 20 below.
(ii) If Executives employment with the Company is terminated during the
Period of Employment with Cause.
(iii) If Executive resigns, retires or otherwise voluntarily terminates
employment with the Company during the Period of Employment without Good Reason.
(b)
Termination with Compensation.
If Executives employment is terminated for any of
the following reasons, Executive shall be entitled by virtue of this Agreement to the
benefits provided in the foregoing Section 5 as follows:
(i) If, during the Period of Employment, the Company discharges Executive
other than for Cause, Executive shall receive all of the benefits and payments
provided in Section 5.
(ii) Executive may terminate his employment with the Company at any time
during the Period of Employment for Good Reason (Good Reason Termination) and
shall receive all of the benefits and payments provided in Section 5.
(iii) If, during the Period of Employment, Executive either (A) retires from
employment with the Company or (B) if the Company discharges Executive due to an
Incapacity Discharge, in either case while Executive has cause to terminate his
employment as a Good Reason Termination (whether or not Executive has provided
Notice of Termination to the Company pursuant to
9
Section 7), Executive shall receive all of the benefits and payments provided
in Section 5.
(iv) If Executive dies while employed by the Company during the Period of
Employment while having cause to terminate his employment as a Good Reason
Termination (whether or not Executive has provided Notice of Termination to the
Company pursuant to Section 7), Executives beneficiary or beneficiaries named on
Exhibit 2 to this Agreement (or Executives estate if he has not named a
beneficiary) shall be entitled to receive those payments provided under Sections
5(a), 5(b) and 5(c) of this Agreement in addition to any benefits that such
beneficiaries would be entitled under any other plan, program or policy of the
Company as a result of Executives employment with the Company.
(v) Executive may become eligible for the benefits and payments under Section
5 for termination of employment prior to a Change in Control in accordance with, and
subject to, the provisions of Section 20 below.
7.
Notice of Termination.
Any termination of Executives employment by the Company or
any termination by Executive as a Good Reason Termination shall be communicated by written notice
to the other party hereto. For purposes of this Agreement, such notice shall be referred to as a
Notice of Termination. Such notice shall, to the extent applicable, set forth the specific reason
for termination, and shall set forth in reasonable detail the facts and circumstances claimed to
provide a basis for termination of Executives employment under the provision so indicated.
8.
Date of Termination.
Date of Termination shall mean:
(a) If Executive terminates Executives employment as a Good Reason Termination, the
date specified in the Notice of Termination, but in no event more than sixty (60) days after
Notice of Termination is given.
(b) If Executives employment is terminated with Cause, the date on which a Notice of
Termination is given, except that the Date of Termination shall not be any date prior to the
date on which the Cure Period expires without the correction of Executives performance (if
applicable).
(c) If Executives employment pursuant to this Agreement is terminated following
absence due to physical incapacity as an Incapacity Discharge, then the Date of Termination
shall be thirty (30) days after Notice of Termination is given (provided that Executive
shall not have returned to the performance of Executives duties on a full-time basis during
such thirty (30) day period).
(d) A termination of employment by either the Company or by Executive shall not affect
any rights Executive or Executives surviving spouse or beneficiaries may have pursuant to
any other agreement or plan of the Company providing benefits to Executive, except as
provided in such agreement or plan.
10
9.
Certain Additional Payments
.
(a) Anything in this Agreement to the contrary notwithstanding, in the event it shall
be determined that any payment or distribution by the Company to Executive or for
Executives benefit (whether paid or payable or distributed or distributable pursuant to the
terms of this Agreement or otherwise, but determined without regard to any additional
payments required under this Section 9) (a Payment) would be subject to the excise tax
imposed by Section 4999 (or any successor provisions) of the Internal Revenue Code of 1986,
as amended (the Code), or any interest or penalty is incurred by Executive with respect to
such excise tax (such excise tax, together with any such interest and penalties, is
hereinafter collectively referred to as the Excise Tax), then Executive shall be entitled
to receive an additional payment (a Gross-Up Payment) in an amount such that after payment
by Executive of all taxes (including any interest or penalties imposed with respect to such
taxes), including, without limitation, any income taxes (and any interest and penalties
imposed with respect thereto) and Excise Tax imposed on the Gross-Up Payment, Executive
retains an amount of the Gross-Up Payment equal to the Excise Tax imposed upon the Payments.
(b) Subject to the provisions of Section 9(c), all determinations required to be made
under this Section 9, including whether and when such a Gross-Up Payment is required and the
amount of such Gross-Up Payment and the assumptions to be utilized in arriving at such
determination, shall be made by Ernst & Young (or their successors) (the Accounting Firm)
which shall provide detailed supporting calculations both to the Company and to Executive
within fifteen (15) business days of the receipt of notice from Executive that there has
been a Payment, or such earlier time as is requested by the Company. In the event that the
Accounting Firm is serving as accountant or auditor for the individual, entity or group
effecting the Change in Control, Executive shall appoint another nationally recognized
accounting firm to make the determinations required hereunder (which accounting firm shall
then be referred to as the Accounting Firm hereunder). All fees and expenses of the
Accounting Firm shall be borne solely by the Company. Any Gross-Up Payment as determined
pursuant to this Section 9, shall be paid by the Company to Executive within five (5) days
of the receipt of the Accounting Firms determination. If the Accounting Firm determines
that no Excise Tax is payable by Executive, it shall furnish Executive with a written
opinion that failure to report the Excise Tax on Executives applicable federal income tax
return would not result in the imposition of a negligence or similar penalty. Any
determination by the Accounting Firm shall be binding upon the Company and Executive. As a
result of the uncertainty of the application of Section 4999 of the Code at the time of the
initial determination by the Accounting Firm hereunder, it is possible that Gross-Up
Payments which will not have been made by the Company should have been made
(Underpayment). In the event that the Company exhausts its remedies pursuant to Section
9(c) and Executive thereafter is required to make a payment of any Excise Tax, the
Accounting Firm shall determine the amount of the Underpayment that has occurred and any
such Underpayment shall be promptly paid by the Company to Executive or for Executives
benefit.
(c) Executive shall notify the Company in writing of any claim by the Internal Revenue
Service that, if successful, would require the payment by the Company of the Gross-Up
Payment. Such notification shall be given as soon as practicable but no later than ten (10)
business days after Executive or his representative is informed in writing of
11
such claim and shall apprise the Company of the nature of such claim and the date on
which such claim is requested to be paid. Executive shall not pay such claim prior to the
expiration of the thirty (30) day period following the date on which Executive gives such
notice to the Company (or such shorter period ending on the date that any payment of taxes
with respect to such claim is due). If the Company notifies Executive in writing prior to
the expiration of such period that it desires to contest such claim, Executive shall:
(i) give the Company any information reasonably requested by the Company
relating to such claim,
(ii) take such action in connection with contesting such claim as the Company
shall reasonably request in writing from time to time, including, without
limitation, accepting legal representation with respect to such claim by an attorney
reasonably selected by the Company,
(iii) cooperate with the Company in good faith in order effectively to contest
such claim, and
(iv) permit the Company to participate in any proceedings relating to such
claim; however, that the Company shall bear and pay directly all costs and expenses
(including additional interest and penalties) incurred in connection with such
contest and shall indemnify and hold Executive harmless, on an after-tax basis, for
any Excise Tax or income tax (including interest and penalties with respect thereto)
imposed as a result of such representation and payment of costs and expenses.
Without limitation on the foregoing provisions of this Section 9(c), the Company
shall control all proceedings taken in connection with such contest and, at its sole
option, may pursue or forego any and all administrative appeals, proceedings,
hearings and conferences with the taxing authority in respect of any such claim and
may, at its sole option, either direct Executive to pay the tax claimed and sue for
a refund or contest the claim in any permissible manner, and Executive agree to
prosecute such contest to a determination before any administrative tribunal, in a
court of initial jurisdiction and in one or more appellate courts, as the Company
shall determine; provided, however, that if the Company directs Executive to pay
such claim and sue for a refund, the Company shall advance the amount of such
payment to Executive, on an interest-free basis and shall indemnify and hold
Executive harmless, on an after-tax basis, from any Excise Tax or income tax
(including interest or penalties with respect thereto) imposed with respect to such
advance or with respect to any imputed income with respect to such advance; and
further provided that any extension of the statute of limitations relating to
payment of taxes for Executives taxable year with respect to which such contested
amount is claimed to be due is limited solely to such contested amount. Furthermore,
the Companys control of the contest shall be limited to issues with respect to
which a Gross-Up Payment would be payable hereunder and Executive shall be entitled
to settle or contest, as the case may be, any other issue raised by the Internal
Revenue Service or any other taxing authority.
(d) If, after the receipt by Executive of an amount advanced by the Company pursuant to
Section 9(c), Executive become entitled to receive any refund with respect to
12
such claim, Executive shall (subject to the Companys complying with the requirements
of Section 9(c)) promptly pay to the Company the amount of such refund (together with any
interest paid or credited thereon after taxes applicable thereto). If, after the receipt by
Executive of an amount advanced by the Company pursuant to Section 9(c), a determination is
made that Executive shall not be entitled to any refund with respect to such claim and the
Company does not notify Executive in writing of its intent to contest such denial of refund
prior to the expiration of thirty (30) days after such determination, then such advance
shall be forgiven and shall not be required to be repaid and the amount of such advance
shall offset, to the extent thereof, the amount of Gross-Up Payment required to be paid.
(e) Notwithstanding the provisions of this Section 9 to the contrary, in no event shall
any payments made to Executive under this Section 9 be made later than the end of the
calendar year following the calendar year in which Executive remits the Excise Tax.
10.
No Obligation to Mitigate Damages, No Effect on Other Contractual Rights.
Executive
shall not be required to refund the amount of any payment or employee benefit provided for or
otherwise mitigate damages under this Agreement by seeking or accepting other employment or
otherwise, nor shall the amount of any payment required to be made under this Agreement be reduced
by any compensation earned by Executive as the result of any employment by another employer after
the date of termination of Executives employment with the Company, or otherwise. Upon receipt of
written notice from Executive that Executive has been reemployed by another company or entity on a
full-time basis, benefits, fringe benefits and perquisites otherwise receivable by Executive
pursuant to Sections 5(d) or 5(e) related to life, health, disability and accident insurance plans
and programs and other similar benefits, company cars, financial planning, country club
memberships, and the like (but not incentive compensation, LTIP, pension plans or other similar
plans and programs) shall be reduced to the extent comparable benefits are made available to
Executive at his new employment and any such benefits actually received by Executive shall be
reported to the Company by Executive.
The provisions of the Agreement, and any payment or benefit provided for hereunder shall not
reduce any amount otherwise payable, or in any way diminish Executives existing rights, or rights
which would occur solely as a result of the passage of time, under any other agreement, contract,
plan or arrangement with the Company.
11.
Successors and Binding Agreement.
(a) The Company shall require any successor (whether direct or indirect, by purchase,
merger, consolidation or otherwise) to all or substantially all of the business or assets of
the Company, by agreement in form and substance satisfactory to Executive, to assume and
agree to perform this Agreement.
(b) This Agreement shall be binding upon the Company and any successor of or to the
Company, including, without limitation, any person acquiring directly or indirectly all or
substantially all of the assets of the Company whether by merger, consolidation, sale or
otherwise (and such successor shall thereafter be deemed the Company for the purposes of
this Agreement), but shall not otherwise be assignable by the Company.
13
(c) This Agreement shall inure to the benefit of and be enforceable by Executive and
Executives personal or legal representatives, executors, administrators, successors, heirs,
distributees, devisees and legatees. If Executive should die while any amounts would still
be payable to Executive pursuant to Sections 5 and 6 hereunder if Executive had continued to
live, all such amounts, unless otherwise provided herein, shall be paid in accordance with
the terms of this Agreement to Executives devisee, legatee, or other designee or, if there
be no such designee, to Executives estate.
12.
Notices
. For the purposes of this Agreement, notices and all other communications
provided for in the Agreement shall be in writing and shall be deemed to have been duly given when
delivered or mailed by United States registered mail, return receipt requested, postage prepaid,
addressed to the respective addresses set forth on the first page of this Agreement, provided that
all notices to the Company shall be directed to the attention of the Chief Executive Officer of the
Company with a copy to the Secretary of the Company, or to such other address as either party may
have furnished to the other in writing, except that notices of change of address shall be effective
only upon receipt.
13.
Governing Law.
The validity, interpretation, construction and performance of this
Agreement shall be governed by the laws of the State of North Carolina, without giving effect to
the principles of conflict of laws of such State.
14.
Miscellaneous.
No provisions of this Agreement may be modified, waived or
discharged, and this Agreement may not be terminated before the end of the Term, unless such
waiver, modification, discharge or termination is agreed to in a writing signed by Executive and
the Company. No waiver by either party hereto at any time of any breach by the other party hereto
or compliance with, any condition or provision of this Agreement to be performed by such other
party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at
any prior or subsequent time. No agreements or representations, oral or otherwise, express or
implied, with respect to the subject matter hereof, have been made by either party which is not set
forth expressly in this Agreement.
15.
Validity.
The invalidity or unenforceability of any provisions of this Agreement
shall not affect the validity or enforceability of any other provision of this Agreement, which
shall remain in full force and effect.
16.
Counterparts.
This Agreement may be executed in one or more counterparts, each of
which shall be deemed to be an original, but all of which together will constitute one and the same
agreement.
17.
Withholding of Taxes.
The Company may withhold from any amounts payable under
this Agreement all federal, state, city or other taxes as shall be required pursuant to any law or
government regulation or ruling.
18.
Nonassignability.
This Agreement is personal in nature and neither of the parties
hereto shall, without the consent of the other, assign or transfer this Agreement or any rights or
obligations hereunder, except as provided in Section 11 above. Without limiting the foregoing,
Executives right to receive payments hereunder shall not be assignable or transferable, whether by
pledge, creation of a security interest or otherwise, other than by a transfer by Executives will
14
or by the laws of descent and distribution and in the event of any attempted assignment or
transfer contrary to this Section 18 the Company shall have no liability to pay any amounts so
attempted to be assigned or transferred.
19.
Legal Fees and Expenses.
If a Change in Control shall have occurred, thereafter
the Company shall pay and be solely responsible for any and all attorneys and related fees and
expenses incurred by Executive to successfully (in whole or in part and whether by modification of
the Companys position, agreement, compromise, settlement, or administrative or judicial
determination) enforce this Agreement or any provision hereof or as a result of the Company or any
Shareholder of the Company contesting the validity or enforceability of this Agreement or any
provision hereof. To secure the foregoing obligation, the Company shall, within 90 days after being
requested by Executive to do so, enter into a contract with an insurance company, open a letter of
credit or establish an escrow in a form satisfactory to Executive. Notwithstanding the provisions
of this Section 19 to the contrary, in no event shall any payments made to Executive under this
Section 19 be made for expenses incurred by Executive following the end of the second calendar year
following the calendar year in which Executives Date of Termination occurs, provided that the
period during which reimbursement for such expenses may be made may extend to the end of the third
calendar year in which Executives Date of Termination occurs.
20.
Employment Rights
. Nothing expressed or implied in this Agreement shall create
any right or duty on Executives part or on the part of the Company to have Executive remain in the
employment of the Company prior to the commencement of the Period of Employment; provided, however,
that any termination or purported termination of Executives employment by the Company without
Cause, or termination of Executives employment by Executive under circumstances that would
constitute Good Reason had a Change in Control occurred, in either case following the commencement
of any discussion with a third party, or the announcement by a third party of the commencement of,
or the intention to commence a tender offer, or other intention to acquire all or a portion of the
equity securities of the Company that ultimately results in a Change in Control shall be deemed to
be a termination of Executives employment after a Change in Control for purposes of (i) this
Agreement and both the Period of Employment and the Payment Period shall be deemed to have begun on
the day prior to such termination and (ii) the Companys Equity Compensation Plan as if the Change
in Control had occurred on the day prior to such termination (resulting in the full vesting and
extended exercisability of the Executives outstanding stock options under, and in accordance with,
the provisions of the Equity Compensation Plan).
21.
Right of Setoff.
There shall be no right of setoff or counterclaim against, or
delay in, any payment by the Company to Executive or Executives designated beneficiary or
beneficiaries provided for in this Agreement in respect of any claim against Executive or any debt
or obligation owed by Executive, whether arising hereunder or otherwise.
22.
Rights to Other Benefits.
The existence of the Agreement and Executives rights
hereunder shall be in addition to, and not in lieu of, Executives rights under any other of the
Companys compensation and benefit plans and programs, and under any other contract or agreement
between Executive and the Company.
23.
Prior Agreements.
This Agreement supersedes and replaces any and all prior
agreements and understandings between the Company and the Executive with respect to the
15
subject matter hereof. Any such prior agreements and understandings are no longer in force or
effect.
24.
Compliance with Section 409A of the Internal Revenue Code
.
Any payments under
this Agreement that are deemed to be deferred compensation subject to the requirements of Section
409A (Section 409A) of the Internal Revenue Code of 1986, as amended, are intended to comply with
the requirements of Section 409A. To this end and notwithstanding any other provision of this
Agreement to the contrary, if at the time of Executives termination of employment with the
Company, (i) the Companys securities are publicly traded on an established securities market; (ii)
Executive is a specified employee (as defined in Section 409A); and (iii) the deferral of the
commencement of any payments or benefits otherwise payable pursuant to this Agreement as a result
of such termination of employment is necessary in order to prevent any accelerated or additional
tax under Section 409A, then the Company will defer the commencement of such payments (without any
reduction in amount ultimately paid or provided to Executive) that are not paid within the
short-term deferral rule under Section 409A (and any regulations thereunder) or within the
involuntary separation exemption of Treasury Regulation § 1.409A-1(b)(9)(iii). Such deferral
shall last until the date that is six (6) months following Executives termination of employment
with the Company (or the earliest date as is permitted under Section 409A). Any amounts the
payment of which are so deferred shall be paid in a lump sum payment within ten (10) days after the
end of such deferral period. If Executive dies during the deferral period prior to the payment of
any deferred amount, then the unpaid deferred amount shall be paid to the personal representative
of Executives estate within sixty (60) days after the date of Executives death. For purposes of
Section 409A, the right to a series of installment payments under this Agreement shall be treated
as a right to a series of separate payments.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective Date.
|
|
|
|
|
|
ENPRO INDUSTRIES, INC.
|
|
|
By:
|
/s/ Stephen E. Macadam
|
|
|
|
Name:
|
Stephen E. Macadam
|
|
|
|
Title:
|
President and Chief Executive Officer
|
|
|
|
|
|
|
|
/s/ Orville G. Lunking
|
|
|
|
Orville G. Lunking
|
|
|
|
|
|
16
EXHIBIT 1
A. If as of Executives Date of Termination Executives years of continuous service under the
applicable retirement plans for purposes of determining eligibility for normal or early retirement
plus the length of Executives Payment Period is at least 5, then
1. If as of Executives Date of Termination Executives age plus the length of
Executives Payment Period is at least 65, Executives retirement benefit under Section 5(f)
will be calculated as a normal retirement benefit to which Executive would have been
entitled under the terms of the retirement plan in which Executive participates had
Executive accumulated benefit service under the retirement plan that included the Payment
Period; and
2. If as of Executives Date of Termination Executives age plus the length of
Executives Payment Period is at least 55 but less than 65, Executives retirement benefit
under Section 5(f) will be calculated as an early retirement benefit to which Executive
would have been entitled under the terms of the retirement plan in which Executive
participates had Executive accumulated benefit service under the retirement plan that
included the Payment Period. The actuarial reduction used shall be the actuarial reduction
factor for early retirement, calculated to Executives actual age plus the length of
Executives Payment Period, at Executives Date of Termination.
B. If as of Executives Date of Termination the sum of Executives years of continuous service
under the applicable retirement plans for purposes of determining eligibility for normal or early
retirement plus the length of Executives Payment Period is less than 5, or Executives age plus
the length of Executives Payment Period is less than 55, Executives retirement benefit under
Section 5(f) will be calculated as a deferred vested pension to which Executive would have been
entitled under the terms of the retirement plans in which Executive participates had Executive
accumulated benefit service under the retirement plan that included the Payment Period. The
actuarial reduction used shall be the actuarial reduction factor for a deferred vested pension,
calculated to Executives actual age at Executives Date of Termination plus the length of
Executives Payment Period.
C. For purposes of Section 5(f), actuarial equivalent shall be determined using the same
methods and assumptions as those utilized under the Companys retirement plans and programs
immediately prior to the Change in Control.
EXHIBIT 2
BENEFICIARY DESIGNATION
I hereby designate the following person(s) as a beneficiary for the purposes of Section
6(b)(iv) to the extent of the percentage interest listed next to their name:
|
|
|
NAME
|
|
PERCENTAGE INTEREST
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TOTAL (CANNOT EXCEED 100%)
|
|
|
|
|
|